[{"title01":"Combined treatment with amlexanox and cytarabine induces apoptosis via the S100A6-Akt pathway in KMT2A::AFF1-positive acute lymphoblastic leukemia","title02":"Combined treatment with amlexanox and cytarabine induces apoptosis via the S100A6-Akt pathway in KMT2A::AFF1<\/i>-positive acute lymphoblastic leukemia","journal":"Leukemia","issue":"2025 Oct 6. doi: 10.1038\/s41375-025-02782-5. Online ahead of print.","author":"Tamai H, Miyake K, Miyake N, Asano J, Ohashi A, Arai A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41053511"},{"title01":"Base edited “universal” donor CAR T-cell strategies for acute myeloid leukaemia","title02":"Base edited “universal” donor CAR T-cell strategies for acute myeloid leukaemia","journal":"Leukemia","issue":"2025 Oct 1. doi: 10.1038\/s41375-025-02720-5. Online ahead of print.","author":"Kadirkamanathan R, Georgiadis C, Kloos A, Joshi A, Etuk A, Preece R, Gough O, Schambach A, Sauer M, Heuser M, Qasim W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41034424"},{"title01":"Ziftomenib in Relapsed or Refractory NPM1-Mutated AML","title02":"Ziftomenib in Relapsed or Refractory NPM1<\/i>-Mutated AML","journal":"J Clin Oncol","issue":"2025 Sep 25:JCO2501694. doi: 10.1200\/JCO-25-01694. Online ahead of print.","author":"Wang ES, Montesinos P, Foran J, Erba H, Rodr\u00edguez-Arbol\u00ed E, Fedorov K, Heiblig M, Heidel FH, Altman JK, Baer MR, Ades L, Pettit K, Peterlin P, Papayannidis C, Berthon C, Walter RB, Shah MV, Balasubramanian S, Khawandanah M, Salamero Garcia O, Bergeron J, Madanat YF, Roboz GJ, Ulrickson M, Redner RL, McCloskey J, Pigneux A, de la Fuente Burguera A, Mitra A, Soifer HS, Tabachri M, Zhang Z, Riches M, Corum D, Leoni M, Issa GC, Fathi AT; KOMET-001.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40997296"},{"title01":"Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes","title02":"Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes","journal":"Br J Haematol","issue":"2025 Sep 29. doi: 10.1111\/bjh.70179. Online ahead of print.","author":"Ali SA, Hicks SM, Coupland LA, Brysland SA, Bhoopalan V, Thong YL, Kaur A, Andrews RK, Gardiner EE, Choi PY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41017483"},{"title01":"Reed-Sternberg-like cells in central nervous system relapse of diffuse large B-cell lymphoma","title02":"Reed-Sternberg-like cells in central nervous system relapse of diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2025 Oct 2. doi: 10.1111\/bjh.70174. Online ahead of print.","author":"Chiriac R, Baseggio L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41039717"},{"title01":"Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma lines","title02":"Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma lines","journal":"Br J Haematol","issue":"2025 Oct 5. doi: 10.1111\/bjh.70188. Online ahead of print.","author":"Hu X, Li L, Nkwocha J, Vasiyani H, Kazi A, Sebti S, Grant S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41047494"},{"title01":"The BH3-only protein NOXA is essential for apoptosis induction by BH3-mimetics targeting BCL2 or BCL-X(L) in DLBCL","title02":"The BH3-only protein NOXA is essential for apoptosis induction by BH3-mimetics targeting BCL2 or BCL-X(L) in DLBCL","journal":"Br J Haematol","issue":"2025 Oct 5. doi: 10.1111\/bjh.70192. Online ahead of print.","author":"Yildirim N, Anders M, Smith VM, Jayne S, Assmann M, Jukes-Jones R, Dyer MJS, Vogler M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41047548"},{"title01":"Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma","title02":"Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2025 Oct 7. doi: 10.1111\/bjh.70185. Online ahead of print.","author":"Munz N, Arribas AJ, Bordone Pittau R, Simonetta F, Stussi G, Bertoni F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41057281"},{"title01":"Transformation and causes of death in follicular lymphoma: A Finnish nationwide population-based study","title02":"Transformation and causes of death in follicular lymphoma: A Finnish nationwide population-based study","journal":"Br J Haematol","issue":"2025 Sep 25. doi: 10.1111\/bjh.70181. Online ahead of print.","author":"Kalashnikov I, Reunamo T, Tanskanen T, Viisanen L, Malila N, Jyrkki\u00f6 S, Lepp\u00e4 S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40999643"},{"title01":"Targeting small ubiquitin-related modifier-specific protease 2 attenuates tumour progression and orchestrates the tumour immune microenvironment in diffuse large B-cell lymphoma","title02":"Targeting small ubiquitin-related modifier-specific protease 2 attenuates tumour progression and orchestrates the tumour immune microenvironment in diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2025 Oct 1. doi: 10.1111\/bjh.70187. Online ahead of print.","author":"Sheng X, Wang D, Li S, Li B, Luan M, Han X, Zhou Q, Zhao Z, Ji C, Lu F, Ye J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41033663"},{"title01":"Prognostic significance of pretransplant (18)F-FDG PET\/CT metrics in relapsed\/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation","title02":"Prognostic significance of pretransplant (18)F-FDG PET\/CT metrics in relapsed\/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation","journal":"Br J Haematol","issue":"2025 Oct 1. doi: 10.1111\/bjh.70186. Online ahead of print.","author":"Suh M, Hyung J, Park CS, Go H, Song IH, Chae EJ, Kim KW, Lee YS, Kwon M, Lee SW, Lee J, Kim S, Lee K, Cho H, Ryu JS, Yoon DH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41035136"},{"title01":"Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis","title02":"Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis","journal":"Leukemia","issue":"2025 Sep 28. doi: 10.1038\/s41375-025-02776-3. Online ahead of print.","author":"Zanwar S, Belge Bilgin G, Broski SM, Thorpe M, Bilgin C, Gonsalves W, Kapoor P, Kourelis T, Hayman S, Abdallah N, Binder M, Cook J, Dispenzieri A, Dingli D, Gertz MA, Leung N, Lin Y, Muchtar E, Warsame R, Kyle RA, Rajkumar SV, Kumar S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41016943"},{"title01":"More is not always more for older patients with multiple myeloma","title02":"More is not always more for older patients with multiple myeloma","journal":"Lancet Oncol","issue":"2025 Oct;26(10):1263-1265.","author":"Shain KH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41038179"},{"title01":"Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial","title02":"Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial","journal":"Lancet Oncol","issue":"2025 Oct;26(10):1323-1333.","author":"Manier S, Lambert J, Hulin C, Macro M, Laribi K, Araujo C, Pica GM, Touzeau C, Godmer P, Slama B, Karlin L, Orsini Piocelle F, Dib M, Sanhes L, Morel P, El Yamani A, Tiab M, Tabrizi R, Richez V, Garderet L, Royer B, Bareau B, Mariette C, Fleck E, Robu D, Calmettes C, Rigaudeau S, Demarquette H, Frenzel L, Decaux O, Mohty M, Arnulf B, Bigot N, Perrot A, Corre J, Mary JY, Avet-Loiseau H, Moreau P, Leleu X, Facon T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41038184"},{"title01":"GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial","title02":"GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial","journal":"Lancet Haematol","issue":"2025 Oct;12(10):e798-e807.","author":"Jin L, Gu S, Ruan Q, Lu J, Qiang W, He H, Fan X, Liu J, Guo P, Meng X, Rajakumaraswamy N, Chen D, Li Z, Du J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41062204"},{"title01":"Genomics Define Malignant Transformation in Myeloma Precursor Conditions","title02":"Genomics Define Malignant Transformation in Myeloma Precursor Conditions","journal":"J Clin Oncol","issue":"2025 Oct 8:JCO2501733. doi: 10.1200\/JCO-25-01733. Online ahead of print.","author":"Maura F, Bergsagel PL, Ziccheddu B, Kumar S, Maclachlan K, Derkach A, Garces JJ, Firestone R, Braggio E, Asmann Y, Durante M, Diamond BT, Papadimitriou M, Hultcrantz M, Marella A, Castellano G, Maeda A, Lionetti M, Matera A, Pioggia S, Da Vi\u00e0 MC, de Magistris C, Leongamornlert D, DeAvila D, Sudalagunta PR, Canevarolo RR, Siegel EM, Agius P, Teer J, McPherson A, Yamashita Y, Silva AS, Blaney P, Baz R, Patel KK, Campbell P, Morgan G, Fonseca R, Landgren O, Orlowski RZ, Shain KH, Bolli N, Usmani S, Rajkumar SV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41061199"},{"title01":"A disulfidptosis-related gene signature predicts prognosis and immune-metabolic landscape in multiple myeloma","title02":"A disulfidptosis-related gene signature predicts prognosis and immune-metabolic landscape in multiple myeloma","journal":"Br J Haematol","issue":"2025 Oct 6. doi: 10.1111\/bjh.70189. Online ahead of print.","author":"Wang L, Wang J, Wang Y, Niu T, Zhao A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41054252"},{"title01":"Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone","title02":"Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone","journal":"Blood","issue":"2025 Oct 8:blood.2025030113. doi: 10.1182\/blood.2025030113. Online ahead of print.","author":"Bertamini L, Fokkema C, Rodriguez-Otero P, van Duin M, Terpos E, D'Agostino M, van der Velden VHJ, van de Donk NWCJ, Delforge M, Driessen C, Hajek R, Einsele H, Vangsted AJ, Vieyra D, Attar RM, Sitthi-Amorn A, Carson R, Schjesvold F, Robak P, Beksac M, Spencer A, Broijl A, Cupedo T, Moreau P, Boccadoro M, Sonneveld P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41060326"},{"title01":"Losing CD38 in myeloma","title02":"Losing CD38 in myeloma","journal":"Blood","issue":"2025 Sep 25;146(13):1529-1530.","author":"Merz M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40996753"},{"title01":"Case 17-2025: A Man with Respiratory Failure and Shock after Kidney Transplantation","title02":"Case 17-2025: A Man with Respiratory Failure and Shock after Kidney Transplantation","journal":"N Engl J Med","issue":"2025 Oct 9;393(14):1447.","author":"Glazier AK, Delmonico FL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41061246"},{"title01":"Case 17-2025: A Man with Respiratory Failure and Shock after Kidney Transplantation. Reply","title02":"Case 17-2025: A Man with Respiratory Failure and Shock after Kidney Transplantation. Reply","journal":"N Engl J Med","issue":"2025 Oct 9;393(14):1447-1448.","author":"Kotton CN, Safa K, Sanders AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41061247"},{"title01":"Cyclophosphamide and Cyclosporin for GVHD Prevention","title02":"Cyclophosphamide and Cyclosporin for GVHD Prevention","journal":"N Engl J Med","issue":"2025 Oct 2;393(13):1349-1350.","author":"Desai N, Mattsson J, Law AD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41032720"},{"title01":"Cyclophosphamide and Cyclosporin for GVHD Prevention","title02":"Cyclophosphamide and Cyclosporin for GVHD Prevention","journal":"N Engl J Med","issue":"2025 Oct 2;393(13):1350.","author":"Akahoshi Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41032721"},{"title01":"Cyclophosphamide and Cyclosporin for GVHD Prevention. Reply","title02":"Cyclophosphamide and Cyclosporin for GVHD Prevention. Reply","journal":"N Engl J Med","issue":"2025 Oct 2;393(13):1350-1351.","author":"Curtis DJ, Reynolds J, Hill GR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41032722"},{"title01":"Misclassification of TP53 germline variants: implications for survival analysis in AML transplant studies","title02":"Misclassification of TP53 germline variants: implications for survival analysis in AML transplant studies","journal":"Leukemia","issue":"2025 Sep 28. doi: 10.1038\/s41375-025-02772-7. Online ahead of print.","author":"Rodriguez L, Delhommeau F, Soussi T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41016942"},{"title01":"Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory\/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial","title02":"Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory\/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial","journal":"J Clin Oncol","issue":"2025 Oct 2:101200JCO2501957. doi: 10.1200\/JCO-25-01957. Online ahead of print.","author":"Budde LE, Zhang H, Kim WS, Maruyama D, Rego EM, Norasetthada L, Hong H, Ozcan M, Jeon YW, Cordeiro de Farias DL, Fogliatto LM, Pavlovsky A, Goto H, Olszewski AJ, Shah N, Hu B, Yin S, Wu H, To I, Ead WS, Ashby J, Janousek M, Pham S, Wang J, Kwan A, Batlevi CL, Wei MC, Westin J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41037766"},{"title01":"Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation","title02":"Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation","journal":"J Clin Oncol","issue":"2025 Oct 3:JCO2501238. doi: 10.1200\/JCO-25-01238. Online ahead of print.","author":"Ueda Oshima M, Vo PT, Boeckh M, Bouvier ME, Carpenter PA, Mielcarek M, Petersdorf EW, Storb R, Gooley T, Sandmaier BM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41043099"},{"title01":"Looking for the Best Allogeneic Donor and the BMT CTN 1702 Study: Noli Tempus Perdere","title02":"Looking for the Best Allogeneic Donor and the BMT CTN 1702 Study: Noli Tempus Perdere","journal":"J Clin Oncol","issue":"2025 Sep 30:JCO2501884. doi: 10.1200\/JCO-25-01884. Online ahead of print.","author":"Rambaldi A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41026968"},{"title01":"The KLF4-CD46 axis: a novel therapeutic target in transplant-associated thrombotic microangiopathy and beyond","title02":"The KLF4-CD46 axis: a novel therapeutic target in transplant-associated thrombotic microangiopathy and beyond","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.288680. Online ahead of print.","author":"Cugno M, L\u00e4mmle B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063700"},{"title01":"MHC disparity hampers thymus-dependent T-cell recovery post-hematopoietic transplantation through dysregulation of TGF-\u03b21 and LRP6 pathways","title02":"MHC disparity hampers thymus-dependent T-cell recovery post-hematopoietic transplantation through dysregulation of TGF-\u03b21 and LRP6 pathways","journal":"Haematologica","issue":"2025 Sep 25. doi: 10.3324\/haematol.2025.288464. Online ahead of print.","author":"Wu N, Ding W, Wu J, Ling M, Yue K, Cheng C, Jia M, Liu J, Huang XJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40994352"},{"title01":"Equivalent incidences of paediatric graft-versus-host disease regardless of donor-recipient matching in the era of modern prophylaxis agents","title02":"Equivalent incidences of paediatric graft-versus-host disease regardless of donor-recipient matching in the era of modern prophylaxis agents","journal":"Br J Haematol","issue":"2025 Sep 27. doi: 10.1111\/bjh.70184. Online ahead of print.","author":"Ariagno S, Greenmyer J, Kuhn A, Pence L, O'Shea M, Greenmyer L, Cole K, Ferdjallah A, Kohorst M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41014188"},{"title01":"Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party","title02":"Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party","journal":"Br J Haematol","issue":"2025 Sep 30. doi: 10.1111\/bjh.70167. Online ahead of print.","author":"Buchbinder N, Michel V, Dalissier A, Kleinschmidt K, Locatelli F, Maschan A, Wynn R, Fagioli F, Zecca M, Jubert C, Versluys B, Sedlacek P, Zubarovskaya L, Gonzalez Vicent M, Biffi A, Michel G, Mirci-Danicar O, Holter W, Ansari M, Galimard JE, Schneider P, Abouqateb M, Ka\u0142wak K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41027844"},{"title01":"Optimizing activation and culture conditions for the production of\u00a0cord blood-derived CAR-T and natural killer cells","title02":"Optimizing activation and culture conditions for the production of\u00a0cord blood-derived CAR-T and natural killer cells","journal":"Br J Haematol","issue":"2025 Sep 30. doi: 10.1111\/bjh.70139. Online ahead of print.","author":"Nakamura N, Liao J, Soda Y, Takahashi M, Kodera H, Kobari Y, Hirai Y, Takaori-Kondo A, Okada T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41030086"},{"title01":"Prognostic significance of pretransplant (18)F-FDG PET\/CT metrics in relapsed\/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation","title02":"Prognostic significance of pretransplant (18)F-FDG PET\/CT metrics in relapsed\/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation","journal":"Br J Haematol","issue":"2025 Oct 1. doi: 10.1111\/bjh.70186. Online ahead of print.","author":"Suh M, Hyung J, Park CS, Go H, Song IH, Chae EJ, Kim KW, Lee YS, Kwon M, Lee SW, Lee J, Kim S, Lee K, Cho H, Ryu JS, Yoon DH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41035136"},{"title01":"Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation","title02":"Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation","journal":"Blood","issue":"2025 Oct 8:blood.2025028625. doi: 10.1182\/blood.2025028625. Online ahead of print.","author":"Ng B, Harris AC, Abdossamadi S, Aubert G, Bajwa RP, Bhatia M, Bittencourt H, Buxbaum NP, Caywood EH, Chaudhury S, Chewning JH, Choi SW, Chopek A, Chu J, Coulter D, Gadalla SM, Hogg RT, Jacobsohn DA, Johnson AK, Joyce M, Kasow KA, Kent M, Kitko CL, Lau D, Lawitschka A, Lewis VA, Li AM, McLaughlin LM, Mitchell D, Nemecek ER, Parthasarathy V, Pawlowska AB, Pirsl F, Pulsipher MA, Qayed M, Rozmus J, Sava\u015fan S, Schechter T, Shenoy S, Suleimenova A, Zheng DJ, Ostroumov E, Gilman A, Klein Geltink RI, Wolff D, Cuvelier GDE, Schultz KR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41060324"},{"title01":"Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation","title02":"Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation","journal":"Blood","issue":"2025 Oct 1:blood.2025029402. doi: 10.1182\/blood.2025029402. Online ahead of print.","author":"Gurer Kluge EE, Meedt E, Feicht J, Cao K, Hiergeist A, Mamilos A, Hirsch D, Hoepting M Dr med, Kattner AS Dr med, Matos C, B\u00fclow S, Thiele Orberg E, Beckhove P, Kandulski A, Evert M, Hildner K, Kreutz M, Edinger M, Wolff D, Herr W, Poeck H, Gessner A, Weber DA, Kehr B, Holler E Prof Dr med, Ghimire S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41032750"},{"title01":"Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation","title02":"Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation","journal":"J Clin Oncol","issue":"2025 Oct 3:JCO2501238. doi: 10.1200\/JCO-25-01238. Online ahead of print.","author":"Ueda Oshima M, Vo PT, Boeckh M, Bouvier ME, Carpenter PA, Mielcarek M, Petersdorf EW, Storb R, Gooley T, Sandmaier BM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41043099"},{"title01":"Lineage bias in hematopoietic stem cells: more niche or intrinsic factors?","title02":"Lineage bias in hematopoietic stem cells: more niche or intrinsic factors?","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.288704. Online ahead of print.","author":"Hayal TB, Wu C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063708"},{"title01":"Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party","title02":"Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party","journal":"Br J Haematol","issue":"2025 Sep 30. doi: 10.1111\/bjh.70167. Online ahead of print.","author":"Buchbinder N, Michel V, Dalissier A, Kleinschmidt K, Locatelli F, Maschan A, Wynn R, Fagioli F, Zecca M, Jubert C, Versluys B, Sedlacek P, Zubarovskaya L, Gonzalez Vicent M, Biffi A, Michel G, Mirci-Danicar O, Holter W, Ansari M, Galimard JE, Schneider P, Abouqateb M, Ka\u0142wak K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41027844"},{"title01":"Prognostic significance of pretransplant (18)F-FDG PET\/CT metrics in relapsed\/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation","title02":"Prognostic significance of pretransplant (18)F-FDG PET\/CT metrics in relapsed\/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation","journal":"Br J Haematol","issue":"2025 Oct 1. doi: 10.1111\/bjh.70186. Online ahead of print.","author":"Suh M, Hyung J, Park CS, Go H, Song IH, Chae EJ, Kim KW, Lee YS, Kwon M, Lee SW, Lee J, Kim S, Lee K, Cho H, Ryu JS, Yoon DH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41035136"},{"title01":"A Notch trans-activation to cis-inhibition switch underlies hematopoietic stem cell aging","title02":"A Notch trans-activation to cis-inhibition switch underlies hematopoietic stem cell aging","journal":"Blood","issue":"2025 Oct 7:blood.2024026505. doi: 10.1182\/blood.2024026505. Online ahead of print.","author":"Matteini F, Thambyrajah R, Montserrat-Vazquez S, Jung S, Ferrer-Perez A, Herrero Molinero P, El Jaramany D, Lozano-Bartolom\u00e9 J, Mejia-Ramirez E, Gonzalez Miranda J, Del Sol A, Bigas A, Florian MC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41056036"},{"title01":"Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation","title02":"Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation","journal":"Blood","issue":"2025 Oct 8:blood.2025028625. doi: 10.1182\/blood.2025028625. Online ahead of print.","author":"Ng B, Harris AC, Abdossamadi S, Aubert G, Bajwa RP, Bhatia M, Bittencourt H, Buxbaum NP, Caywood EH, Chaudhury S, Chewning JH, Choi SW, Chopek A, Chu J, Coulter D, Gadalla SM, Hogg RT, Jacobsohn DA, Johnson AK, Joyce M, Kasow KA, Kent M, Kitko CL, Lau D, Lawitschka A, Lewis VA, Li AM, McLaughlin LM, Mitchell D, Nemecek ER, Parthasarathy V, Pawlowska AB, Pirsl F, Pulsipher MA, Qayed M, Rozmus J, Sava\u015fan S, Schechter T, Shenoy S, Suleimenova A, Zheng DJ, Ostroumov E, Gilman A, Klein Geltink RI, Wolff D, Cuvelier GDE, Schultz KR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41060324"},{"title01":"Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation","title02":"Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation","journal":"Blood","issue":"2025 Oct 1:blood.2025029402. doi: 10.1182\/blood.2025029402. Online ahead of print.","author":"Gurer Kluge EE, Meedt E, Feicht J, Cao K, Hiergeist A, Mamilos A, Hirsch D, Hoepting M Dr med, Kattner AS Dr med, Matos C, B\u00fclow S, Thiele Orberg E, Beckhove P, Kandulski A, Evert M, Hildner K, Kreutz M, Edinger M, Wolff D, Herr W, Poeck H, Gessner A, Weber DA, Kehr B, Holler E Prof Dr med, Ghimire S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41032750"},{"title01":"Hypocellular acute promyelocytic leukaemia mimicking aplastic anaemia: A diagnostic pitfall","title02":"Hypocellular acute promyelocytic leukaemia mimicking aplastic anaemia: A diagnostic pitfall","journal":"Br J Haematol","issue":"2025 Oct 5. doi: 10.1111\/bjh.70175. Online ahead of print.","author":"Chen H, Wang H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41047489"},{"title01":"Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls","title02":"Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls","journal":"Br J Haematol","issue":"2025 Oct 6. doi: 10.1111\/bjh.70164. Online ahead of print.","author":"Kalibbala D, Mboizi V, Nambatya G, Murungi S, Ashaba J, Nabaggala C, Turyagyenda L, Munube D, Kasirye P, Wambaka B, Mpungu A, Ssenkusu JM, Namazzi R, Bangirana P, Opoka RO, Mupere E, Idro R, Green NS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41053883"},{"title01":"The single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia","title02":"The single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia","journal":"Blood","issue":"2025 Oct 1:blood.2025028960. doi: 10.1182\/blood.2025028960. Online ahead of print.","author":"Sheng Z, Jiang N, Gao Y, Zhang Y, Zhang X, Li N, Feng Q, Zhang Y, Wang L, Semple JW, Wang S, Li S, Peng J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41032749"},{"title01":"Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis","title02":"Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis","journal":"Leukemia","issue":"2025 Oct 1. doi: 10.1038\/s41375-025-02768-3. Online ahead of print.","author":"Setiawan T, Muhammad JA, Marcellina N, Wirawan LM, Jun N, Sari IN, Oehler VG, Kim DW, Kwon HY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41034423"},{"title01":"Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study","title02":"Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study","journal":"Lancet Haematol","issue":"2025 Oct;12(10):e808-e822.","author":"Yin W, Yan X, Cai J, Han B, Yin P, Lu G, Cheng W, Zhang J, Wu H, Ren J, Ren P, Zhou Z, Wang H, Shi Y, Gan L, Wu D, Jin J, Song Y, Jiang Z, Yan X, Niu T, Hu Y, Li F, Gao S, Cheng T, Wang J, Zhang X, Huang X, Liu Q, Zhu X, He P, Chen Y, Yang T, Li J, Wei X, Lai Y, Wang J, Yan J, Yu J, Zhu X, Xu W, Liu Y, Gao J, Jiang H, Zheng Y, Wang H, He Y, Fang Y, Shen S, Chen J, Chen B, Zhang S, Shen Y, Wang J, Mi J, Zhao W, Zhang H, Zhou M, Wei W, He J, Chen Z, Chen SJ; China Acute Leukaemia Epidemiology; Clinical and Multi-omics Data Consortium.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41062205"},{"title01":"Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review","title02":"Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.288780. Online ahead of print.","author":"Senthil H, Streilein S, Whiteside T, Minuk L, Landego I, Kotb R, Menard C, Kansara R, Moltzan CJ, Johnston JB, Skrabek P, Yang L, Geirnaert M, Banerji V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063693"},{"title01":"Acute leukemia of ambiguous lineage: the known and the uncertain","title02":"Acute leukemia of ambiguous lineage: the known and the uncertain","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.287793. Online ahead of print.","author":"Sherban A, Wolach O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063702"},{"title01":"Gatekeepers of mitochondrial metabolism: the emerging role of the SLC25 family in leukemia","title02":"Gatekeepers of mitochondrial metabolism: the emerging role of the SLC25 family in leukemia","journal":"Haematologica","issue":"2025 Sep 25. doi: 10.3324\/haematol.2025.288787. Online ahead of print.","author":"Haran A, Nachmias B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40994341"},{"title01":"Addition of hydroxyurea (hydroxycarbamide) enhances the efficacy of fludarabine\/cytarabine-based salvage regimens against acute myeloid leukaemia","title02":"Addition of hydroxyurea (hydroxycarbamide) enhances the efficacy of fludarabine\/cytarabine-based salvage regimens against acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Sep 27. doi: 10.1111\/bjh.70180. Online ahead of print.","author":"Lilienthal I, Tao S, Nilsson C, Leonard E, Zhang R, Sorteberg AL, Fredrikson L, Xagoraris I, Fard SS, Tsesmetzis N, Zachariadis V, Cai H, Sandhow L, Langeb\u00e4ck A, Bohlin A, Tamm KP, Bengtz\u00e9n S, Schinazi RF, Lehmann S, Kim B, Rassidakis GZ, Qian H, J\u00e4dersten M, Herold N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41014199"},{"title01":"Infant acute lymphoblastic leukaemia-Progress from worldwide clinical efforts","title02":"Infant acute lymphoblastic leukaemia-Progress from worldwide clinical efforts","journal":"Br J Haematol","issue":"2025 Oct 1. doi: 10.1111\/bjh.70166. Online ahead of print.","author":"Barrett N, Gruber TA, Miyamura T, Duguid A, Stutterheim J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41033852"},{"title01":"AML with mutated TP53, therapy-related, with basophilic differentiation, partial CD22, and ring sideroblasts","title02":"AML with mutated TP53, therapy-related, with basophilic differentiation, partial CD22, and ring sideroblasts","journal":"Blood","issue":"2025 Oct 2;146(14):1737.","author":"Xu Z, McGinnis E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41037297"},{"title01":"AML halts neutrophil maturation","title02":"AML halts neutrophil maturation","journal":"Blood","issue":"2025 Oct 2;146(14):1638-1639..","author":"Sandhow L, Passaro D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41037301"},{"title01":"Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed\/Refractory Chronic Lymphocytic Leukemia","title02":"Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed\/Refractory Chronic Lymphocytic Leukemia","journal":"Blood","issue":"2025 Oct 7:blood.2024027009. doi: 10.1182\/blood.2024027009. Online ahead of print.","author":"Brown JR, Nguyen B, Desikan SP, Won H, Tantawy SI, McNeely SC, Marella N, Randeria HS, Hanson LM, Parker A, Calado Botelho S, Woyach JA, Patel K, Tam CS, Eyre TA, Cheah CY, Shah NN, Ghia P, Jurczak W, Balbas M, Nair BC, Abada PB, Wang C, Wang D, Roeker LE, Gandhi V, Wierda WG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41055698"},{"title01":"Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia","title02":"Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia","journal":"Blood","issue":"2025 Oct 8:blood.2025031243. doi: 10.1182\/blood.2025031243. Online ahead of print.","author":"Schroeder B, Yuan CM, Wang HW, Mohindroo C, Zhou H, Raffeld M, Xi L, Arons E, Feurtado JC, James-Echenique L, Calvo KR, Maric I, Kreitman RJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41060318"},{"title01":"MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia","title02":"MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia","journal":"Blood","issue":"2025 Oct 8:blood.2025028914. doi: 10.1182\/blood.2025028914. Online ahead of print.","author":"Pastoors D, Havermans M, Mulet-Lazaro R, Smeenk L, Ottema S, Erpelinck-Verschueren CAJ, van Herk S, Anthonissen M, Grob T, Subramanian S, Thoms JAI, Pimanda JE, Wouters BJ, Beverloo BH, Haferlach T, Haferlach C, Zuber J, Bindels E, Delwel R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41060369"},{"title01":"Mechanisms of immune escape and extramedullary tropism in leukemia cutis","title02":"Mechanisms of immune escape and extramedullary tropism in leukemia cutis","journal":"Blood","issue":"2025 Sep 30:blood.2025029121. doi: 10.1182\/blood.2025029121. Online ahead of print.","author":"Penter L, Maurer K, Cieri N, Lu W, Lyu H, Selig M, Joosten M, Ihlow J, Li S, Livak KJ, Bullinger L, Ritz J, Bachireddy P, Davids MS, Garcia JS, Soiffer RJ, Wu CJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41026928"},{"title01":"Fetal context conveys heritable protection against MLL-rearranged AML that depends on MLL3","title02":"Fetal context conveys heritable protection against MLL-rearranged AML that depends on MLL3","journal":"Blood","issue":"2025 Oct 1:blood.2025029686. doi: 10.1182\/blood.2025029686. Online ahead of print.","author":"Mendoza-Castrejon J, Yang W, Denby ED, Wang HC, Casey EB, Muthukumar R, Patel RM, Yoon J, Li Y, White JM, Chen R, Batista LFZ, Magee JA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41032751"},{"title01":"Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma","title02":"Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma","journal":"Leukemia","issue":"2025 Oct 7. doi: 10.1038\/s41375-025-02777-2. Online ahead of print.","author":"Vallois D, Missiaglia E, Veloza L, Fischer A, Cavalieri D, Rattina V, Bisig B, Roh V, Wiehle L, Sarkis R, Bachy E, Bonnet C, Bruneau J, Cairoli A, De Wind R, Drieux F, Dubois R, Emile JF, Fataccioli V, Laribi K, Ledoux-Pilon A, Lemonnier F, Llamas-Gutierrez F, Morel P, Parrens M, Poullot E, Quintanilla-Martinez L, Sandrini J, Somja J, Xerri L, Tournilhac O, Gaulard P, Siebert R, de Leval L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41057685"},{"title01":"Primary thyroid diffuse large B-cell lymphoma in a teenager","title02":"Primary thyroid diffuse large B-cell lymphoma in a teenager","journal":"Lancet Haematol","issue":"2025 Oct;12(10):e850.","author":"Le Calvez B, Mathis S, Lemaire P, Meignin V, Leblanc T, Vercellino L, Chevillon F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41062206"},{"title01":"Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2\/3 superiority trial","title02":"Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2\/3 superiority trial","journal":"Lancet","issue":"2025 Oct 3:S0140-6736(25)01432-1. doi: 10.1016\/S0140-6736(25)01432-1. Online ahead of print.","author":"Lewis DJ, Jerkeman M, Sorrell L, Wright D, Glimelius I, Poulsen CB, Pasanen A, Rawstron A, Wader KF, Morley N, Burton C, Davies AJ, Lagerl\u00f6f I, Dalal S, De Tute R, McNamara C, Crosbie N, Toldbod HE, Sanders J, Allgar V, Aroori S, Warner M, Scully C, Wainman B, Christensen JH, Riise J, Sonnevi K, Bishton MJ, Eyre TA, Rule S; ENRICH investigators.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41052510"},{"title01":"Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory\/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial","title02":"Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory\/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial","journal":"J Clin Oncol","issue":"2025 Oct 2:101200JCO2501957. doi: 10.1200\/JCO-25-01957. Online ahead of print.","author":"Budde LE, Zhang H, Kim WS, Maruyama D, Rego EM, Norasetthada L, Hong H, Ozcan M, Jeon YW, Cordeiro de Farias DL, Fogliatto LM, Pavlovsky A, Goto H, Olszewski AJ, Shah N, Hu B, Yin S, Wu H, To I, Ead WS, Ashby J, Janousek M, Pham S, Wang J, Kwan A, Batlevi CL, Wei MC, Westin J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41037766"},{"title01":"Assessing Remission in Diffuse Large B-Cell Lymphoma: Will Minimal Residual Disease Add Value to Positron Emission Tomography?","title02":"Assessing Remission in Diffuse Large B-Cell Lymphoma: Will Minimal Residual Disease Add Value to Positron Emission Tomography?","journal":"J Clin Oncol","issue":"2025 Oct 7:JCO2501932. doi: 10.1200\/JCO-25-01932. Online ahead of print.","author":"Rossi D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41056509"},{"title01":"Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review","title02":"Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.288780. Online ahead of print.","author":"Senthil H, Streilein S, Whiteside T, Minuk L, Landego I, Kotb R, Menard C, Kansara R, Moltzan CJ, Johnston JB, Skrabek P, Yang L, Geirnaert M, Banerji V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063693"},{"title01":"Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experience","title02":"Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experience","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.288058. Online ahead of print.","author":"Marr KC, Tang T, Simkin J, Kim J, Lo AC, Villa D, Gerrie AS, Hapgood G, Scott DW, Sehn LH, Woods RR, Savage KJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063706"},{"title01":"Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study","title02":"Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study","journal":"Haematologica","issue":"2025 Sep 25. doi: 10.3324\/haematol.2025.287919. Online ahead of print.","author":"Chung E, Wang L, Wellard C, Barraclough A, Campbell BA, Chong G, Ciaccio PD, Gregory GP, Hapgood G, Johnston AM, Tam CS, Opat S, Wood EM, McQuilten ZK, Hawkes EA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40994345"},{"title01":"Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy","title02":"Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy","journal":"Haematologica","issue":"2025 Oct 2. doi: 10.3324\/haematol.2025.288699. Online ahead of print.","author":"Yang J, Hayden AR, Villa D, Jiang A, Gerrie AS, Venner CP, Farinha P, Scott DW, Sehn LH, Savage KJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41035405"},{"title01":"Talquetamab, a GPRC5D\u00d7CD3 bispecific antibody, in Chinese patients with relapsed\/refractory multiple myeloma: efficacy and safety from the phase 1\/2 MonumenTAL-1 study","title02":"Talquetamab, a GPRC5D\u00d7CD3 bispecific antibody, in Chinese patients with relapsed\/refractory multiple myeloma: efficacy and safety from the phase 1\/2 MonumenTAL-1 study","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.287334. Online ahead of print.","author":"An G, Jin J, Cai Z, Jing H, Fu C, He P, Xia Z, Liu R, Li L, Gai X, Zhang H, Zhu D, Luo X, Sun B, Xu H, Zhou L, Campagna M, Masterson TJ, Lau BW, Renaud T, Heuck C, Singh I, Vishwamitra D, Qiu L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063704"},{"title01":"Progressive multifocal leukoencephalopathy and BK virus-nephropathy with bispecific antibody therapy in multiple myeloma","title02":"Progressive multifocal leukoencephalopathy and BK virus-nephropathy with bispecific antibody therapy in multiple myeloma","journal":"Haematologica","issue":"2025 Oct 9. doi: 10.3324\/haematol.2025.288521. Online ahead of print.","author":"Siegel A, Reci S, Grossman L, Gleason C, Crary J, Song L, Park J, Verina D, Desai S, Kappes K, Stillman I, LaBaer J, Aleman A, Jagannath S, Parekh S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063705"},{"title01":"Hepatitis E virus infections in people with multiple myeloma: an emerging challenge in the era of immunotherapeutic approaches","title02":"Hepatitis E virus infections in people with multiple myeloma: an emerging challenge in the era of immunotherapeutic approaches","journal":"Haematologica","issue":"2025 Sep 25. doi: 10.3324\/haematol.2025.288381. Online ahead of print.","author":"Al-Bazaz M, Pischke S, Alsdorf W, Sonnemann P, Cichutek S, Wiesch JSZ, Schaefers C, Artzenroth J, Leypoldt L, Kamili A, Bokemeyer C, Weisel K, Kosch R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40994343"},{"title01":"Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib","title02":"Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib","journal":"Leukemia","issue":"eukemia. 2025 Oct 2. doi: 10.1038\/s41375-025-02778-1. Online ahead of print.","author":"Tedeschi A, Frustaci AM, Menna P, Minotti G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41038988"},{"title01":"Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial","title02":"Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial","journal":"Leukemia","issue":"2025 Oct 7. doi: 10.1038\/s41375-025-02780-7. Online ahead of print.","author":"Hund I, Hess ME, Andrieux G, Stomper J, Greve G, Niem\u00f6ller C, Ma T, Uhl D, Grishina O, Thol F, Heuser M, Bug G, Crysandt M, Neubauer A, Duyster J, D\u00f6hner H, Boerries M, L\u00fcbbert M, Becker H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41057684"},{"title01":"Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessment","title02":"Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessment","journal":"Leukemia","issue":"2025 Oct 7. doi: 10.1038\/s41375-025-02774-5. Online ahead of print.","author":"Voss RK, Pastor Loyola VB, Cardenas MF, Kumar P, Maciaszek JL, Namwanje M, Ma J, Neary JL, Jin M, Umeda M, Wilkinson MR, Payne-Turner D, Eldomery MK, Ma J, Gu J, Dalton J, Melton S, Liu YC, Foy S, Rusch M, Wheeler DA, Zhang J, Nichols KE, Karol SE, Inaba H, Ribeiro R, Rubnitz JE, Klco JM, Wang L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41057686"},{"title01":"How do ionizing radiations from inter-planetary travel cause leukaemia?","title02":"How do ionizing radiations from inter-planetary travel cause leukaemia?","journal":"Leukemia","issue":"2025 Sep 29. doi: 10.1038\/s41375-025-02761-w. Online ahead of print.","author":"Badie C, Gale RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41023183"},{"title01":"Misclassification of TP53 germline variants: implications for survival analysis in AML transplant studies","title02":"Misclassification of TP53 germline variants: implications for survival analysis in AML transplant studies","journal":"Leukemia","issue":"2025 Sep 28. doi: 10.1038\/s41375-025-02772-7. Online ahead of print.","author":"Rodriguez L, Delhommeau F, Soussi T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41016942"},{"title01":"The sobering reality of fertility preservation in young female patients with acute leukemia","title02":"The sobering reality of fertility preservation in young female patients with acute leukemia","journal":"Haematologica","issue":"2025 Sep 25. doi: 10.3324\/haematol.2025.288538. Online ahead of print.","author":"Frisch A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40994349"},{"title01":"Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor","title02":"Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor","journal":"Haematologica","issue":"2025 Oct 2. doi: 10.3324\/haematol.2025.288553. Online ahead of print.","author":"Short NJ, Loghavi S, Yilmaz M, Karrar O, Kim K, Dinardo CD, Kadia TM, Maroun M, Borthakur G, Issa GC, Jabbour J, Oran B, Shpall EJ, Popat U, Patel KP, Routbort M, Konopleva M, Ravandi F, Kantarjian H, Daver N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41035402"},{"title01":"Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study","title02":"Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study","journal":"Haematologica","issue":"2025 Oct 2. doi: 10.3324\/haematol.2025.288516. Online ahead of print.","author":"Lokhorst DN, Smit Y, Van den Bemt BJF, Hermens RPMG, Nijziel MR, Jie AK, Daenen LGM, Klein SK, Posthuma EFM, Westerweel PE, Donker M, Hoogendoorn M, Bekker CL, Blijlevens NMA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41035410"},{"title01":"NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT\/\u03b2-catenin pathway","title02":"NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT\/\u03b2-catenin pathway","journal":"Haematologica","issue":"2025 Oct 2. doi: 10.3324\/haematol.2025.287651. Online ahead of print.","author":"Veltri G, Peloso A, Cani A, Mariotto E, Corallo D, Aveic S, Russo L, Cescon M, Santinon G, Frasson C, Simon K, Arrighi A, Iorio E, Minuzzo SA, Indraccolo S, Marmiroli S, Ntziachristos P, Biffi A, Pigazzi M, Buldini B, Bresolin S, Serafin V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41035400"},{"title01":"The French-American-British classification system for acute myeloid leukemia","title02":"The French-American-British classification system for acute myeloid leukemia","journal":"Haematologica","issue":"2025 Oct 1;110(10):2246-2247.","author":"Pollyea DA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41031420"},{"title01":"Leucostasis-induced limb ischaemia in acute myeloid leukaemia","title02":"Leucostasis-induced limb ischaemia in acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Oct 2. doi: 10.1111\/bjh.70177. Online ahead of print.","author":"Sandberg Y, Mingels L, van Zutven LJCM, Lam KH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41039705"},{"title01":"Hypocellular acute promyelocytic leukaemia mimicking aplastic anaemia: A diagnostic pitfall","title02":"Hypocellular acute promyelocytic leukaemia mimicking aplastic anaemia: A diagnostic pitfall","journal":"Br J Haematol","issue":"2025 Oct 5. doi: 10.1111\/bjh.70175. Online ahead of print.","author":"Chen H, Wang H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41047489"},{"title01":"Empirical and projected economic burden of chronic myeloid leukaemia in Sweden from 2015 to 2030: A population-based study","title02":"Empirical and projected economic burden of chronic myeloid leukaemia in Sweden from 2015 to 2030: A population-based study","journal":"Br J Haematol","issue":"2025 Oct 7. doi: 10.1111\/bjh.70193. Online ahead of print.","author":"Chen EY, Dickman PW, Di Mari F, Dahl\u00e9n T, Stenke L, Bj\u00f6rkholm M, Clements MS, Hao S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41057969"},{"title01":"Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party","title02":"Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party","journal":"Br J Haematol","issue":"2025 Sep 30. doi: 10.1111\/bjh.70167. Online ahead of print.","author":"Buchbinder N, Michel V, Dalissier A, Kleinschmidt K, Locatelli F, Maschan A, Wynn R, Fagioli F, Zecca M, Jubert C, Versluys B, Sedlacek P, Zubarovskaya L, Gonzalez Vicent M, Biffi A, Michel G, Mirci-Danicar O, Holter W, Ansari M, Galimard JE, Schneider P, Abouqateb M, Ka\u0142wak K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/41027844"},{"title01":"Resolving inter- and intra-patient heterogeneity in NPM1-mutated AML at single-cell resolution","title02":"Resolving inter- and intra-patient heterogeneity in NPM1<\/i>-mutated AML at single-cell resolution","journal":"Leukemia","issue":"2025 Sep 15. doi: 10.1038\/s41375-025-02745-w. Online ahead of print.","author":"Karakaslar EO, Argiro EM, Struckman NE, Shirali Hz R, Severens JF, Honders MW, Kloet SL, Veelken H, Reinders MJ, Griffioen M, van den Akker EB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954214"},{"title01":"Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survival","title02":"Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survival","journal":"Leukemia","issue":"2025 Sep 11. doi: 10.1038\/s41375-025-02752-x. Online ahead of print.","author":"Miraki-Moud F, Ariza-McNaughton L, KoKo T, Othman J, Stronge R, de Bono J, Russell N, Thomas I, Gilkes A, Burnett A, Santiago LR, Cafferty F, Taussig L, Thornhill A, O'Connor S, Bonnet D, Taussig DC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40935826"},{"title01":"Response to Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","title02":"Response to Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","journal":"Haematologica","issue":"2025 Sep 18. doi: 10.3324\/haematol.2025.289110. Online ahead of print.","author":"Sanz J, Mohty M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963383"},{"title01":"Metallothionein 1: the Achilles heel of Dnmt3a;Npm1-mutant acute myeloid leukemia","title02":"Metallothionein 1: the Achilles heel of Dnmt3a;Npm1<\/i>-mutant acute myeloid leukemia","journal":"Haematologica","issue":"2025 Sep 18. doi: 10.3324\/haematol.2025.288820. Online ahead of print.","author":"Yan B, Guryanova OA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963388"},{"title01":"Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed\/refractory acute myeloid leukemia","title02":"Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed\/refractory acute myeloid leukemia","journal":"Haematologica","issue":"2025 Sep 18. doi: 10.3324\/haematol.2025.288178. Online ahead of print.","author":"Verdeyen K, Reuvekamp T, Van der Velden WJFM, Wouters BJ, Von dem Borne PA, Van Rhenen A, Lissenberg-Witte BI, Van Lammeren D, Van Sluis GL, De Jongh E, Fiets RB, Corsten MF, Van der Spek AC, Gerrits AM, Van Bladel ER, Tick LW, De Weerdt O, Van Zaane B, Cruijsen MJ, Posthuma EFM, Van Elssen CHMJ, Klein SK, Van de Loosdrecht AA, De Leeuw DC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963393"},{"title01":"MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia","title02":"MECOM<\/i> fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM<\/i> rearranged acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Sep 22. doi: 10.1111\/bjh.70171. Online ahead of print.","author":"Jen WY, Tang G, Kugler E, Croden J, Sasaki K, Bazinet A, Bataller A, Montalban-Bravo G, Borthakur G, Toruner GA, Loghavi S, Short NJ, Issa GC, Bouligny IM, Pierce S, Popat U, Pemmaraju N, Jabbour E, Garcia-Manero G, Bhalla K, Ravandi F, Daver NG, DiNardo CD, Kantarjian HM, Kadia TM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983567"},{"title01":"Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia","title02":"Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A<\/i>-rearranged acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Sep 21. doi: 10.1111\/bjh.70183. Online ahead of print.","author":"Chavan A, Frett B, Armstrong DT, Acharya B, Lockyer P, Boerma M, Roy Choudhury S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40976985"},{"title01":"A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia","title02":"A novel PML<\/i> germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Sep;207(3):1118-1121.","author":"Soussi T, Kundu S, Gerbaud P, Pandzic T, Baskin B, Ladenvall C, Delhommeau F, Sj\u00f6blom T, Baliakas P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954117"},{"title01":"Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol-A prospective study","title02":"Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol-A prospective study","journal":"Br J Haematol","issue":"2025 Sep 14. doi: 10.1111\/bjh.70159. Online ahead of print.","author":"Quist-Paulsen P, Horvei L, Dalgaard J, Moksnes M, Eilertsen AL, Paulson M, Azrakhsh NA, Majeed W, Wik HS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40947499"},{"title01":"Fusion Gene Depletion Eliminates Stemness and Induces Bidirectional Differentiation of Acute Myeloid Leukemia","title02":"Fusion Gene Depletion Eliminates Stemness and Induces Bidirectional Differentiation of Acute Myeloid Leukemia","journal":"Blood","issue":"2025 Sep 24:blood.2025028988. doi: 10.1182\/blood.2025028988. Online ahead of print.","author":"Derevyanko PK, Swart LE, Mata Casimiro LD, van Oort A, Du Plessis M, van den Brink L, Ashtiani M, Zwaan CM, Krippner-Heidenreich A, Bonifer C, Schiffelers RM, Vormoor JJ, Kellaway S, Heidenreich O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40991849"},{"title01":"CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias","title02":"CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias","journal":"Blood","issue":"2025 Sep 24:blood.2025028954. doi: 10.1182\/blood.2025028954. Online ahead of print.","author":"Fleming T, Antoszewski M, Lambo S, Gundry M, Piussi R, Wahlster L, Shah SB, Reed F, Dong K, Paulo JA, Gygi S, Mimoso CA, Goldman S, Adelman K, Perry JA, Pikman Y, Stegmaier K, Barrachina MN, Machlus KR, Hovestadt V, Arruda A, Minden MD, Voit RA, Sankaran VG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40991835"},{"title01":"INCREASED LEF1 PROTEIN LEVELS AND ISOFORM SWITCHING DRIVE CELL PROLIFERATION IN CHRONIC LYMPHOCYTIC LEUKEMIA","title02":"INCREASED LEF1 PROTEIN LEVELS AND ISOFORM SWITCHING DRIVE CELL PROLIFERATION IN CHRONIC LYMPHOCYTIC LEUKEMIA","journal":"Blood","issue":"2025 Sep 22:blood.2025030129. doi: 10.1182\/blood.2025030129. Online ahead of print.","author":"Mateos-Jaimez J, Vidal Crespo A, Charalampopoulou S, Fernandez Perez R, Chapaprieta V, Jim\u00e9nez-Mart\u00ednez V, Caviedes-C\u00e1rdenas L, Duran-Ferrer M, Espadas G, Sabido E, Largeot A, Herbst SA, Dietrich S, Bastos Boente M, Alcoceba M, Nadeu F, Ringshausen I, Paggetti J, Moussay E, Colomer D, Campo E, Maiques-Diaz A, Martin-Subero JI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983031"},{"title01":"The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort","title02":"The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort","journal":"Blood","issue":"2025 Sep 19:blood.2025029916. doi: 10.1182\/blood.2025029916. Online ahead of print.","author":"Neven Q, Arfeuille C, Caye-Eude A, Durand P, Lainey E, Fenneteau O, Nelken B, Nolla M, Sterin A, Grain A, Khouri C, Simonin M, Dourthe ME, Fahd M, Millot F, Neven B, Petit A, Chevret S, Dalle JH, Baruchel A, Cav\u00e9 H, Strullu M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40971523"},{"title01":"FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML","title02":"FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML","journal":"Blood","issue":"2025 Sep 19:blood.2025029391. doi: 10.1182\/blood.2025029391. Online ahead of print.","author":"Raj R, Catueno S, Gibson A, McCall D, Garcia MB, Nunez C, Roth ME, Sasaki K, Tewari P, Issa GC, Farhat A, Connors JS, Sheikh IN, Nishida Y, Yi JS, Stevens AM, Bataller A, Bhalla KN, Petropoulos D, Daver NG, Kadia TM, Cuglievan B, DiNardo CD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40971491"},{"title01":"BAP1\/TP53 loss defines a BCL-xL-dependent erythroleukemia","title02":"BAP1\/TP53<\/i> loss defines a BCL-xL-dependent erythroleukemia","journal":"Blood","issue":"2025 Sep 18;146(12):1385-1387.","author":"Ho TC, Kapur R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40965944"},{"title01":"ELEVATE-ing clinical trial reporting in CLL","title02":"ELEVATE-ing clinical trial reporting in CLL","journal":"Blood","issue":"2025 Sep 11;146(11):1253-1254.","author":"Simon F, Al-Sawaf O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40932743"},{"title01":"Subcutaneous Panniculitis-like T-Cell Lymphoma","title02":"Subcutaneous Panniculitis-like T-Cell Lymphoma","journal":"N Engl J Med","issue":"2025 Sep 18;393(11):1117.","author":"Okada S, Nishikubo M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40948476"},{"title01":"Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study","title02":"Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study","journal":"Lancet Haematol","issue":"2025 Sep 17:S2352-3026(25)00252-2. doi: 10.1016\/S2352-3026(25)00252-2. Online ahead of print.","author":"Visco C, Tabanelli V, Sacchi MV, Evangelista A, Quaglia FM, Fiori S, Bomben R, Tisi MC, Riva M, Merli A, Rotondo F, Fraenza C, Carazzolo ME, Corradini P, Farina L, Castellino C, Castellino A, Zilioli VR, Muzi C, Piazza F, Re A, Hohaus S, Rossi FG, Musuraca G, Di Rocco A, Puccini B, Sciarra R, Ballerini F, Cavallo F, Bruna R, Moia R, Moioli A, Bernardelli A, Drandi D, Arcari A, Merli F, Gini G, Freilone R, Tani M, Pavone V, Ladetto M, Pileri SA, Balzarotti M; Fondazione Italiana Linfomi.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40975105"},{"title01":"Advancing understanding of mature T-cell and natural killer-cell lymphomas","title02":"Advancing understanding of mature T-cell and natural killer-cell lymphomas","journal":"Lancet Haematol","issue":"2025 Sep 14:S2352-3026(25)00237-6. doi: 10.1016\/S2352-3026(25)00237-6. Online ahead of print.","author":"Qi S, Cai Q.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40961950"},{"title01":"Emerging therapeutic strategies for mature T-cell and natural killer-cell lymphomas","title02":"Emerging therapeutic strategies for mature T-cell and natural killer-cell lymphomas","journal":"Lancet Haematol","issue":"2025 Sep 14:S2352-3026(25)00228-5. doi: 10.1016\/S2352-3026(25)00228-5. Online ahead of print.","author":"Tse E, Querfeld C, Ishitsuka K, Kwong YL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40961949"},{"title01":"Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma","title02":"Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma","journal":"J Clin Oncol","issue":"2025 Sep 24:JCO2500925. doi: 10.1200\/JCO-25-00925. Online ahead of print.","author":"Morschhauser F, Salles G, Sehn LH, Herrera AF, Friedberg JW, Trn\u011bn\u00fd M, Lenz G, Sharman JP, Herbaux C, Burke JM, Matasar M, Collins GP, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Pinto A, Rai S, Izutsu K, Greil R, Mykhalska L, Bergua-Burgu\u00e9s JM, Cheung MC, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Jiang Y, McCall B, Chohan S, Sugidono M, Yan M, Batlevi CL, Tilly H, Flowers CR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40991874"},{"title01":"Brentuximab vedotin plus nivolumab as bridging therapy to CAR T-cells in relapsed\/refractory primary mediastinal B-cell lymphoma","title02":"Brentuximab vedotin plus nivolumab as bridging therapy to CAR T-cells in relapsed\/refractory primary mediastinal B-cell lymphoma","journal":"Haematologica","issue":"2025 Sep 18. doi: 10.3324\/haematol.2025.287672. Online ahead of print.","author":"Santoro A, Improta CM, Sarina B, Mannina D, De Philippis C, Taurino D, Mariotti J, Balzarotti M, Bramanti S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963380"},{"title01":"MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapy","title02":"MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapy","journal":"Br J Haematol","issue":"2025 Sep 11. doi: 10.1111\/bjh.70137. Online ahead of print.","author":"Kuhnl A, Bouziana S, Barrington SF, Galani S, Menne T, Northend M, Stevens L, Kamat S, Osborne W, Johnson R, Kumar E, Sanderson R, Patten PEM, Benjamin R, Frew J, Prestwich R, Brady JL, Mikhaeel NG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40936317"},{"title01":"Minimally invasive percutaneous lymphangiography and embolisation for spontaneous chyle leaks in patients with lymphoma","title02":"Minimally invasive percutaneous lymphangiography and embolisation for spontaneous chyle leaks in patients with lymphoma","journal":"Br J Haematol","issue":"2025 Jul 15. doi: 10.1111\/bjh.70007. Online ahead of print.","author":"Khavandi MM, Strati P, Habibollahi P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40955110"},{"title01":"Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial","title02":"Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial","journal":"Blood","issue":"2025 Sep 12:blood.2025028823. doi: 10.1182\/blood.2025028823. Online ahead of print.","author":"Zucca E, Ceriani L, Ciccone G, Di Rocco A, Pirosa MC, Kriachok I, Botto B, Balzarotti M MD, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka AP, Ferreri AJM, Merli F, Zhao WL, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Foss\u00e5 A, Janikova A, Cwynarski K, Mikhaeel NG, Jerkeman M, Stathis A, Cozens KS, Ielmini N, De Martino I, Walewski J, Trn\u011bn\u00fd M, Cavalli F, Ricardi U, Johnson PWM, Davies AJ, Martelli M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40939190"},{"title01":"The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma","title02":"The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma","journal":"Leukemia","issue":"2025 Sep 19. doi: 10.1038\/s41375-025-02766-5. Online ahead of print.","author":"Frede J, Poller JC, Shi K, Stuart H, Sotudeh N, Havig C, Lim K, Wiggers CRM, Cho EY, Vijaykumar T, Liu J, Waldschmidt JM, Nair MS, Anand P, Dimitrova V, Montanaro A, Yee AJ, Munshi NC, Anderson KC, Martin N, Kaiser SM, Raab MS, Raje NS, Knoechel B, Lohr JG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40973768"},{"title01":"Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study","title02":"Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study","journal":"Leukemia","issue":"2025 Sep 12. doi: 10.1038\/s41375-025-02762-9. Online ahead of print.","author":"Andersen LS, Navarro RB, Ekberg S, R\u00f6gnvaldsson S, Levy MR, Sverrisd\u00f3ttir IS, Vi\u00f0arsson B, \u00d6nundarson PT, Agnarsson BA, Sigur\u00f0ard\u00f3ttir M, \u00deorsteinsd\u00f3ttir I, \u00d3lafsson \u00cd, \u00de\u00f3r\u00f0ard\u00f3ttir \u00c1R, Ey\u00fe\u00f3rsson E, J\u00f3nsson \u00c1, \u00d3lafsson A, Durie BGM, Harding S, Landgren O, L\u00f6ve TJ, Kristinsson SY, Thorsteinsd\u00f3ttir S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40940581"},{"title01":"From myeloma to POEMS: extending the potential of T-cell redirecting therapies","title02":"From myeloma to POEMS: extending the potential of T-cell redirecting therapies","journal":"Haematologica","issue":"2025 Sep 18. doi: 10.3324\/haematol.2025.288466. Online ahead of print.","author":"Cook J, Dispenzieri A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963394"},{"title01":"Prognostic value of premaintenance FDG PET\/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial","title02":"Prognostic value of premaintenance FDG PET\/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial","journal":"Blood","issue":"2025 Sep 24:blood.2025030084. doi: 10.1182\/blood.2025030084. Online ahead of print.","author":"Kraeber-Bodere F, Jamet B, Zweegman S, Perrot A, Hulin C, Caillot D, Facon T, Leleu X, Belhadj K, Itti E, Karlin L, Bailly C, Levin MD, Minnema MC, Bodet-Milin C, de Keizer B, Corre J, Sonneveld P, Moreau P, Carlier T, Touzeau C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40991848"},{"title01":"High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing","title02":"High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing","journal":"Blood","issue":"2025 Sep 24:blood.2025029999. doi: 10.1182\/blood.2025029999. Online ahead of print.","author":"Schavgoulidze A, Perrot A, Leleu X, Cazaubiel T, Chretien ML, Feugier P, Belhadj K, Manier S, Roussel M, Brechignac S, Orsini Piocelle F, Mohty M, Schiano de Colella JM, Macro M Dr, Adiko D, Dib M, Fontan J, Motard C, Bouscary D, Pascal L, Roland V, Lifermann F, Bakala JA, Montes L, Kennel C, Rey P, Richez V, Keddar F, Frenzel L, Calmettes C, Chaleteix C, Plantier I, Chalayer E, Schmitt A, Roul C, Demarquette H, Cerutti C, Pavageau L, Derrier L, Avet-Loiseau H, Corre J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40991836"},{"title01":"Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study","title02":"Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study","journal":"Blood","issue":"2025 Sep 22:blood.2025029360. doi: 10.1182\/blood.2025029360. Online ahead of print.","author":"Chari A, van de Donk NWCJ, Dholaria B, Weisel KC, Mateos MV, Goldschmidt H, Martin TG, Morillo D, Reece D, Rodriguez-Otero P, Bhutani M, D'Souza A, Oriol A, Rosi\u00f1ol L, Bahlis NJ, Vishwamitra D, Skerget S, Verona RI, Bakshi KK, Kang L, Prior TJ, Vandenberk L, Tolbert J, Lee S, Smit D, W\u00e4sch R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983036"},{"title01":"Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma","title02":"Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma","journal":"Blood","issue":"2025 Sep 19:blood.2024027496. doi: 10.1182\/blood.2024027496. Online ahead of print.","author":"Navarro F, Lozano T, Fuentes-Garc\u00eda A, S\u00e1nchez-Moreno I, Larrayoz M, Justicia P, Perucha B, Martinez-Tabar M, Martinez-Turrillas R, Casares N, Mart\u00edn-Otal C, Gorraiz M, Meermeier EW, Chesi M, Lake D, Bergsagel PL, Santamar\u00eda E, Calleja-Cervantes ME, San Mart\u00edn-\u00dariz P, Jordana-Urriza L, Agirre X, Hervas-Stubbs S, Rodriguez-Madoz JR, Mart\u00ednez-Climent JA, Prosper F, Lasarte JJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40971494"},{"title01":"Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma","title02":"Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma","journal":"Blood","issue":"2025 Sep 12:blood.2025029950. doi: 10.1182\/blood.2025029950. Online ahead of print.","author":"Yan Z, Han Z, Wang Y, Beus M, Zhang Y, Picado A, Wells CI, Wu J, Weidenhammer LB, Pires KM, Leibold EA, Liu L, Gooden DM, Spasojevic I, Soderblom E, Kang Y, Boise LH, Willson TM, Nikiforov MA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40953235"},{"title01":"ClpP: a new Achilles’ heel in myeloma","title02":"ClpP: a new Achilles’ heel in myeloma","journal":"Blood","issue":"2025 Sep 11;146(11):1254-1255.","author":"Sacco A, Roccaro AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40932746"},{"title01":"Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation","title02":"Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation","journal":"J Clin Oncol","issue":"2025 Sep 18:JCO2500206. doi: 10.1200\/JCO-25-00206. Online ahead of print.","author":"Lee SJ, Logan B, Horowitz MM, Dehn JG, Pidala J, Grunwald MR, Westervelt P, Farhadfar N, Hogan WJ, Bashey A, Hayes-Lattin B, Hill L, Brunstein C, Arai S, Srour SA, Symons H, Uberti J, Vasu S, Pusic I, Juckett M, Leifer E, He N, Devine S, Shaw BE, Ciurea SO.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40966481"},{"title01":"Response to Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","title02":"Response to Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","journal":"Haematologica","issue":"2025 Sep 18. doi: 10.3324\/haematol.2025.289110. Online ahead of print.","author":"Sanz J, Mohty M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963383"},{"title01":"Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed\/refractory acute myeloid leukemia","title02":"Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed\/refractory acute myeloid leukemia","journal":"Haematologica","issue":"2025 Sep 18. doi: 10.3324\/haematol.2025.288178. Online ahead of print.","author":"Verdeyen K, Reuvekamp T, Van der Velden WJFM, Wouters BJ, Von dem Borne PA, Van Rhenen A, Lissenberg-Witte BI, Van Lammeren D, Van Sluis GL, De Jongh E, Fiets RB, Corsten MF, Van der Spek AC, Gerrits AM, Van Bladel ER, Tick LW, De Weerdt O, Van Zaane B, Cruijsen MJ, Posthuma EFM, Van Elssen CHMJ, Klein SK, Van de Loosdrecht AA, De Leeuw DC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963393"},{"title01":"Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study","title02":"Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study","journal":"Br J Haematol","issue":"2025 Sep 22. doi: 10.1111\/bjh.70154. Online ahead of print.","author":"Ustun C, Zhang MJ, Peterson A, Baek A, Agha M, Alkhateeb H, Chhabra S, Coltoff A, de Lima M, Gandhi A, Ho V, Kassim A, Lin A, Gowda L, Borthakur G, DeAngelo DJ, McGuirk J, Mensah F, Nadiminti KV, Nishihori T, Pantin J, Trunk A, Uberti J, Marcucci G, Gotlib J, Akin C, Hamadani M, Pullarkat V, Valent P, Grunwald M, Juckett M, Oran B, Saber W, Burns LJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983528"},{"title01":"The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)","title02":"The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)","journal":"Br J Haematol","issue":"2025 Sep 21. doi: 10.1111\/bjh.70036. Online ahead of print.","author":"Baccelli F, Compagno F, Tridello G, Delle Cave F, Zama D, Masetti R, Petris MG, Chiusaroli L, Spadea M, Trevisan F, Colombini A, Conci S, Meazza C, Muggeo P, Micheletti MV, Pancaldi A, Mura R, Onofrillo D, De Santis R, La Spina M, Castagnola E, Perruccio K, Barone A, Giurici N, Petrone A, Mercolini F, Rinieri S, Cesaro S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40976850"},{"title01":"Can we move beyond myeloablative conditioning (MAC)? A\u00a0comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65\u2009years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis","title02":"Can we move beyond myeloablative conditioning (MAC)? A\u00a0comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65\u2009years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis","journal":"Br J Haematol","issue":"2025 Sep 18. doi: 10.1111\/bjh.70170. Online ahead of print.","author":"Alyamany R, Alnughmush A, Remberger M, Law AD, Lam W, Kim DDH, Michelis FV, Pasic I, Novitzky-Basso I, Gerbitz A, Kumar R, Mattsson J, Viswabandya A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40968076"},{"title01":"Cord blood porphyrin analysis in neonates at risk of inheriting protoporphyria: An observational cohort study","title02":"Cord blood porphyrin analysis in neonates at risk of inheriting protoporphyria: An observational cohort study","journal":"Br J Haematol","issue":"2025 Sep;207(3):1148-1151.","author":"Schulenburg-Brand D, Peek R, Bentley L, Swingler R, Pavlova YT, Dawe RS, McGuire VA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954119"},{"title01":"Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment","title02":"Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment","journal":"Br J Haematol","issue":"2025 Sep 14. doi: 10.1111\/bjh.70146. Online ahead of print.","author":"Rodriguez-Rodriguez S, Desai N, Chen C, Jamani K, Sohier-Pohier C, Lemieux C, White J, Elemary M, Kennah M, Alfaro Moya T, Al-Shaibani E, Novitzky-Basso I, Pasic I, Law AD, Michelis FV, Viswabandya A, Kumar R, Mattsson J, Kim DDH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40947302"},{"title01":"Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor\/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemia","title02":"Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor\/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemia","journal":"Br J Haematol","issue":"2025 Sep 14. doi: 10.1111\/bjh.70133. Online ahead of print.","author":"Wu L, Zhou M, Chen X, Mo W, Zhou R, Li Y, Wang C, Xu S, Yang F, Zhang Y, He X, Li X, Wang S, Zhang Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40947584"},{"title01":"Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study","title02":"Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study","journal":"Blood","issue":"2025 Sep 22:blood.2025029640. doi: 10.1182\/blood.2025029640. Online ahead of print.","author":"Herrmann US, Felber M, Worth AJ, Haskologlu S, Dogu F, Lewis VA, Strahm B, Groll AH, Gennery AR, Hauck F, Wynn R, Coussons M, Meyts I, Lindemans CA, Bordon Cueto de Braem MV, Bredius RG, K\u00fchl JS, V\u00f6ller M, Zirngibl F, Zaidman I, Laberko A, Zeilhofer U, Hauri-Hohl MM, Lankester AC, Ikinciogullari A, Guilcher GMT, Hackenberg A, Ye\u015filipek MA, Davies EG, Hershfield M, Parikh SH, Gilbert P, Bettoni da Cunha Riehm C, Albert MH, Schulz AS, Honig M, Neven B, G\u00fcng\u00f6r T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983033"},{"title01":"Sclerotic GVHD and Scleroderma Share Dysregulated Gene Expression that is Ameliorated by EREG Therapeutic Antibody","title02":"Sclerotic GVHD and Scleroderma Share Dysregulated Gene Expression that is Ameliorated by EREG Therapeutic Antibody","journal":"Blood","issue":"2025 Sep 17:blood.2025029836. doi: 10.1182\/blood.2025029836. Online ahead of print.","author":"Newton NM, Agrawal K, Odell AV, Tracy TS, Hackett CS, Eldrup AB, Whitfield M, Martyanov V, Girardi M, Sefik E, Flavell RA, Odell ID.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40961242"},{"title01":"Mac-Man clearance of alloreactive T cells in GVHD","title02":"Mac-Man clearance of alloreactive T cells in GVHD","journal":"Blood","issue":"2025 Sep 11;146(11):1262-1263.","author":"Buxbaum NP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40932747"},{"title01":"Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission","title02":"Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission","journal":"Leukemia","issue":"2025 Sep 16. doi: 10.1038\/s41375-025-02770-9. Online ahead of print.","author":"Wang X, Ramdas B, Kumar R, Zhang J, Kapur R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40958034"},{"title01":"Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study","title02":"Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study","journal":"Br J Haematol","issue":"2025 Sep 22. doi: 10.1111\/bjh.70154. Online ahead of print.","author":"Ustun C, Zhang MJ, Peterson A, Baek A, Agha M, Alkhateeb H, Chhabra S, Coltoff A, de Lima M, Gandhi A, Ho V, Kassim A, Lin A, Gowda L, Borthakur G, DeAngelo DJ, McGuirk J, Mensah F, Nadiminti KV, Nishihori T, Pantin J, Trunk A, Uberti J, Marcucci G, Gotlib J, Akin C, Hamadani M, Pullarkat V, Valent P, Grunwald M, Juckett M, Oran B, Saber W, Burns LJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983528"},{"title01":"The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)","title02":"The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)","journal":"Br J Haematol","issue":"2025 Sep 21. doi: 10.1111\/bjh.70036. Online ahead of print.","author":"Baccelli F, Compagno F, Tridello G, Delle Cave F, Zama D, Masetti R, Petris MG, Chiusaroli L, Spadea M, Trevisan F, Colombini A, Conci S, Meazza C, Muggeo P, Micheletti MV, Pancaldi A, Mura R, Onofrillo D, De Santis R, La Spina M, Castagnola E, Perruccio K, Barone A, Giurici N, Petrone A, Mercolini F, Rinieri S, Cesaro S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40976850"},{"title01":"Can we move beyond myeloablative conditioning (MAC)? A\u00a0comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65\u2009years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis","title02":"Can we move beyond myeloablative conditioning (MAC)? A\u00a0comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65\u2009years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis","journal":"Br J Haematol","issue":"2025 Sep 18. doi: 10.1111\/bjh.70170. Online ahead of print.","author":"Alyamany R, Alnughmush A, Remberger M, Law AD, Lam W, Kim DDH, Michelis FV, Pasic I, Novitzky-Basso I, Gerbitz A, Kumar R, Mattsson J, Viswabandya A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40968076"},{"title01":"Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study","title02":"Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study","journal":"Blood","issue":"2025 Sep 22:blood.2025029640. doi: 10.1182\/blood.2025029640. Online ahead of print.","author":"Herrmann US, Felber M, Worth AJ, Haskologlu S, Dogu F, Lewis VA, Strahm B, Groll AH, Gennery AR, Hauck F, Wynn R, Coussons M, Meyts I, Lindemans CA, Bordon Cueto de Braem MV, Bredius RG, K\u00fchl JS, V\u00f6ller M, Zirngibl F, Zaidman I, Laberko A, Zeilhofer U, Hauri-Hohl MM, Lankester AC, Ikinciogullari A, Guilcher GMT, Hackenberg A, Ye\u015filipek MA, Davies EG, Hershfield M, Parikh SH, Gilbert P, Bettoni da Cunha Riehm C, Albert MH, Schulz AS, Honig M, Neven B, G\u00fcng\u00f6r T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983033"},{"title01":"Clonal tracing of blood stem cells across mouse and human lifespans","title02":"Clonal tracing of blood stem cells across mouse and human lifespans","journal":"Blood","issue":"2025 Sep 22:blood.2024028195. doi: 10.1182\/blood.2024028195. Online ahead of print.","author":"Rodriguez-Fraticelli AE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40983030"},{"title01":"UPS delivers apolarity and senescence to HSCs","title02":"UPS delivers apolarity and senescence to HSCs","journal":"Blood","issue":"2025 Sep 18;146(12):1382-1383.","author":"Geiger H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40965939"},{"title01":"A genome-wide screen identifies Runx2 as a novel regulator of hematopoietic stem cell expansion and T-cell commitment","title02":"A genome-wide screen identifies Runx2 as a novel regulator of hematopoietic stem cell expansion and T-cell commitment","journal":"Blood","issue":"2025 Sep 17:blood.2025029115. doi: 10.1182\/blood.2025029115. Online ahead of print.","author":"Meaker GA, Nicholls M, Chahrour C, Hsu I, Smith A, Bozhilov Y, Leung MGH, Vassort H Mr, Olender L, Beaven O, Huang X, Brown EJ, Vanden Bempt M, Khoo HM, Bhadury J, Milne TA, Wilkinson AC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40961240"},{"title01":"The diagnostic performance of the basic versus the detailed telomere Flow FISH test in young patients with aplastic anaemia","title02":"The diagnostic performance of the basic versus the detailed telomere Flow FISH test in young patients with aplastic anaemia","journal":"Br J Haematol","issue":"2025 Sep 23. doi: 10.1111\/bjh.70155. Online ahead of print.","author":"DeCleene NF, Nguyen DT, Kirk SE, Helber HL, Sasa GS, Bertuch AA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40988089"},{"title01":"Germline mosaicism in a family affected by Diamond-Blackfan anaemia","title02":"Germline mosaicism in a family affected by Diamond-Blackfan anaemia","journal":"Br J Haematol","issue":"2025 Sep 21. doi: 10.1111\/bjh.70173. Online ahead of print.","author":"Dunlea E, Lynch SA, Angelov D, Cotter M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40976991"},{"title01":"A new unstable haemoglobin, Hb Alger, causes a transfusion-dependent anaemia in early childhood","title02":"A new unstable haemoglobin, Hb Alger, causes a transfusion-dependent anaemia in early childhood","journal":"Br J Haematol","issue":"2025 Jul 31. doi: 10.1111\/bjh.70040. Online ahead of print.","author":"Bouazizi S, Cerino M, Lim S, Desgrouas C, Badens C, Szepetowski S, Bonello-Palot N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40963508"},{"title01":"A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemia","title02":"A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemia","journal":"Br J Haematol","issue":"2025 Sep 12. doi: 10.1111\/bjh.70152. Online ahead of print.","author":"Brenac G, Dautriche A, Freppel R, Facile A, Revol B, Beurrier M, Bonnotte B, Audia S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40936476"},{"title01":"Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor\/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemia","title02":"Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor\/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemia","journal":"Br J Haematol","issue":"2025 Sep 14. doi: 10.1111\/bjh.70133. Online ahead of print.","author":"Wu L, Zhou M, Chen X, Mo W, Zhou R, Li Y, Wang C, Xu S, Yang F, Zhang Y, He X, Li X, Wang S, Zhang Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40947584"},{"title01":"VEXAS anemia is a mosaic erythroblastopenia","title02":"VEXAS anemia is a mosaic erythroblastopenia","journal":"Blood","issue":"2025 Sep 19:blood.2025029081. doi: 10.1182\/blood.2025029081. Online ahead of print.","author":"Rodrigues F, Hardouin G, El Hoss S, Ghoul A, Gautier EF, Dussiot M, A Lizarralde-Iragorri M, Santini A, Peltier S, Amireault P, Soldan V, Miccio A, Debili M, Jachiet V, Trovati Maciel T, Rossignol J, Allemand E, M\u00e9kinian AM, Georgin-Lavialle SA Pr, Salma M, Soler E, Gleizes PE, O'Donohue MF, Kosmider O, Rodriguez MS, Hermine O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40971475"},{"title01":"Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A\u00a0prospective, multicentre, phase 2 clinical trial","title02":"Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A\u00a0prospective, multicentre, phase 2 clinical trial","journal":"Br J Haematol","issue":"2025 Sep 15. doi: 10.1111\/bjh.70168. Online ahead of print.","author":"Liu Q, Dong X, Rong C, Shen Y, Xu L, Zhou M, Xu X, Cai J, Wu L, Chen S, Qiu D, Zhao J, Zhou P, Liu S, Liu W, Hu H, Zhao Y, Zhang Y, Zhou Y, Shen Y, Ye B, Xia Y, Shou L, Wu D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954566"},{"title01":"Correction: Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML","title02":"Correction: Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML","journal":"Leukemia","issue":"2025 Sep 19. doi: 10.1038\/s41375-025-02773-6. Online ahead of print.","author":"Ohlstrom D, Bakhtiari M, Mumme H, Michaud M, De Janon Gutierrez A, DeRyckere D, Ferguson KE, Chien F, Pilcher W, Satpathy S, Jordan S, Graham D, Bhasin S, Bhasin M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40973769"},{"title01":"Clonal evolution and apoptosis resistance in myelodysplastic neoplasms and acute myeloid leukemia under treatment: insights from integrative longitudinal profiling","title02":"Clonal evolution and apoptosis resistance in myelodysplastic neoplasms and acute myeloid leukemia under treatment: insights from integrative longitudinal profiling","journal":"Leukemia","issue":"2025 Sep 19. doi: 10.1038\/s41375-025-02756-7. Online ahead of print.","author":"Mazzeo P, Penir SM, Shumilov E, Wolf S, H\u00e4upl B, Markus K, Shirneshan K, Rittscher K, Brzuszkiewicz E, Aydilek E, Treiber H, Oellerich T, Ganster C, Haase D, Koch R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40973765"},{"title01":"Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study","title02":"Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study","journal":"Leukemia","issue":"2025 Sep 19. doi: 10.1038\/s41375-025-02755-8. Online ahead of print.","author":"Visentin A, Gaffo E, F\u00fcrstenau M, Rogers KA, Panagiotis B, Cui C, Miller C, Haferlach C, Plevova K, Oscier D, Davis Z, Nguyen-Khac F, Roncaglia E, Rigolin GM, Athanasiadou A, Baran-Marszak F, Valiente A, Terol MJ, Abrisqueta P, Espinet B, Puiggros A, Martines A, Bonaldi L, Mauro FR, Scarf\u00f2 L, Chatzikonstantinou T, Tausch E, Kreuzer KA, Kater A, Bosch F, Doubek M, Panagiotidis P, Kalashnikova O, Frezzato F, Calabretto G, Ruocco V, Orsi S, Cellini A, Angotzi F, Serafin A, Yi S, Eichhorst B, Woyach JA, Cuneo A, Ghia P, Stamatopoulos K, Trentin L, Bortoluzzi S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40973766"},{"title01":"Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)","title02":"Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)","journal":"Leukemia","issue":"2025 Sep 19. doi: 10.1038\/s41375-025-02644-0. Online ahead of print.","author":"Cusan M, Larkin K, Nicolet D, Jurinovic V, Mr\u00f3zek K, Batcha AMN, Rothenberg-Thurley M, Schneider S, Sauerland C, G\u00f6rlich D, Krug U, Berdel WE, Woermann BJ, Hiddemann W, Braess J, Spiekermann K, Greif PA, Blachly JS, Mims AS, Walker CJ, Walker MC, Oakes CC, Orwick S, Carroll AJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Byrd JC, Metzeler KH, Herold T, Eisfeld AK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40973764"},{"title01":"Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML","title02":"Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML","journal":"Leukemia","issue":"2025 Sep 16. doi: 10.1038\/s41375-025-02769-2. Online ahead of print.","author":"Purhonen M, Tatun M, Luukkainen K, Hung K, Sundquist H, Tafjord O, S\u00f6derlund S, Adnan-Awad S, Dohlen A, Heikkinen J, Koskenvesa P, Siitonen S, Mustjoki S, Shanmuganathan N, Bryce C, Danielsson S, Hjorth-Hansen H, Olsson-Str\u00f6mberg U, Kumagai T, Kimura S, Ross DM, Br\u00fcck O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40958033"},{"title01":"Downregulation of MICA\/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia","title02":"Downregulation of MICA\/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia","journal":"Leukemia","issue":"2025 Sep 15. doi: 10.1038\/s41375-025-02767-4. Online ahead of print.","author":"Pollyea D, Kerre T, Deeren D, Beguin Y, Lin TL, Sallman DA, Anguille S, Blum WG, Flament A, Breman E, Lonez C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954213"},{"title01":"Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemia","title02":"Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemia","journal":"Leukemia","issue":"2025 Sep 11. doi: 10.1038\/s41375-025-02763-8. Online ahead of print.","author":"Miranda-Galvis M, Tjioe KC, Sharara M, Maloney M, Keruakous AR, Jillella A, Kota V, Guha A, Cortes JE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40935825"},{"title01":"Loncastuximab tesirine elicits complete responses in secondary central nervous system lymphoma","title02":"Loncastuximab tesirine elicits complete responses in secondary central nervous system lymphoma","journal":"Br J Haematol","issue":"2025 Sep 21. doi: 10.1111\/bjh.70178. Online ahead of print.","author":"Olszewski AJ, Treaba DO, Winter A, Donnelly S, Ollila TA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40976986"},{"title01":"Comprehensive analysis of (177)Lu-lilotomab satetraxetan in lymphoma cell lines: Implications for precision radioimmunotherapy and combination schemes","title02":"Comprehensive analysis of (177)Lu-lilotomab satetraxetan in lymphoma cell lines: Implications for precision radioimmunotherapy and combination schemes","journal":"Br J Haematol","issue":"2025 Sep 18. doi: 10.1111\/bjh.70143. Online ahead of print.","author":"Patzke S, Cascione L, Melhus KB, Munz N, Arribas AJ, Gaudio E, Generalov R, Repetto-Llamazares AHV, Dahle J, Bertoni F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40967736"},{"title01":"Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm","title02":"Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm","journal":"Br J Haematol","issue":"2025 Sep;207(3):1104-1107. doi: 10.1111\/bjh.20261. Epub 2025 Jul 7.","author":"Nordkin M, Fadaos N, Leiba R, Sharon-Horesh N, Varon B, Beyar-Katz O, Levi T, Horowitz NA, Tzoran I, Lavi N, Zuckerman T, Dann EJ, Ringelstein-Harlev S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954124"},{"title01":"Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T-cell lymphoblastic lymphoma","title02":"Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T-cell lymphoblastic lymphoma","journal":"Br J Haematol","issue":"2025 Sep 16. doi: 10.1111\/bjh.70097. Online ahead of print.","author":"Li Y, Jin L, Liu W, Liu Y, Yang K, Jia Y, Yang X, Dai Y, Yang L, Liu R, Jiang L, Zheng M, Xu J, Liu A, Sun L, Gao H, Jin R, Zheng Q, Zhang Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40958529"},{"title01":"Incidence and impact of prior history of serious infection in paediatric lymphoma: A population-based study","title02":"Incidence and impact of prior history of serious infection in paediatric lymphoma: A population-based study","journal":"Br J Haematol","issue":"2025 Sep 15. doi: 10.1111\/bjh.70157. Online ahead of print.","author":"Bahabri AS, Lau C, Kim VHD, Alexander S, Gupta S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40953918"},{"title01":"Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes","title02":"Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes","journal":"Br J Haematol","issue":"2025 Sep 14. doi: 10.1111\/bjh.70161. Online ahead of print.","author":"Broccoli A, Argnani L, Pileri A, Mazzoni C, Sordi B, Pimpinelli N, Fava P, Quaglino P, Pennese E, Perrone T, Bernardelli A, Visco C, Teoli M, Flenghi L, Ibatici A, Massone C, Zinzani PL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40947509"},{"title01":"CCRL2 and who? An important driver in TP53-mutant myeloid leukemias","title02":"CCRL2 and who? An important driver in TP53<\/i>-mutant myeloid leukemias","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288631. Online ahead of print.","author":"Arnold O, Saygin C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931868"},{"title01":"Wild-type p53 overexpression in NPM1-mutated acute myeloid leukemia: potential implications for disease biology and therapy response","title02":"Wild-type p53 overexpression in NPM1<\/i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy response","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288054. Online ahead of print.","author":"Barone PD, Dzedzik S, Kleinman AS, Chin CR, Meydan C, Valencia I, Sugita M, Guzman ML, Fein JA, Kaner JD, Desai P, Roboz GJ, Melnick AM, Mason CE, Patel SS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931876"},{"title01":"Gene expression signature of IKZF1 deleted B-cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4","title02":"Gene expression signature of IKZF1<\/i> deleted B-cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4<\/i>","journal":"Br J Haematol","issue":"2025 Aug 28. doi: 10.1111\/bjh.70014. Online ahead of print.","author":"Sharma P, Leons GK, Singh V, Naseer S, Ribeyron L, Bakhshi S, Gupta R, Gajendra S, Thoudam DS, Sarawat SK, Khan MA, Pushpam D, Sahoo RK, Roy A, Gupta SK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40878232"},{"title01":"Lineage switch from KMT2A-rearranged congenital B-ALL to AML in an infant: a genomic perspective","title02":"Lineage switch from KMT2A<\/i>-rearranged congenital B-ALL to AML in an infant: a genomic perspective","journal":"Blood","issue":"2025 Aug 28;146(9):1142.","author":"Kodgule R, Vij KR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40875548"},{"title01":"Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era","title02":"Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288306. Online ahead of print.","author":"Tassi E, Orofino G, Beretta V, Valtolina V, Bergonzi GM, Noviello M, Xue E, Doglio M, Acerbis A, Lazzari L, Giglio F, Piemontese S, Diral E, Bruno A, Farina F, Dell'Acqua R, Vago L, Assanelli A, Ruggeri A, Clerici D, Corti C, Lupo-Stanghellini MT, Ciceri F, Bonini C, Greco R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905077"},{"title01":"Dental plaque microbiota following allogeneic hematopoietic cell transplantation and risk of chronic graft-versus-host disease","title02":"Dental plaque microbiota following allogeneic hematopoietic cell transplantation and risk of chronic graft-versus-host disease","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288279. Online ahead of print.","author":"Gem H, Ebadi M, Sebastian G, Abasaeed R, Lloid M, Minot SS, Dean DR, Rashidi A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905099"},{"title01":"Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide","title02":"Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.287860. Online ahead of print.","author":"Villalba M, Montoro J, Balaguer-Rosell\u00f3 A, Chor\u00e3o P, Cant\u00f3 PA, Granados P, G\u00f3mez-Segu\u00ed I, Solves P, Such E, Cervera J, Barrrag\u00e1n E, Santiago M, Gil-Ort\u00ed JV, Lamas B, Bataller A, Louro A, De la Rubia J, Sanz M\u00c1, Sanz J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905088"},{"title01":"Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group","title02":"Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.287344. Online ahead of print.","author":"Moore KLF, Rognvaldsson S, Szabo AG, Vaitek\u0117nait\u0117 V, Loigom D, Genell A, Thorsen J, Norgaard JN, Thorsteinsdottir S, Knut-Bojanowska D, Lysen A, Schjesvold F, Peceliunas V, Kaare A, Palk K, Parnat M, Sigurdsson A, Vangsted AJ, Blimark CH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905090"},{"title01":"HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","title02":"HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.289055. Online ahead of print.","author":"Desai N, Mattsson J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931871"},{"title01":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Response to Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","title02":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Response to Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288957. Online ahead of print.","author":"Bethge W, Dreger P; German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy e.V. (DAG-HSZT), German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931877"},{"title01":"Age-related differences in donor selection priorities for allogeneic hematopoietic transplantation","title02":"Age-related differences in donor selection priorities for allogeneic hematopoietic transplantation","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288004. Online ahead of print.","author":"Kawamura K, Kanda J, Seo S, Kimura F, Hirayama M, Uchida N, Doki N, Takeda W, Nishida T, Katayama Y, Tanaka M, Sawa M, Yoshihara S, Eto T, Kawakita T, Nakamae H, Ota S, Ishimaru F, Fukuda T, Atsuta Y, Kanda Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931859"},{"title01":"Allogeneic hematopoietic cell transplantation rescues congenital red cell aplasia in H syndrome due to SLC29A3 mutations","title02":"Allogeneic hematopoietic cell transplantation rescues congenital red cell aplasia in H syndrome due to SLC29A3<\/i> mutations","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.288098. Online ahead of print.","author":"Quigg TC, Kurt BA, Seaver LH, Holsworth AR, Duffner UA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874332"},{"title01":"Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation","title02":"Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2024.287157. Online ahead of print.","author":"Bordat J, Kaphan E, Robin M, Xhaard A, De Fontbrune FS, Chevillon F, Socie G, De Latour RP, Michonneau D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874329"},{"title01":"Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)","title02":"Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)","journal":"Br J Haematol","issue":"2025 Sep 9. doi: 10.1111\/bjh.70074. Online ahead of print.","author":"Tsai XC, Yao ZH, Chou SW, Hu HC, Liu YC, Chen CH, Yeh SP, Huang WC, Lin TL, Yang TM, Lai CH, Ko HK, Kuo YW, Hsu HH, Cheng SL, Li CC, Ko BS, Wang HC; Taiwan Society of Blood and Marrow Transplantation and Taiwan Society of Pulmonary and Critical Care Medicine.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40926299"},{"title01":"UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)","title02":"UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)","journal":"Br J Haematol","issue":"2025 Sep 9. doi: 10.1111\/bjh.70061. Online ahead of print.","author":"Clark A, Clouston H, Rao K, Folarin N, De la Fuente J, Hamblin A, Olavarria E, Richardson D, Talley P, Potter V, Loke J, McVeigh T, Snowden J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40926330"},{"title01":"Enterococcus proliferates via the phosphotransferase system in the disrupted gut microbiota after allogeneic haematopoietic stem cell transplantation","title02":"Enterococcus proliferates via the phosphotransferase system in the disrupted gut microbiota after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Sep 7. doi: 10.1111\/bjh.70142. Online ahead of print.","author":"Hino A, Kusakabe S, Oka K, Kudo H, Ariyoshi T, Hayashi A, Takahashi M, Onizuka M, Takeda K, Mori M, Hosen N, Fukushima K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40916567"},{"title01":"Adoptive transfer of third-party donor CMV-specific T cells for refractory cytomegalovirus infection following umbilical cord blood transplantation","title02":"Adoptive transfer of third-party donor CMV-specific T cells for refractory cytomegalovirus infection following umbilical cord blood transplantation","journal":"Br J Haematol","issue":"2025 Sep 10. doi: 10.1111\/bjh.70136. Online ahead of print.","author":"Sun G, Tu J, Tang B, Lu Z, Fang X, Liu H, Han Y, Sun Z, Zheng C, Zhu X, Tong J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931393"},{"title01":"The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation","title02":"The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation","journal":"Br J Haematol","issue":"2025 Sep 3. doi: 10.1111\/bjh.70105. Online ahead of print.","author":"Pei XY, Yin XY, Sun HL, Zhao ZF, Ma L, Wei FF, Zhao XS, Zhang YY, Sun YQ, Mo XD, Wang Y, Xu LP, Zhang XH, Huang XJ, Lv M, Zhao XY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40903398"},{"title01":"Dental plaque microbiota following allogeneic hematopoietic cell transplantation and risk of chronic graft-versus-host disease","title02":"Dental plaque microbiota following allogeneic hematopoietic cell transplantation and risk of chronic graft-versus-host disease","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288279. Online ahead of print.","author":"Gem H, Ebadi M, Sebastian G, Abasaeed R, Lloid M, Minot SS, Dean DR, Rashidi A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905099"},{"title01":"Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide","title02":"Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.287860. Online ahead of print.","author":"Villalba M, Montoro J, Balaguer-Rosell\u00f3 A, Chor\u00e3o P, Cant\u00f3 PA, Granados P, G\u00f3mez-Segu\u00ed I, Solves P, Such E, Cervera J, Barrrag\u00e1n E, Santiago M, Gil-Ort\u00ed JV, Lamas B, Bataller A, Louro A, De la Rubia J, Sanz M\u00c1, Sanz J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905088"},{"title01":"Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group","title02":"Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.287344. Online ahead of print.","author":"Moore KLF, Rognvaldsson S, Szabo AG, Vaitek\u0117nait\u0117 V, Loigom D, Genell A, Thorsen J, Norgaard JN, Thorsteinsdottir S, Knut-Bojanowska D, Lysen A, Schjesvold F, Peceliunas V, Kaare A, Palk K, Parnat M, Sigurdsson A, Vangsted AJ, Blimark CH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905090"},{"title01":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Response to Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","title02":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Response to Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288957. Online ahead of print.","author":"Bethge W, Dreger P; German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy e.V. (DAG-HSZT), German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931877"},{"title01":"Allogeneic hematopoietic cell transplantation rescues congenital red cell aplasia in H syndrome due to SLC29A3 mutations","title02":"Allogeneic hematopoietic cell transplantation rescues congenital red cell aplasia in H syndrome due to SLC29A3<\/i> mutations","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.288098. Online ahead of print.","author":"Quigg TC, Kurt BA, Seaver LH, Holsworth AR, Duffner UA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874332"},{"title01":"Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation","title02":"Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2024.287157. Online ahead of print.","author":"Bordat J, Kaphan E, Robin M, Xhaard A, De Fontbrune FS, Chevillon F, Socie G, De Latour RP, Michonneau D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874329"},{"title01":"UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)","title02":"UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)","journal":"Br J Haematol","issue":"2025 Sep 9. doi: 10.1111\/bjh.70061. Online ahead of print.","author":"Clark A, Clouston H, Rao K, Folarin N, De la Fuente J, Hamblin A, Olavarria E, Richardson D, Talley P, Potter V, Loke J, McVeigh T, Snowden J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40926330"},{"title01":"Enterococcus proliferates via the phosphotransferase system in the disrupted gut microbiota after allogeneic haematopoietic stem cell transplantation","title02":"Enterococcus proliferates via the phosphotransferase system in the disrupted gut microbiota after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Sep 7. doi: 10.1111\/bjh.70142. Online ahead of print.","author":"Hino A, Kusakabe S, Oka K, Kudo H, Ariyoshi T, Hayashi A, Takahashi M, Onizuka M, Takeda K, Mori M, Hosen N, Fukushima K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40916567"},{"title01":"The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation","title02":"The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation","journal":"Br J Haematol","issue":"2025 Sep 3. doi: 10.1111\/bjh.70105. Online ahead of print.","author":"Pei XY, Yin XY, Sun HL, Zhao ZF, Ma L, Wei FF, Zhao XS, Zhang YY, Sun YQ, Mo XD, Wang Y, Xu LP, Zhang XH, Huang XJ, Lv M, Zhao XY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40903398"},{"title01":"Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as\u00a0outpatient versus inpatient","title02":"Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as\u00a0outpatient versus inpatient","journal":"Br J Haematol","issue":"2025 Sep 2. doi: 10.1111\/bjh.70104. Online ahead of print.","author":"Avila Rodriguez AM, Hu X, Varga C, Comenzo R, Sarosiek S, Sloan JM, Sanchorawala V, Doros G, Quillen K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40898649"},{"title01":"Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory\/relapsed Hodgkin lymphoma: A retrospective analysis","title02":"Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory\/relapsed Hodgkin lymphoma: A retrospective analysis","journal":"Br J Haematol","issue":"2025 Aug 31. doi: 10.1111\/bjh.70091. Online ahead of print.","author":"Mariotti J, Pinton C, Giordano L, Taurino D, Sarina B, De Philippis C, Mannina D, Tentori C, Santoro A, Bramanti S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40887735"},{"title01":"Quality of life the first year after allogeneic haematopoietic stem cell transplantation-A randomized controlled trial examining extracorporeal photophoresis to prevent graft-versus-host disease","title02":"Quality of life the first year after allogeneic haematopoietic stem cell transplantation-A randomized controlled trial examining extracorporeal photophoresis to prevent graft-versus-host disease","journal":"Br J Haematol","issue":"2025 Aug 26. doi: 10.1111\/bjh.70119. Online ahead of print.","author":"Iversen PO, Gedde-Dahl T, Tj\u00f8nnfjord GE, Ali MM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40875520"},{"title01":"Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging","title02":"Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging","journal":"Blood","issue":"2025 Sep 8:blood.2024027432. doi: 10.1182\/blood.2024027432. Online ahead of print.","author":"Zhang S, Ayemoba CE, Di Staulo AM, Joves K, Patel CM, Leung EHW, Bueno MLP, Du X, Poncz M, Ong SG, Nerlov C, Maryanovich M, Chronis C, Pinho S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40920871"},{"title01":"CUX1 restrains latent hematopoietic stem cell plasticity by suppressing stem cell-intrinsic inflammatory pathways","title02":"CUX1 restrains latent hematopoietic stem cell plasticity by suppressing stem cell-intrinsic inflammatory pathways","journal":"Blood","issue":"2025 Sep 8:blood.2024026815. doi: 10.1182\/blood.2024026815. Online ahead of print.","author":"Martinez TC, Jotte MRM, Khan S, Stoddart A, Blaylock HZ, Malik A, McNerney ME.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40920873"},{"title01":"Getting back on track to meet global anaemia reduction targets: a Lancet Haematology Commission","title02":"Getting back on track to meet global anaemia reduction targets: a Lancet Haematology<\/i> Commission","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e717-e767.","author":"Atkinson SH, Suchdev PS, Bode M, Carducci B, Cerami C, Mwangi MN, Namaste S, Winichagoon P, Leung S, Mutua AM, Abuga KM, Angeles-Agdeppa I, Blythe R, Carvalho N, Cepeda-Lopez A, Cross JH, de Pee S, Di Ruggiero E, Fanzo J, Gentilini U, Gichohi-Wainaina WN, Glover-Wright C, Gomes F, Hess S, Holloway-Brown J, Joof F, Karakochuk C, Kassebaum NJ, Larson L, Mettananda S, Muriuki JM, Mwangome M, Ohuma EO, Oliver V, Perumal N, Phiri K, Samuel F, Sinharoy S, Tizifa T, Valleriani G, van Zutphen-K\u00fcffer KG, Vasta F, Verhoef H, Wang Y, Yadav K, Yang Z, Young M, Zimmermann MB, Pasricha SR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882649"},{"title01":"Estimated unit costs of anaemia interventions for women of reproductive age in 193 UN member states: a costing study","title02":"Estimated unit costs of anaemia interventions for women of reproductive age in 193 UN member states: a costing study","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e684-e693.","author":"Oliver VL, Wang Y, Leung S, Blythe R, Glover-Wright C, Holloway-Brown J, Bode M, Pasricha SR, Carvalho N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882647"},{"title01":"Cost-effective targets for anaemia reduction in 191 countries: a modelling study","title02":"Cost-effective targets for anaemia reduction in 191 countries: a modelling study","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e674-e683.","author":"Blythe R, Carvalho N, Holloway-Brown J, Leung S, Oliver VL, Wang Y, Glover-Wright C, Pasricha SR, Bode M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882648"},{"title01":"Two mothers’ perspectives on childhood anaemia in Kilifi, Kenya","title02":"Two mothers’ perspectives on childhood anaemia in Kilifi, Kenya","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e672-e673.","author":"Mutua AM, Atkinson SH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882651"},{"title01":"Experience of the Anaemia Mukt Bharat anaemia control programme in India","title02":"Experience of the Anaemia Mukt<\/i> Bharat anaemia control programme in India","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e671-e672.","author":"Yadav K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882650"},{"title01":"Anaemia in a time of climate crisis","title02":"Anaemia in a time of climate crisis","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e668-e669.","author":"Fanzo J, Carducci B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882652"},{"title01":"USAID’s enduring impact on anaemia management must be preserved","title02":"USAID’s enduring impact on anaemia management must be preserved","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e666-e668.","author":"Dary O, Peniston AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882654"},{"title01":"Global initiatives to accelerate anaemia reduction","title02":"Global initiatives to accelerate anaemia reduction","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e664-e665.","author":"Rogers LM, Nieves Garcia-Casal M, Flores-Urrutia MC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882653"},{"title01":"Towards achievable targets for anaemia reduction","title02":"Towards achievable targets for anaemia reduction","journal":"Lancet Haematol","issue":"2025 Sep;12(9):e663.","author":"The Lancet Haematology.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40882646"},{"title01":"Romiplostim for aplastic anemia: beyond an eltrombopag alternative","title02":"Romiplostim for aplastic anemia: beyond an eltrombopag alternative","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288632. Online ahead of print.","author":"Nakao S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905092"},{"title01":"Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study","title02":"Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study","journal":"Br J Haematol","issue":"2025 Sep 8. doi: 10.1111\/bjh.70144. Online ahead of print.","author":"Ishiyama K, Yamazaki M, Maruyama H, Hosono N, Yamaguchi H, Asada N, Tanimoto K, Sugiura H, Usuki K, Yoshimura K, Ogawa S, Kanakura Y, Matsumura I, Akashi K, Nakao S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40921497"},{"title01":"Intestinal hepcidin overexpression promotes iron deficiency anemia and counteracts iron overload via DMT1 downregulation","title02":"Intestinal hepcidin overexpression promotes iron deficiency anemia and counteracts iron overload via DMT1 downregulation","journal":"Blood","issue":"2025 Sep 9:blood.2025028370. doi: 10.1182\/blood.2025028370. Online ahead of print.","author":"Falabr\u00e8gue M, Aurrand C, Cazaulon L, Boussetta N, Zumerle S, Karim Z, Djebrani-Oussedik N, Poupon J, Guilmeau S, Dupe E, Aucouturier A, Langella P, Bermudez-Humaran LG, Vaulont S, Peyssonnaux C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40925095"},{"title01":"Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study","title02":"Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study","journal":"Br J Haematol","issue":"2025 Sep 7. doi: 10.1111\/bjh.70145. Online ahead of print.","author":"Dam M, Centanni M, Centanni D, Friberg LE, Karlsson MO, Lynggaard LS, Johannsdottir IM, Lepik K, Vaitkeviciene GE, Griskevicius L, P\u00f6yh\u00f6nen T, Py\u00f6r\u00e4l\u00e4 M, J\u00f3nsson \u00d3G, Quist-Paulsen P, Schmiegelow K, Christoforaki T, Overgaard U, Hansen SN, Albertsen BK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40916350"},{"title01":"Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemia","title02":"Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemia","journal":"Br J Haematol","issue":"2025 Sep 10. doi: 10.1111\/bjh.70113. Online ahead of print.","author":"Poh C, Chen X, Voutsinas J, Naresh K, Dizon JJ, Shadman M, Lynch RC, Till BG, Ujjani CS, Di M, Raghunathan V, Warren EH, Smith SD, Wu QV, Cherian S, Gopal AK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931545"},{"title01":"Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia","title02":"Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Sep 3. doi: 10.1111\/bjh.70135. Online ahead of print.","author":"Boudry A, Goursaud L, Lebon D, Dumezy F, Harrivel V, Boue-Raguet A, Joudinaud R, Marceau-Renaut A, Geffroy S, Hauspie C, Brijs J, Fenwarth L, Berthon C, Marolleau JP, Figeac M, Preudhomme C, Duployez N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40903763"},{"title01":"The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia","title02":"The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2025 Sep 1. doi: 10.1111\/bjh.20260. Online ahead of print.","author":"Pourhassan H, Tinajero J, Ma H, Jackson R, Pillai R, Ngo D, Agrawal V, Koller P, Ball B, Blackmon A, Salhotra A, Al Malki M, Aribi A, Otoukesh S, Artz A, Becker P, Nakamura R, Stein A, Forman S, Marcucci G, Pullarkat V, Aldoss I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40890465"},{"title01":"Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia","title02":"Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia","journal":"Br J Haematol","issue":"2025 Aug 31. doi: 10.1111\/bjh.70106. Online ahead of print.","author":"Meyer JA, Xirenayi S, Werner J, Turakulov R, Hechmer A, Abdullaev Z, Hamdy N, Olshen A, Stieglitz E, Hammad M, Elhaddad A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40887320"},{"title01":"Measurable residual disease-guided therapy in acute myeloid leukaemia: Practical insights","title02":"Measurable residual disease-guided therapy in acute myeloid leukaemia: Practical insights","journal":"Br J Haematol","issue":"2025 Aug 31. doi: 10.1111\/bjh.70038. Online ahead of print.","author":"Nachmias B, Haran A, Yisraeli Salman M, Stein EM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40887043"},{"title01":"Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia","title02":"Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia","journal":"Br J Haematol","issue":"2025 Aug 29. doi: 10.1111\/bjh.70131. Online ahead of print.","author":"Hoang T, Cheung MC, Juurlink DN, Chan KKW, Lau C, Liu N, Abdel-Qadir H, Prica A, Hay AE, Vijenthira A, Mozessohn L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40878718"},{"title01":"Breaking ribosomes to fight leukemia","title02":"Breaking ribosomes to fight leukemia","journal":"Blood","issue":"2025 Sep 4;146(10):1155-1156.95.","author":"Papapetrou EP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40906502"},{"title01":"Acalabrutinib treatment for older (\u226580 years old) and\/or frail patients with CLL: primary end point analysis of the CLL-Frail trial","title02":"Acalabrutinib treatment for older (\u226580 years old) and\/or frail patients with CLL: primary end point analysis of the CLL-Frail trial","journal":"Blood","issue":"2025 Sep 4:blood.2025028550. doi: 10.1182\/blood.2025028550. Online ahead of print.","author":"Simon F, Ligtvoet R, Bohn JP, N\u00f6sslinger T, von Tresckow J, Liersch R, Gaska T, Jentsch-Ulrich K, G\u00e4rtner M, Wolff T, Schwaner I, Wolf D, Schneider C, Vehling-Kaiser U, Ritgen M, Spoer C, Eckart MJ, Decker T, Chakupurakal G, Sch\u00f6ttker B, Kisro J, Kreuzer KA, Tausch E, Stilgenbauer S, Robrecht S, Stumpf J, Fink A, F\u00fcrstenau M, Fischer K, Goede V, Hallek MJ, Eichhorst BF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40906922"},{"title01":"Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells","title02":"Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells","journal":"Blood","issue":"2025 Sep 4:blood.2024028194. doi: 10.1182\/blood.2024028194. Online ahead of print.","author":"Venkatesh H, Granados Centeno E, Luo Q, Arroyo M, Heltemes Harris LM, Knutson TP, Qiu Y, Haaning A, Webber BR, Bachanova V, Farrar MA, Tracy SI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40906918"},{"title01":"Clinical management of bispecific antibody therapy for lymphoma: A British Society for Haematology Good Practice Paper","title02":"Clinical management of bispecific antibody therapy for lymphoma: A British Society for Haematology Good Practice Paper","journal":"Br J Haematol","issue":"2025 Sep 5. doi: 10.1111\/bjh.70018. Online ahead of print.","author":"Chaganti S, Dulobdas V, Wilson MR, Tucker D, Townsend W, Parry-Jones N, Lewis D, Fox CP, Osborne W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40910188"},{"title01":"Two-year follow-up of relmacabtagene autoleucel in relapsed or refractory follicular lymphoma in RELIANCE study","title02":"Two-year follow-up of relmacabtagene autoleucel in relapsed or refractory follicular lymphoma in RELIANCE study","journal":"Br J Haematol","issue":"2025 Sep 1. doi: 10.1111\/bjh.20122. Online ahead of print.","author":"Song Y, Zou D, Yang H, Wu J, Guo Y, Li W, Liu H, Xia Z, Zhang Y, Zhou Z, Zhu J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40888120"},{"title01":"Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas","title02":"Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas","journal":"Br J Haematol","issue":"2025 Aug 31. doi: 10.1111\/bjh.70132. Online ahead of print.","author":"Montes L, Choquet S, Uzunov M, Morel V, Baron M, Roos-Weil D, Joris M, Delette C, Lebon D, Azar N, Metz C, Nichelli L, Le Garff-Tavernier M, Boccon-Gibod C, Lacan C, Souchet L, Hoang-Xuan K, Soussain C, Boussen I, Houillier C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40887743"},{"title01":"European-based polygenic risk score and genome-wide association study of B-cell non-Hodgkin lymphoma subtypes in Israeli Jews and Palestinian Arabs","title02":"European-based polygenic risk score and genome-wide association study of B-cell non-Hodgkin lymphoma subtypes in Israeli Jews and Palestinian Arabs","journal":"Br J Haematol","issue":"2025 Aug 31. doi: 10.1111\/bjh.70125. Online ahead of print.","author":"Kleinstern G, Robinson DP, Abu Seir R, Perlman R, Liu J, Jebrini N, Elyan H, Ben Yehuda D, Slager SL, Paltiel O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40887045"},{"title01":"Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory\/relapsed Hodgkin lymphoma: A retrospective analysis","title02":"Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory\/relapsed Hodgkin lymphoma: A retrospective analysis","journal":"Br J Haematol","issue":"2025 Aug 31. doi: 10.1111\/bjh.70091. Online ahead of print.","author":"Mariotti J, Pinton C, Giordano L, Taurino D, Sarina B, De Philippis C, Mannina D, Tentori C, Santoro A, Bramanti S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40887735"},{"title01":"Towards a chemo-free approach for follicular lymphoma","title02":"Towards a chemo-free approach for follicular lymphoma","journal":"Br J Haematol","issue":"2025 Aug 30. doi: 10.1111\/bjh.70126. Online ahead of print.","author":"Luminari S, Barbieri E, Nizzoli ME.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40884311"},{"title01":"Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma","title02":"Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma","journal":"Blood","issue":"2025 Sep 8:blood.2025029909. doi: 10.1182\/blood.2025029909. Online ahead of print.","author":"Falchi L, Sureda A, Lepp\u00e4 S, Vermaat JS, Nijland M, Christensen JH, de Vos S, Holte H, Merryman RW, Lugtenburg PJ, Abrisqueta P, Linton K, Sunkersett G, Hoehn D, Rana A, Abbas A, Marek J, Hao Y, Steele AJ, Morehouse C, Hutchings M, Belada D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40920572"},{"title01":"Classic Hodgkin lymphoma: the journey over the destination","title02":"Classic Hodgkin lymphoma: the journey over the destination","journal":"Blood","issue":"2025 Sep 4;146(10):1152-1153.","author":"Havranek O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40906501"},{"title01":"The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma","title02":"The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma","journal":"Blood","issue":"2025 Sep 2:blood.2025029163. doi: 10.1182\/blood.2025029163. Online ahead of print.","author":"Tatterton DJ, Newby ML, Allen JD, Sale BJ, Chiodin G, Duriez PJ, Butler J, McCann KJ, Scott DW, Morin RD, Dreval K, Davies AJ, Bryant D, Crispin M, Forconi F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40896832"},{"title01":"Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell Lymphoma","title02":"Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell Lymphoma","journal":"Blood","issue":"2025 Sep 2:blood.2024027997. doi: 10.1182\/blood.2024027997. Online ahead of print.","author":"Pal I, Illendula A, Joyner AM, Manavalan JS, Deddens TM, Sabzevari A, Damera DP, Zuberi S, Marchi E, Fox TE, Brown MD, Danappa Jayappa K, Khalife J, Craig JW, Loughran TP, Feith DJ, O'Connor OA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40896830"},{"title01":"Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma","title02":"Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma","journal":"Leukemia","issue":"2025 Sep 10. doi: 10.1038\/s41375-025-02757-6. Online ahead of print.","author":"Neubert S, Munawar U, Mersi J, Noderer J, Nerreter S, Kurian S, Han S, Verbruggen C, Besant E, Rein N, K\u00f6ppel M, Lehmann J, K\u00f6hler T, Labinsky H, H\u00e4usl S, Tamamushi Y, Zhou X, Pinter J, Herzog AL, Lopau K, Hoxha E, Rummelt C, Gerhard-Hartmann E, Rosenwald A, Steinbrunn T, Nerreter T, Hudecek M, Einsele H, Rasche L, Kort\u00fcm KM, Waldschmidt JM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931044"},{"title01":"The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma","title02":"The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma","journal":"Leukemia","issue":"2025 Aug 26. doi: 10.1038\/s41375-025-02736-x. Online ahead of print.","author":"Zocchi S, Trichet P, Guernalec P, Agdada M, Alonso Bartolom\u00e9 A, Ogor V, Choisy C, Vias C, Sabat\u00e9-Cadenas X, Bories JC, Goodhardt M, Shkumatava A, Garrick D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40858807"},{"title01":"Tumultuous Development of Venetoclax in t(11;14) Multiple Myeloma","title02":"Tumultuous Development of Venetoclax in t(11;14) Multiple Myeloma","journal":"J Clin Oncol","issue":"2025 Sep 10:JCO2501088. doi: 10.1200\/JCO-25-01088. Online ahead of print.","author":"Kaiser MF, Cliff ERS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40929614"},{"title01":"HBV infection in the era of T-cell engagers in multiple myeloma: unresolved challenges and unmet needs. Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies","title02":"HBV infection in the era of T-cell engagers in multiple myeloma: unresolved challenges and unmet needs. Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288942. Online ahead of print.","author":"Rago A, Ridola L, Di Toritto TC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905098"},{"title01":"Infection risk in 158 patients with relapsed\/refractory multiple myeloma treated with bispecific antibodies: a single-center experience","title02":"Infection risk in 158 patients with relapsed\/refractory multiple myeloma treated with bispecific antibodies: a single-center experience","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288187. Online ahead of print.","author":"Cani L, Scott SA, Roberts D, Joseph NS, Hofmeister CC, Gupta VA, Dhodapkar MV, Lonial S, Nooka AK, Kaufman JL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905083"},{"title01":"The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes – insights from a single-site study","title02":"The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes – insights from a single-site study","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.287760. Online ahead of print.","author":"Bauer MA, Farmer P, Su JL, Schootman M, Li C, Van Rhee F, Al Hadidi S, Schinke C, Shaughnessy JD, Zhan F, Ashby C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905079"},{"title01":"Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group","title02":"Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.287344. Online ahead of print.","author":"Moore KLF, Rognvaldsson S, Szabo AG, Vaitek\u0117nait\u0117 V, Loigom D, Genell A, Thorsen J, Norgaard JN, Thorsteinsdottir S, Knut-Bojanowska D, Lysen A, Schjesvold F, Peceliunas V, Kaare A, Palk K, Parnat M, Sigurdsson A, Vangsted AJ, Blimark CH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905090"},{"title01":"Response to Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with haematological malignancies","title02":"Response to Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with haematological malignancies","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.289053. Online ahead of print.","author":"Rees MJ, Quach H, Jardine D, Thompson A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931863"},{"title01":"Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma","title02":"Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.288203. Online ahead of print.","author":"Musa H, Mielnik M, Trudel S, Weisel K, Mockus-Daehn T, Ferron-Brady G, Hong Q, Ma Y, Patel S, Suchindran S, Zhou X, Richardson PG, Cohen AD, Lowther DE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874339"},{"title01":"Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed\/refractory multiple myeloma: results from the French real-world EMMY study","title02":"Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed\/refractory multiple myeloma: results from the French real-world EMMY study","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.287954. Online ahead of print.","author":"Chalopin T, Hulin C, Royer B, Bastie JN, Bobin A, Merzoug KB, Macro M, Karlin L, Jacquet C, Mohty M, Frenzel L, Sonntag C, Fontan J, Rigaudeau S, Roussel M, Sanhes L, Chaoui D, Vincent L, Orfeuvre H, Bouketouche M, Garlantezec R, Decaux O, Perrot A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874328"},{"title01":"Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group","title02":"Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group","journal":"Br J Haematol","issue":"2025 Sep 3. doi: 10.1111\/bjh.70041. Online ahead of print.","author":"Moore S, Miller H, Parrish C, Seymour F, Miller L, Chandler T, Land J, Karpha I, Brearton G, Thompson S, Clayton L, Jones J, McMillan A, McCourt O, Pawlyn C, Mian H, Cook G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40903837"},{"title01":"Differences in adverse events between manuscript and drug labels for myeloma T-cell-redirecting therapies","title02":"Differences in adverse events between manuscript and drug labels for myeloma T-cell-redirecting therapies","journal":"Br J Haematol","issue":"2025 Jul 27. doi: 10.1111\/bjh.70042. Online ahead of print.","author":"Bashy B, Shah D, Steensma D, Van Oekelen O, Chakraborty R, Mohyuddin GR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40923801"},{"title01":"Emerging role of G protein-coupled receptor class C group 5 member D-directed immunotherapy in multiple myeloma: Advances, resistance and combination strategies","title02":"Emerging role of G protein-coupled receptor class C group 5 member D-directed immunotherapy in multiple myeloma: Advances, resistance and combination strategies","journal":"Br J Haematol","issue":"2025 Aug 29. doi: 10.1111\/bjh.70116. Online ahead of print.","author":"Wang X, Cui Y, Wang Y, Fang B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40879107"},{"title01":"Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy","title02":"Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy","journal":"Blood","issue":"2025 Sep 8:blood.2025028441. doi: 10.1182\/blood.2025028441. Online ahead of print.","author":"Bruno T, Cappelletto MC, Cortile C, Di Giovenale S, Amadio B, De Nicola F, Falcone I, Giuliani S, Palermo B, Catena V, Ciuffreda L, Cerruti F, Cascio P, Merola R, Masi S, De Pascale V, Annibali O, Ferraro S +39, Gumenyuk S, Pisani F, Marchesi F, Mengarelli A, Fanciulli M, Corleone G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40920573"},{"title01":"Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry","title02":"Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry","journal":"Leukemia","issue":"2025 Sep 1. doi: 10.1038\/s41375-025-02744-x. Online ahead of print.","author":"Alfonso-Pierola A, Martinez-Cuadr\u00f3n D, Rodr\u00edguez-Veiga R, Gil C, Mart\u00ednez-S\u00e1nchez P, Bernal T, Benavente C, Romero-Riquelme MA, Serrano-Lopez J, Bergua JM, Garc\u00eda-Boyero R, Tormo M, Herrera P, Sossa-Melo CL, P\u00e9rez-Simon JA, Rodr\u00edguez-Medina C, Bass-Maturana MF, L\u00f3pez-Lorenzo JL, Algarra-Algarra L, Vidriales-Vicente B, P\u00e9rez-Encinas M, Barrios-Garc\u00eda M, Vives S, Sayas-Lloris MJ, Capurro M, Hidalgo S, Olave M, Cuervo-Lozada D, Lavilla-Rubira E, Casado F, Mena-Dur\u00e1n A, Valero-Nu\u00f1ez M, Casado-Calder\u00f3n S, Balerdi A, Torres V, Fern\u00e1ndez R, Noriega V, Stevenazzi M, Labrador J, Le\u00f3n-Maldonado P, de Rueda-Ciller B, Arce-Fern\u00e1ndez O, Amigo ML, Raposo-Puglia J\u00c1, Sol\u00e9 M, Boluda B, Ayala R, Barrag\u00e1n E, Montesinos P; PETHEMA Group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40890512"},{"title01":"Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as\u00a0outpatient versus inpatient","title02":"Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as\u00a0outpatient versus inpatient","journal":"Br J Haematol","issue":"2025 Sep 2. doi: 10.1111\/bjh.70104. Online ahead of print.","author":"Avila Rodriguez AM, Hu X, Varga C, Comenzo R, Sarosiek S, Sloan JM, Sanchorawala V, Doros G, Quillen K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40898649"},{"title01":"Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory\/relapsed Hodgkin lymphoma: A retrospective analysis","title02":"Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory\/relapsed Hodgkin lymphoma: A retrospective analysis","journal":"Br J Haematol","issue":"2025 Aug 31. doi: 10.1111\/bjh.70091. Online ahead of print.","author":"Mariotti J, Pinton C, Giordano L, Taurino D, Sarina B, De Philippis C, Mannina D, Tentori C, Santoro A, Bramanti S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40887735"},{"title01":"Quality of life the first year after allogeneic haematopoietic stem cell transplantation-A randomized controlled trial examining extracorporeal photophoresis to prevent graft-versus-host disease","title02":"Quality of life the first year after allogeneic haematopoietic stem cell transplantation-A randomized controlled trial examining extracorporeal photophoresis to prevent graft-versus-host disease","journal":"Br J Haematol","issue":"2025 Aug 26. doi: 10.1111\/bjh.70119. Online ahead of print.","author":"Iversen PO, Gedde-Dahl T, Tj\u00f8nnfjord GE, Ali MM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40875520"},{"title01":"Innate lymphoid cells prevent graft-versus-host disease via IL-9-driven T-cell senescence","title02":"Innate lymphoid cells prevent graft-versus-host disease via IL-9-driven T-cell senescence","journal":"Blood","issue":"2025 Sep 4:blood.2025028504. doi: 10.1182\/blood.2025028504. Online ahead of print.","author":"Tufa DM, Hoffmeyer E, Schaller KL, Kooiman B, Woods E, Wang D, Jones DC, Hall SC, Cruz Cruz J, Vernaris M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40906917"},{"title01":"Hole in one: CD137-ADC eliminates GVHD","title02":"Hole in one: CD137-ADC eliminates GVHD","journal":"Blood","issue":"2025 Aug 28;146(9):1038-1040.","author":"Nierkens S, Lindemans CA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40875553"},{"title01":"Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry","title02":"Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry","journal":"Leukemia","issue":"2025 Sep 1. doi: 10.1038\/s41375-025-02744-x. Online ahead of print.","author":"Alfonso-Pierola A, Martinez-Cuadr\u00f3n D, Rodr\u00edguez-Veiga R, Gil C, Mart\u00ednez-S\u00e1nchez P, Bernal T, Benavente C, Romero-Riquelme MA, Serrano-Lopez J, Bergua JM, Garc\u00eda-Boyero R, Tormo M, Herrera P, Sossa-Melo CL, P\u00e9rez-Simon JA, Rodr\u00edguez-Medina C, Bass-Maturana MF, L\u00f3pez-Lorenzo JL, Algarra-Algarra L, Vidriales-Vicente B, P\u00e9rez-Encinas M, Barrios-Garc\u00eda M, Vives S, Sayas-Lloris MJ, Capurro M, Hidalgo S, Olave M, Cuervo-Lozada D, Lavilla-Rubira E, Casado F, Mena-Dur\u00e1n A, Valero-Nu\u00f1ez M, Casado-Calder\u00f3n S, Balerdi A, Torres V, Fern\u00e1ndez R, Noriega V, Stevenazzi M, Labrador J, Le\u00f3n-Maldonado P, de Rueda-Ciller B, Arce-Fern\u00e1ndez O, Amigo ML, Raposo-Puglia J\u00c1, Sol\u00e9 M, Boluda B, Ayala R, Barrag\u00e1n E, Montesinos P; PETHEMA Group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40890512"},{"title01":"Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era","title02":"Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288306. Online ahead of print.","author":"Tassi E, Orofino G, Beretta V, Valtolina V, Bergonzi GM, Noviello M, Xue E, Doglio M, Acerbis A, Lazzari L, Giglio F, Piemontese S, Diral E, Bruno A, Farina F, Dell'Acqua R, Vago L, Assanelli A, Ruggeri A, Clerici D, Corti C, Lupo-Stanghellini MT, Ciceri F, Bonini C, Greco R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905077"},{"title01":"Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML","title02":"Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML","journal":"Leukemia","issue":"2025 Sep 10. doi: 10.1038\/s41375-025-02748-7. Online ahead of print.","author":"Ohlstrom D, Bakhtiari M, Mumme H, Michaud M, De Janon Gutierrez A, DeRyckere D, Ferguson KE, Chien F, Pilcher W, Satpathy S, Jordan S, Graham D, Bhasin S, Bhasin M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931047"},{"title01":"A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia","title02":"A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia","journal":"Leukemia","issue":"2025 Sep 10. doi: 10.1038\/s41375-025-02739-8. Online ahead of print.","author":"Kanari M, Jimenez Garcia I, Steffen FD, Krattiger LA, Bataclan C, Liu W, Simona BR, Deplancke B, Naveiras O, Ehrbar M, Bornhauser B, Bourquin JP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931046"},{"title01":"PML::RAR\u03b1+ myeloid cells display metabolic alterations that can be targeted to treat resistant\/relapse acute promyelocytic leukemias","title02":"PML::RAR\u03b1+ myeloid cells display metabolic alterations that can be targeted to treat resistant\/relapse acute promyelocytic leukemias","journal":"Leukemia","issue":"2025 Sep 10. doi: 10.1038\/s41375-025-02738-9. Online ahead of print.","author":"Zaza A, Zardo G, Banella C, Tucci S, de Marinis E, Gentile M, Travaglini S, Divona M, Ottone T, Castelli G, Cerio AM, Angelini DF, Faraoni I, Palmieri R, Niscola P, Ammatuna E, Venditti A, Nervi C, Voso MT, Catalano G, Noguera NI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931045"},{"title01":"Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial","title02":"Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial","journal":"Leukemia","issue":"2025 Sep 3. doi: 10.1038\/s41375-025-02747-8. Online ahead of print.","author":"Mocking TR, Haaksma LH, Reuvekamp T, Kelder A, Scholten WJ, Ngai LL, Breems DA, Fischer T, Gjertsen BT, Gri\u0161kevi\u010dius L, Juliusson G, Maertens JA, Manz MG, Pabst T, Passweg JR, Porkka K, Valk PJM, Gradowska P, L\u00f6wenberg B, de Leeuw DC, Janssen JJWM, Ossenkoppele GJ, van de Loosdrecht AA, Cloos J, Bachas C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40903492"},{"title01":"Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1\u03b1","title02":"Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1\u03b1","journal":"Leukemia","issue":"2025 Sep 2. doi: 10.1038\/s41375-025-02749-6. Online ahead of print.","author":"Xu G, Wang F, Chen M, Gao W, Liu Y, Zhu J, Wang C, Jiang H, Li Y, Zhang P, Yuan J, Zhang T, Zhao C, Wang L, Wang L, Jiang J, Cao W, Zhang Z, Fu H, Dong T, Hu J, Li K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40897850"},{"title01":"Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry","title02":"Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry","journal":"Leukemia","issue":"2025 Sep 1. doi: 10.1038\/s41375-025-02744-x. Online ahead of print.","author":"Alfonso-Pierola A, Martinez-Cuadr\u00f3n D, Rodr\u00edguez-Veiga R, Gil C, Mart\u00ednez-S\u00e1nchez P, Bernal T, Benavente C, Romero-Riquelme MA, Serrano-Lopez J, Bergua JM, Garc\u00eda-Boyero R, Tormo M, Herrera P, Sossa-Melo CL, P\u00e9rez-Simon JA, Rodr\u00edguez-Medina C, Bass-Maturana MF, L\u00f3pez-Lorenzo JL, Algarra-Algarra L, Vidriales-Vicente B, P\u00e9rez-Encinas M, Barrios-Garc\u00eda M, Vives S, Sayas-Lloris MJ, Capurro M, Hidalgo S, Olave M, Cuervo-Lozada D, Lavilla-Rubira E, Casado F, Mena-Dur\u00e1n A, Valero-Nu\u00f1ez M, Casado-Calder\u00f3n S, Balerdi A, Torres V, Fern\u00e1ndez R, Noriega V, Stevenazzi M, Labrador J, Le\u00f3n-Maldonado P, de Rueda-Ciller B, Arce-Fern\u00e1ndez O, Amigo ML, Raposo-Puglia J\u00c1, Sol\u00e9 M, Boluda B, Ayala R, Barrag\u00e1n E, Montesinos P; PETHEMA Group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40890512"},{"title01":"HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","title02":"HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.289055. Online ahead of print.","author":"Desai N, Mattsson J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931871"},{"title01":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Response to Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","title02":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Response to Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288957. Online ahead of print.","author":"Bethge W, Dreger P; German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy e.V. (DAG-HSZT), German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931877"},{"title01":"Immune intervention is dispensable for retinoic acid\/arsenic therapy of murine acute promyelocytic leukemia","title02":"Immune intervention is dispensable for retinoic acid\/arsenic therapy of murine acute promyelocytic leukemia","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288562. Online ahead of print.","author":"Esnault C, Fortin G, Qiu F, Soilihi H, Souqu\u00e8re S, Niwa-Kawakita M, Lanchais K, Dirami T, Pierron G, De Th\u00e9 H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931862"},{"title01":"ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemia","title02":"ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemia","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288275. Online ahead of print.","author":"Breimer GE, Rozeman EA, Braunius WW, Daenen LGM, Kester LA, Leguit RJ, Mahieu R, Solleveld-Westerink N, Straatman L, Schutgens F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931869"},{"title01":"Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia","title02":"Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.288131. Online ahead of print.","author":"Duarte C, Abbot D, Bosma G, Kent A, Schwartz M, Collins C, Angelos MG, McMahon C, Gutman J, Pollyea DA, Amaya M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931864"},{"title01":"Early cytokine and chemokine signals shape the anti-AML activity of bispecific engager-secreting T cells","title02":"Early cytokine and chemokine signals shape the anti-AML activity of bispecific engager-secreting T cells","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.287934. Online ahead of print.","author":"Holl NJ, Fearnow A, Christodoulou I, Vorri SC, Rahnama R, Choe J, Ghosal A, Ng WI, Vyas V, Song HW, Varadhan R, Bonifant CL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931866"},{"title01":"Blinatumomab restores asparaginase activity in pediatric B-cell acute lymphoblastic leukemia patients with PEG-Asparaginase hypersensitivity","title02":"Blinatumomab restores asparaginase activity in pediatric B-cell acute lymphoblastic leukemia patients with PEG-Asparaginase hypersensitivity","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.287910. Online ahead of print.","author":"Tang X, Zhao L, Li W, Liu S, Li X, Zhu L, Wang D, Chen S, Liu Z, Liu S, Wen F, Abla O, Wang Y, Mai H, Fu X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931858"},{"title01":"IGLV3-21(R110)-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia","title02":"IGLV3-21(R110)-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2025.287697. Online ahead of print.","author":"Fischer C, Chen SS, Nimmerfroh J, Eugster A, St\u00fccheli S, Schulthei\u00df C, Widmer C, Heim D, Kasenda B, Passweg J, Kobold S, Egli L, Coianiz N, Chijioke O, Chiorazzi N, Follo M, L\u00e4ubli H, Peipp M, Binder M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931870"},{"title01":"The glutaminase activity of ASNS fuels glutamine metabolism in leukemia","title02":"The glutaminase activity of ASNS fuels glutamine metabolism in leukemia","journal":"Haematologica","issue":"2025 Sep 11. doi: 10.3324\/haematol.2024.287099. Online ahead of print.","author":"Chan WK, Tan L, Martinez SA, Du D, Horvath TD, Pontikos M, Rusling LA, Chiu Y, Tran BQ, Rempe SB, Sukharev S, Weinstein JN, Lorenzi PL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40931860"},{"title01":"Pediatric acute leukemias and myelodysplastic syndromes, progress and challenges: introduction to a review series","title02":"Pediatric acute leukemias and myelodysplastic syndromes, progress and challenges: introduction to a review series","journal":"Haematologica","issue":"2025 Sep 1;110(9):1921-1922.","author":"Izraeli S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40888337"},{"title01":"Beyond somatic mutations: the role of next generation sequencing in identifying germline predisposition in patients with acute myeloid leukemia","title02":"Beyond somatic mutations: the role of next generation sequencing in identifying germline predisposition in patients with acute myeloid leukemia","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.288448. Online ahead of print.","author":"Loghavi S, Ravandi F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874334"},{"title01":"The age of fit-equity: ignoring age and fitness in treatment selection for chronic lymphocytic leukemia","title02":"The age of fit-equity: ignoring age and fitness in treatment selection for chronic lymphocytic leukemia","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.288379. Online ahead of print.","author":"Owen C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874327"},{"title01":"The immunophenotypic and genetic characterization of pediatric T -L ymphoblastic leukemia with a mature immunophenotype","title02":"The immunophenotypic and genetic characterization of pediatric T -L ymphoblastic leukemia with a mature immunophenotype","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.288233. Online ahead of print.","author":"Khanlari M, Wang W, Tizro P, Eldomery MK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874330"},{"title01":"Multilineage involvement in ABL-class fusion-positive pediatric B-cell acute lymphoblastic leukemia: CML-like biology","title02":"Multilineage involvement in ABL-class fusion-positive pediatric B-cell acute lymphoblastic leukemia: CML-like biology","journal":"Haematologica","issue":"2025 Aug 28. doi: 10.3324\/haematol.2025.287931. Online ahead of print.","author":"Van Outersterp I, Boer JM, Sonneveld E, De Jong AX, Nierkens S, Van der Velden VHJ, Buijs A, Luesink M, Den Boer ML, Hoogerbrugge PM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40874338"},{"title01":"An old leukaemia in young patients-Genetic characteristics of paediatric chronic myeloid leukaemia","title02":"An old leukaemia in young patients-Genetic characteristics of paediatric chronic myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Sep 8. doi: 10.1111\/bjh.70134. Online ahead of print.","author":"Metzler M, Branford S, Hijiya N, Sakamoto K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40921705"},{"title01":"Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia","title02":"Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia","journal":"Blood","issue":"2025 Sep 3:blood.2025029302. doi: 10.1182\/blood.2025029302. Online ahead of print.","author":"Ren H, Elliott N, Lye B, Sharif Shohan MU, Cross JW, Field LM, Ponnusamy K, Rice S, Jackson T, Leontari I, El Ouazzani N, Thomas R, Inglott S, Bartram J, Smith O Professor, Bond J, Roberts I, Halsey C, Bashford-Rogers R, Milne TA, Roy A, Karadimitris A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40898981"},{"title01":"Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations","title02":"Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations","journal":"Blood","issue":"2025 Sep 2:blood.2025030259. doi: 10.1182\/blood.2025030259. Online ahead of print.","author":"Shanmuganathan N, Yeung DT, Wadham C, Fernandes A, Maqsood M, Shahrin N, Saunders VA Ms, Kenyon R, Lin M, Toubia J, McConnell J, Kaczorowski D, Ross DM, Yong AS, Chee L, Shortt J, Viiala N, Braley JA, Kok CH, Hughes TP, Branford S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40896831"},{"title01":"Meddling with METTL3 in acute megakaryoblastic leukemia","title02":"Meddling with METTL3 in acute megakaryoblastic leukemia","journal":"Blood","issue":"2025 Aug 28;146(9):1035-1036.","author":"Crispino JD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40875550"},{"title01":"NPM1: the ultimate target in AML","title02":"NPM1: the ultimate target in AML","journal":"Blood","issue":"2025 Aug 28;146(9):1031-1032.","author":"R\u00e9cher C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40875551"},{"title01":"Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice","title02":"Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice","journal":"Br J Haematol","issue":"2025 Sep 7. doi: 10.1111\/bjh.70128. Online ahead of print.","author":"Vodicka P, Hamova I, Velasova A, Kupcova K, Zemankova P, Nehasil P, Tkachenko A, Lochovska K, Muzikova S, Hrabetova S, Dlouha J, Blahovcova P, Frouz T, Senavova J, Dlouha L, Polgarova K, Klanova M, Salkova J, Benesova K, Klener P, Trneny M, Havranek O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40916568"},{"title01":"Outcomes of patients treated with venetoclax plus azacitidine versus azacitidine alone stratified by advanced age and acute myeloid leukemia composite model","title02":"Outcomes of patients treated with venetoclax plus azacitidine versus azacitidine alone stratified by advanced age and acute myeloid leukemia composite model","journal":"Leukemia","issue":"2025 Sep 5. doi: 10.1038\/s41375-025-02730-3. Online ahead of print.","author":"Venditti A, Hou JZ, Fenaux P, Jonas BA, Vrhovac R, Montesinos P, Garcia JS, Rizzieri D, Thirman MJ, Zhang M, Potluri J, Miller C, Dhalla M, Pullarkat V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40913104"},{"title01":"Retinoic acid disrupts an NPM1c\/ROS\/SENP3\/ARF oncogenic axis in acute myeloid leukemia","title02":"Retinoic acid disrupts an NPM1c\/ROS\/SENP3\/ARF oncogenic axis in acute myeloid leukemia","journal":"Leukemia","issue":"2025 Aug 26. doi: 10.1038\/s41375-025-02731-2. Online ahead of print.","author":"Hleihel R, Skayneh H, Wu HC, Hamie M, Kurdi A, Dakour J, Machaalani C, El-Sabban M, de Th\u00e9 H, Bazarbachi A, El Hajj H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40858804"},{"title01":"Beating the STATs: targeting the metabolome in acute myeloid leukemia","title02":"Beating the STATs: targeting the metabolome in acute myeloid leukemia","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288349. Online ahead of print.","author":"Nachmias B, Wolach O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905076"},{"title01":"Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA\/ELN expert panel","title02":"Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA\/ELN expert panel","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.288228. Online ahead of print.","author":"Wang SA, Arenillas L, Buccisano F, Bruggemann M, Kern W, Menes M, Plesa A, Stone L, Wellnitz D, Westerman DA, Wood BL, Freeman SD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905082"},{"title01":"Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide","title02":"Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2025.287860. Online ahead of print.","author":"Villalba M, Montoro J, Balaguer-Rosell\u00f3 A, Chor\u00e3o P, Cant\u00f3 PA, Granados P, G\u00f3mez-Segu\u00ed I, Solves P, Such E, Cervera J, Barrrag\u00e1n E, Santiago M, Gil-Ort\u00ed JV, Lamas B, Bataller A, Louro A, De la Rubia J, Sanz M\u00c1, Sanz J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905088"},{"title01":"SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia","title02":"SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia","journal":"Haematologica","issue":"2025 Sep 4. doi: 10.3324\/haematol.2024.287269. Online ahead of print.","author":"Chen M, Li W, Tao Y, Hu C, Ge R, Kang S, Yue P, Man CH, Wang L, Yan X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40905075"},{"title01":"Targeting p16(INK4a)-mediated cellular senescence as a therapeutic strategy for FLT3-ITD-driven acute myeloid leukemia","title02":"Targeting p16(INK4a)<\/sup>-mediated cellular senescence as a therapeutic strategy for FLT3-ITD-driven acute myeloid leukemia","journal":"Leukemia","issue":"2025 Aug 21. doi: 10.1038\/s41375-025-02743-y. Online ahead of print.","author":"Zheng J, Jin L, Chen Y, Duan Y, Zong S, Wu P, Zhu X, Yang W, Hu T, Zhang Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40841767"},{"title01":"Metallothionein 1 mediates growth and survival of Dnmt3a;Npm1-mutant acute myeloid leukemia","title02":"Metallothionein 1 mediates growth and survival of Dnmt3a;Npm1-mutant<\/i> acute myeloid leukemia","journal":"Haematologica","issue":"2025 Aug 14. doi: 10.3324\/haematol.2025.287662. Online ahead of print.","author":"Colom D\u00edaz PA, Mistry JJ, Young KA, Chou CH, Boyer N, Levine RL, Salomonis N, Grimes HL, Trowbridge JJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820834"},{"title01":"White blood cell count as a powerful prognostic marker and treatment guide in paediatric acute myeloid leukaemia with NUP98 rearrangement","title02":"White blood cell count as a powerful prognostic marker and treatment guide in paediatric acute myeloid leukaemia with NUP98<\/i> rearrangement","journal":"Br J Haematol","issue":"2025 Aug 14. doi: 10.1111\/bjh.70096. Online ahead of print.","author":"Shi H, Shu W, Tao Y, Jia X, Shen Y, Yang H, Xun Y, Baptista-Hon DT, You H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40814214"},{"title01":"Intrasinusoidal pleomorphic mantle cell lymphoma mimicking intravascular large B-cell lymphoma","title02":"Intrasinusoidal pleomorphic mantle cell lymphoma mimicking intravascular large B-cell lymphoma","journal":"Blood","issue":"2025 Aug 14;146(7):897.","author":"Qiu L, Thakral B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811000"},{"title01":"Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?","title02":"Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?","journal":"Blood","issue":"2025 Aug 14:blood.2024026018. doi: 10.1182\/blood.2024026018. Online ahead of print.","author":"Casulo C, Sehn LH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811857"},{"title01":"The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma","title02":"The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma","journal":"Leukemia","issue":"2025 Aug 26. doi: 10.1038\/s41375-025-02736-x. Online ahead of print.","author":"Zocchi S, Trichet P, Guernalec P, Agdada M, Alonso Bartolom\u00e9 A, Ogor V, Choisy C, Vias C, Sabat\u00e9-Cadenas X, Bories JC, Goodhardt M, Shkumatava A, Garrick D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40858807"},{"title01":"After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections","title02":"After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections","journal":"Haematologica","issue":"2025 Aug 21. doi: 10.3324\/haematol.2025.288539. Online ahead of print.","author":"Beyar-Katz O, Stern A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40836786"},{"title01":"Racial differences in the proportion of myeloma cases attributable to excess body weight and diabetes mellitus in the United States","title02":"Racial differences in the proportion of myeloma cases attributable to excess body weight and diabetes mellitus in the United States","journal":"Haematologica","issue":"2025 Aug 21. doi: 10.3324\/haematol.2025.287724. Online ahead of print.","author":"Anuraj A, Rath D, Derkach A, Usmani SZ, Shah UA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40836775"},{"title01":"Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies","title02":"Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.288359. Online ahead of print.","author":"Rees MJ, Quach H, Jardine D, Thompson A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820805"},{"title01":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","title02":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.288041. Online ahead of print.","author":"Mizuno S, Gras L, Baaij LGA, Koster L, D'Souza A, Hari PN, Estrada-Merly N, Saber W, Cowan AJ, Iida M, Okamoto S, Takamatsu H, Kawamura K, Kodera Y, Hamad N, Ko BS, Liam C, Ho KW, Goh AS, Keat TS, Elhaddad AM, Bazarbachi A, Chaudhry BQUN, Alfar R, Bekadja MA, Benakli M, Ortiz CAF, Riva E, Verburgh E, Galeano S, Bass F, Mian H, McCurdy A, Wang FR, Neumann D, Koh MBC, Snowden JA, Sch\u00f6nland S, McLornan DP, Hayden PJ, Balari AMS, Greinix HT, Aljurf M, Atsuta Y, Rondelli D, Niederwieser DW, Garderet L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820767"},{"title01":"FOXM1 down-regulation is a trigger of isatuximab-induced direct cell death in multiple myeloma cells with 1q","title02":"FOXM1 down-regulation is a trigger of isatuximab-induced direct cell death in multiple myeloma cells with 1q","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.287904. Online ahead of print.","author":"Kikuchi J, Osada N, Matsuoka S, Ohta T, Kazama H, Shirai H, Meloni M, Chiron M, Yasui H, Nakasone H, Furukawa Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820736"},{"title01":"Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial","title02":"Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.287510. Online ahead of print.","author":"Bringhen S, Cani L, Giuliani N, Mangiacavalli S, Benevolo G, Antonioli E, Zambello R, Ria R, Vincelli ID, Ronconi S, More S, Falcone AP, Allegra A, D'Agostino M, Evangelista A, Capra A, Sciorsci E, Curci P, Tosi P, Liberati AM, Cafro AM, Belotti A, Patriarca F, Mannina D, Mancuso K, Cattel F, Ciccone G, Bruno B, Boccadoro M, Larocca A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820797"},{"title01":"Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study)","title02":"Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study)","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2025.287889. Online ahead of print.","author":"Lee JY, Jung S, Choi S, Park SS, Kim JS, Lee JJ, Park SK, Kim HJ, Lee GW, Park YH, Eom HS, Kim JA, Kim MK, Kim Y, Shin HJ, Lee HS, Kwon J, Min CK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820811"},{"title01":"Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis","title02":"Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis","journal":"Haematologica","issue":"2025 Aug 14. doi: 10.3324\/haematol.2025.288174. Online ahead of print.","author":"Vandenboom H, Akhtar O, Szabo A, Narra R, Mohan M, D'Souza A, Pasquini M, Dhakal B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820831"},{"title01":"Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic Profiling","title02":"Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic Profiling","journal":"Blood","issue":"2025 Aug 20:blood.2025029987. doi: 10.1182\/blood.2025029987. Online ahead of print.","author":"Beer SA, Cairns DA, Pawlyn C Dr, Holroyd AE, Ferris E, Cook G, Drayson M, Boyd KD, Proszek PZ, Davies FE, de Tute RM, Jenner MW, Morgan GJ, Owen RG, Hubank MJ, Houlston RS, Jackson GH, Kaiser MF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40834881"},{"title01":"A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy","title02":"A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy","journal":"Blood","issue":"2025 Aug 19:blood.2025028587. doi: 10.1182\/blood.2025028587. Online ahead of print.","author":"Bruins WSC, Smits F, Duetz C, Groen K, Korst CLBM, de Jonge AV dr, Verkleij CPM, Rentenaar R, Cosovic M, Eken M, Twickler I, Homan-Weert PM, Sonneveld P, Moreau P, Claesen J, van de Donk NWCJ, Zweegman S, Mutis T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40829164"},{"title01":"Linc-ing RNA isoforms to function in multiple myeloma","title02":"Linc-ing RNA isoforms to function in multiple myeloma","journal":"Blood","issue":"2025 Aug 14;146(7):773-774.","author":"Agirre X, Pr\u00f3sper F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811003"},{"title01":"CD70-CAR-Ts: a second wind for high-risk myeloma","title02":"CD70-CAR-Ts: a second wind for high-risk myeloma","journal":"Blood","issue":"2025 Aug 14;146(7):769-771.","author":"Rodr\u00edguez-Lobato LG, Fern\u00e1ndez de Larrea C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811005"},{"title01":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","title02":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.288041. Online ahead of print.","author":"Mizuno S, Gras L, Baaij LGA, Koster L, D'Souza A, Hari PN, Estrada-Merly N, Saber W, Cowan AJ, Iida M, Okamoto S, Takamatsu H, Kawamura K, Kodera Y, Hamad N, Ko BS, Liam C, Ho KW, Goh AS, Keat TS, Elhaddad AM, Bazarbachi A, Chaudhry BQUN, Alfar R, Bekadja MA, Benakli M, Ortiz CAF, Riva E, Verburgh E, Galeano S, Bass F, Mian H, McCurdy A, Wang FR, Neumann D, Koh MBC, Snowden JA, Sch\u00f6nland S, McLornan DP, Hayden PJ, Balari AMS, Greinix HT, Aljurf M, Atsuta Y, Rondelli D, Niederwieser DW, Garderet L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820767"},{"title01":"Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","title02":"Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.287750. Online ahead of print.","author":"Sanz J, Ferhat AT, Kulagin A, Kr\u00f6ger N, Rovira M, Lazzari L, Arat M, Montoro J, Versluis J, Rem\u00e9nyi P, Sica S, Blaise D, Saif MA, Vydra J, Fagioli F, Nur E, Giebel S, Peric Z, Brissot E, Nagler A, Piemontese S, Mohty M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820728"},{"title01":"Single-cell RNA sequencing reveals heterogeneity of mucosa-associated invariant T cells in donor grafts and its diagnostic relevance in gastrointestinal graft-versus-host disease","title02":"Single-cell RNA sequencing reveals heterogeneity of mucosa-associated invariant T cells in donor grafts and its diagnostic relevance in gastrointestinal graft-versus<\/i>-host disease","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2024.287114. Online ahead of print.","author":"Gao M, Zhang K, Li S, Guo H, Sun Y, Kong J, Han T, Chang Y, Huang X, Zhao X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820727"},{"title01":"Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study)","title02":"Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study)","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2025.287889. Online ahead of print.","author":"Lee JY, Jung S, Choi S, Park SS, Kim JS, Lee JJ, Park SK, Kim HJ, Lee GW, Park YH, Eom HS, Kim JA, Kim MK, Kim Y, Shin HJ, Lee HS, Kwon J, Min CK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820811"},{"title01":"KLF4 overexpression protects against complement-mediated endothelial injury in transplant-associated thrombotic microangiopathy","title02":"KLF4 overexpression protects against complement-mediated endothelial injury in transplant-associated thrombotic microangiopathy","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2025.287676. Online ahead of print.","author":"Jiang S, Qi J, Pan T, Yao Z, Lu S, Han Y, Wu D, Han Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820810"},{"title01":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","title02":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2025.287456. Online ahead of print.","author":"Balduzzi A, Glogova E, Peters C, Sedlacek P, Dalle JH, Locatelli F, Meisel R, Burkhardt B, Buechner J, Wachowiak J, Bierings M, Staciuk R, Graphakos S, G\u00fcng\u00f6r T, Yesilipek A, Svec P, Palma J, Krivan G, Diaz-de-Heredia C, Limido F, Ansari M, Kalwak K, Bader P, Ifversen M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820816"},{"title01":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","title02":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","journal":"Haematologica","issue":"2025 Aug 14. doi: 10.3324\/haematol.2025.288731. Online ahead of print.","author":"Deeren D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820855"},{"title01":"When the first graft fails: a strategic approach to donor selection for second transplant","title02":"When the first graft fails: a strategic approach to donor selection for second transplant","journal":"Haematologica","issue":"2025 Aug 14. doi: 10.3324\/haematol.2025.288565. Online ahead of print.","author":"Kongtim P, Ciurea SO.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820850"},{"title01":"A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","title02":"A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 27. doi: 10.1111\/bjh.70124. Online ahead of print.","author":"Desai N, Rodriguez-Rodriguez S, Al-Shaibani E, Alfaro Moya T, Law AD, Novitzky-Basso I, Pasic I, Michelis FV, Kumar R, Kim DDH, Mattsson J, Viswabandya A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40859738"},{"title01":"Comprehensive risk stratification for adult T-cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation","title02":"Comprehensive risk stratification for adult T-cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 26. doi: 10.1111\/bjh.70102. Online ahead of print.","author":"Yu F, Yu X, Hu X, Jiang E, Zhou J, Lu Y, Zhu X, Wan J, Miao K, Fu Y, Niu J, Wan L, Zhou F, Song X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40856278"},{"title01":"Has early mortality following single-unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan","title02":"Has early mortality following single-unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan","journal":"Br J Haematol","issue":"2025 Aug 16. doi: 10.1111\/bjh.70099. Online ahead of print.","author":"Konuma T, Kanda J, Uchida N, Tanaka M, Kimura F, Nakasone H, Uehara Y, Tokunaga M, Toyosaki M, Miyakoshi S, Doki N, Ishiwata K, Kobayashi H, Onishi Y, Kozai Y, Kato K, Ishimaru F, Fukuda T, Atsuta Y, Takahashi S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40817823"},{"title01":"Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation","title02":"Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation","journal":"Br J Haematol","issue":"2025 Aug 14. doi: 10.1111\/bjh.70101. Online ahead of print.","author":"Shimoni A, Peczynski C, Labopin M, Dominietto A, Koc M, Arat M, Tischer J, Sica S, G\u00fclbas Z, Soci\u00e9 G, Blaise D, Pioltelli P, Ozdogu H, Vydra J, Ciceri F, Nagler A, Mohty M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40810334"},{"title01":"Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD","title02":"Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD","journal":"Blood","issue":"2025 Aug 22:blood.2025028553. doi: 10.1182\/blood.2025028553. Online ahead of print.","author":"Etra AM, Ferrara JLM, Levine JE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40845051"},{"title01":"Protecting the epithelium and taming GVHD","title02":"Protecting the epithelium and taming GVHD","journal":"Blood","issue":"2025 Aug 21;146(8):903-905.","author":"Ye Y, Mohty M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839253"},{"title01":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","title02":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.288041. Online ahead of print.","author":"Mizuno S, Gras L, Baaij LGA, Koster L, D'Souza A, Hari PN, Estrada-Merly N, Saber W, Cowan AJ, Iida M, Okamoto S, Takamatsu H, Kawamura K, Kodera Y, Hamad N, Ko BS, Liam C, Ho KW, Goh AS, Keat TS, Elhaddad AM, Bazarbachi A, Chaudhry BQUN, Alfar R, Bekadja MA, Benakli M, Ortiz CAF, Riva E, Verburgh E, Galeano S, Bass F, Mian H, McCurdy A, Wang FR, Neumann D, Koh MBC, Snowden JA, Sch\u00f6nland S, McLornan DP, Hayden PJ, Balari AMS, Greinix HT, Aljurf M, Atsuta Y, Rondelli D, Niederwieser DW, Garderet L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820767"},{"title01":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","title02":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2025.287456. Online ahead of print.","author":"Balduzzi A, Glogova E, Peters C, Sedlacek P, Dalle JH, Locatelli F, Meisel R, Burkhardt B, Buechner J, Wachowiak J, Bierings M, Staciuk R, Graphakos S, G\u00fcng\u00f6r T, Yesilipek A, Svec P, Palma J, Krivan G, Diaz-de-Heredia C, Limido F, Ansari M, Kalwak K, Bader P, Ifversen M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820816"},{"title01":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","title02":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","journal":"Haematologica","issue":"2025 Aug 14. doi: 10.3324\/haematol.2025.288731. Online ahead of print.","author":"Deeren D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820855"},{"title01":"A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","title02":"A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 27. doi: 10.1111\/bjh.70124. Online ahead of print.","author":"Desai N, Rodriguez-Rodriguez S, Al-Shaibani E, Alfaro Moya T, Law AD, Novitzky-Basso I, Pasic I, Michelis FV, Kumar R, Kim DDH, Mattsson J, Viswabandya A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40859738"},{"title01":"Comprehensive risk stratification for adult T-cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation","title02":"Comprehensive risk stratification for adult T-cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 26. doi: 10.1111\/bjh.70102. Online ahead of print.","author":"Yu F, Yu X, Hu X, Jiang E, Zhou J, Lu Y, Zhu X, Wan J, Miao K, Fu Y, Niu J, Wan L, Zhou F, Song X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40856278"},{"title01":"Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation","title02":"Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation","journal":"Br J Haematol","issue":"2025 Aug 14. doi: 10.1111\/bjh.70101. Online ahead of print.","author":"Shimoni A, Peczynski C, Labopin M, Dominietto A, Koc M, Arat M, Tischer J, Sica S, G\u00fclbas Z, Soci\u00e9 G, Blaise D, Pioltelli P, Ozdogu H, Vydra J, Ciceri F, Nagler A, Mohty M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40810334"},{"title01":"Checkpoint-primed allo-HCT in HL: cure gains, risk remains","title02":"Checkpoint-primed allo-HCT in HL: cure gains, risk remains","journal":"Blood","issue":"2025 Aug 21;146(8):911-912.","author":"Br\u00f6ckelmann PJ, von Tresckow B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839258"},{"title01":"Allo-HCT in Hodgkin lymphoma after CPI","title02":"Allo-HCT in Hodgkin lymphoma after CPI","journal":"Blood","issue":"2025 Aug 21;146(8):1030.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839251"},{"title01":"The PERKs of ER homeostasis for hematopoietic stem cells","title02":"The PERKs of ER homeostasis for hematopoietic stem cells","journal":"Blood","issue":"2025 Aug 14;146(7):768-769.","author":"Salik B, van Galen P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811008"},{"title01":"The landscape of disease: mapping aplastic anemia","title02":"The landscape of disease: mapping aplastic anemia","journal":"Blood","issue":"2025 Aug 21;146(8):905-906.9791.","author":"Brunner PM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839257"},{"title01":"When TNF\u03b1 is out, IFN-\u03b3 drives anemia of inflammation","title02":"When TNF\u03b1 is out, IFN-\u03b3 drives anemia of inflammation","journal":"Blood","issue":"2025 Aug 21;146(8):908-910.","author":"Silvestri L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839259"},{"title01":"Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study","title02":"Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study","journal":"Br J Haematol","issue":"2025 Aug 25. doi: 10.1111\/bjh.70069. Online ahead of print.","author":"Lucchini E, Vianelli N, Consoli U, Carli G, Carrai V, Carpenedo M, De Stefano V, Gaidano G, Palandri F, Auteri G, Rossi E, Patriarca A, Innao V, Marchesini G, Ballerini M, Rossetti MC, Mosini G, Sciancalepore P, Agnelli Giacchello J, Musto P, Rivolti E, Soverini G, Borchiellini A, Clissa C, Pane F, Galimberti S, Pavone V, Poloni A, Buccisano F, Musso M, Fazi P, Paoloni F, Gorreo Renzulli L, Zaja F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40855761"},{"title01":"Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States","title02":"Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States","journal":"Br J Haematol","issue":"2025 Aug 17. doi: 10.1111\/bjh.20257. Online ahead of print.","author":"Cooper N, Kruse C, Deneen Morgan S, Laurent J, Arvelo-Saillant M, Roussy JP, Cordoba M, Gouia I, Schmitt LA, Reineke E, Gernsheimer T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820557"},{"title01":"Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial","title02":"Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial","journal":"J Clin Oncol","issue":"2025 Aug 18:JCO2500535. doi: 10.1200\/JCO-25-00535. Online ahead of print.","author":"Platzbecker U, Ad\u00e8s L, Montesinos P, Ammatuna E, Fenaux P, Baldus C, Bernardi M, Berthon C, Bocchia M, Bonmati C, Borlenghi E, Bornh\u00e4user M, Carp D, Chantepie S, Crea E, Divona M, D\u00f6hner H, Ehninger G, Esteve Reyner J, Frayfer J, Garrido Diaz A, Gil C, Guarnera L, Hamm AF, Heiblig M, Heidenreich D, Kr\u00e4mer AJ, Ledoux MP, Lunghi M, Mancini V, Metzeler K, Miggiano MC, M\u00fcller-Tidow C, Peterlin P, Piciocchi A, Rieger K, R\u00f6llig C, Rossi G, Sanz MA, Serve H, S\u00f6hne M, Spiekermann K, Tavernier-Tardy E, Thiede C, Vives Polo S, Vogel W, Zappasodi P, Ziller-Walter P, Voso MT; SAL, AMCL-CG, AML-SG, OSHO, PETHEMA, HOVON and GIMEMA study groups.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40825164"},{"title01":"Toward chemotherapy-reduced cure for TCF3::HLF B-cell acute lymphoblastic leukemia using CD-19-directed immunotherapy","title02":"Toward chemotherapy-reduced cure for TCF3::HLF B-cell acute lymphoblastic leukemia using CD-19-directed immunotherapy","journal":"Haematologica","issue":"2025 Aug 21. doi: 10.3324\/haematol.2025.288192. Online ahead of print.","author":"Zeckanovic A, Baruchel A, Bourquin JP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40836779"},{"title01":"Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention","title02":"Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.288227. Online ahead of print.","author":"Bankar A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820796"},{"title01":"Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","title02":"Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","journal":"Haematologica","issue":"2025 Jul 31. doi: 10.3324\/haematol.2025.287750. Online ahead of print.","author":"Sanz J, Ferhat AT, Kulagin A, Kr\u00f6ger N, Rovira M, Lazzari L, Arat M, Montoro J, Versluis J, Rem\u00e9nyi P, Sica S, Blaise D, Saif MA, Vydra J, Fagioli F, Nur E, Giebel S, Peric Z, Brissot E, Nagler A, Piemontese S, Mohty M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820728"},{"title01":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","title02":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2025.287456. Online ahead of print.","author":"Balduzzi A, Glogova E, Peters C, Sedlacek P, Dalle JH, Locatelli F, Meisel R, Burkhardt B, Buechner J, Wachowiak J, Bierings M, Staciuk R, Graphakos S, G\u00fcng\u00f6r T, Yesilipek A, Svec P, Palma J, Krivan G, Diaz-de-Heredia C, Limido F, Ansari M, Kalwak K, Bader P, Ifversen M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820816"},{"title01":"Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemia","title02":"Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemia","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2024.286803. Online ahead of print.","author":"McCarville MB, Ashcraft E, Ribeiro RC, Rees M, Swanson HD, Inaba H, Jeha S, Cheng C, Pui CH, Karol SE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820809"},{"title01":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","title02":"Do high-volume centers really save more lives? A call for scientific rigor and transparency. Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy","journal":"Haematologica","issue":"2025 Aug 14. doi: 10.3324\/haematol.2025.288731. Online ahead of print.","author":"Deeren D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820855"},{"title01":"Paediatric-inspired regimen reduces central nervous system relapse in adult acute lymphoblastic leukaemia","title02":"Paediatric-inspired regimen reduces central nervous system relapse in adult acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2025 Aug 27. doi: 10.1111\/bjh.70067. Online ahead of print.","author":"Liang H, He B, Chen J, Luo B, Cai Z, Ding C, Lin J, Wang Z, Zhou X, Liu X, Xuan L, Liu Q, Zhou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40859800"},{"title01":"Back to life: Biological parenthood of young adult acute leukaemia survivors","title02":"Back to life: Biological parenthood of young adult acute leukaemia survivors","journal":"Br J Haematol","issue":"2025 Aug 26. doi: 10.1111\/bjh.70107. Online ahead of print.","author":"Egger-Heidrich K, Sockel K, Schetelig J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40855938"},{"title01":"Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML study","title02":"Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML study","journal":"Br J Haematol","issue":"2025 Aug 18. doi: 10.1111\/bjh.70094. Online ahead of print.","author":"Herlin MK, Kjeldsen E, Abrahamsson J, Arad-Cohen N, Cheuk D, De Moerloose B, Jahnukainen K, J\u00f3nsson \u00d3G, Kaspers GJL, Kovalova Z, Navarro JMF, Noren-Nystr\u00f6m U, Palle J, Pasaulien\u0117 R, Saks K, Zeller B, Holmfeldt L, Hasle H, Juul-Dam KL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40826900"},{"title01":"Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation","title02":"Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation","journal":"Br J Haematol","issue":"2025 Aug 14. doi: 10.1111\/bjh.70101. Online ahead of print.","author":"Shimoni A, Peczynski C, Labopin M, Dominietto A, Koc M, Arat M, Tischer J, Sica S, G\u00fclbas Z, Soci\u00e9 G, Blaise D, Pioltelli P, Ozdogu H, Vydra J, Ciceri F, Nagler A, Mohty M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40810334"},{"title01":"CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia","title02":"CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia","journal":"Blood","issue":"2025 Aug 27:blood.2025029532. doi: 10.1182\/blood.2025029532. Online ahead of print.","author":"Geyer MB, DeWolf S, Mi X, Weis K, Shaffer BC, Cadzin B, McAvoy D, Katsamakis ZA, Lorenc R, Lewis AM, Gipson B, Cuibus MA, Girotra NN, Wu K, Smith N, Burns ER, Um JS, Yoo S, Kharabi Masouleh B, Galera PK, Hosszu K, Chaudhari J, Wang X, Lin Q, Curran KJ, Park JH, Scheinberg DA, van den Brink MRM, Abdel-Wahab O, Brentjens RJ, Daniyan AF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40864984"},{"title01":"The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL","title02":"The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL","journal":"Blood","issue":"2025 Aug 27:blood.2025028899. doi: 10.1182\/blood.2025028899. Online ahead of print.","author":"Al-Sawaf O, F\u00fcrstenau M, Giza A, Robrecht S, von Tresckow J, Fink A, Simon F, Tausch E, Schneider C, Sivcheva L, Schwarer AP, Loscertales J, Weinkove R, Strumberg D, Kilfoyle A, Juliusson G, da Cunha-Bang C, Illmer T, Gregor M, Thornton P, Janssens A, Tadmor T, Lindstrom V, Staber PB, Levin MD, Wendtner CM, Kreuzer KA, Ritgen M, Stilgenbauer S, Kater AP, Niemann CU, Fischer K, Eichhorst BF, Hallek MJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40864973"},{"title01":"Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia","title02":"Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia","journal":"Blood","issue":"2025 Aug 26:blood.2025029132. doi: 10.1182\/blood.2025029132. Online ahead of print.","author":"O'Brien C, Nursimulu N, Tyagi A, Culp-Hill R, Arruda A, Murphy T, Minden MD, Kent A, Stevens BM, Pollyea DA, Hope K, Kumar S, Reisz JA, D'Alessandro A, Jones CL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40857673"},{"title01":"A burden too high for CAR T cells in CLL","title02":"A burden too high for CAR T cells in CLL","journal":"Blood","issue":"2025 Aug 21;146(8):901-902","author":"Kater AP, Themeli M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839252"},{"title01":"Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging","title02":"Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging","journal":"Blood","issue":"2025 Aug 19:blood.2024027692. doi: 10.1182\/blood.2024027692. Online ahead of print.","author":"Cheng W, Yi X, Wang Z, Li JF, Zhang JY, Zhang RH, Zhang QQ, Weng X, Huang T, Zhu YM, Wang C, Yin W, Zhang JN, Wu HY, Li JM, Zhu H, Chen L, Wang WF, Dai Y, Gao CX, Liu X, Wang S, Wang S, Jiao B, Chen Z, Fang H, Yin T, Shen Y, Chen SJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40829168"},{"title01":"An adaptive survival prediction model in CMML","title02":"An adaptive survival prediction model in CMML","journal":"Blood","issue":"2025 Aug 14;146(7):775-777.","author":"Shomali W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811004"},{"title01":"Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia","title02":"Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia","journal":"Blood","issue":"2025 Aug 14:blood.2025028985. doi: 10.1182\/blood.2025028985. Online ahead of print.","author":"Montefiori LE, Iacobucci I, Gao Q, Moore J, Wright WC, Wei H, Baviskar P, Sona S, Jin H, Budhraja A, Lott J, Tatarata QZ, Cheng Z, Khan TM, Backhaus EA, Johnson MD, Mehr CM, Freeman BB 3rd, Janke LJ, Haferlach T, Geeleher P, Mead PE, Konopleva MY, Opferman JT, Mullighan CG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811853"},{"title01":"Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia","title02":"Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia","journal":"Blood","issue":"2025 Aug 14:blood.2025028674. doi: 10.1182\/blood.2025028674. Online ahead of print.","author":"Zhou X, Chen J, Tang YL, Sun H, Chen Q, Chen X, Zhang Y, Fang J, Cao P, Ma X, Chen L, Xie Y, Wen L, Huang LB, Fan Z, Lou J, Xu W, Zhang N, Li J, Luo Y, Dai Y, Du H, Yang K, He Z, Yang X, Wang L, Liu B, Lin D, Zhang Y, Xu F, Zhang M, Wang Y, Yan S, Nan H, Zhang J, Xu L, Ma X, Tang R, Wang F, Yuan L, Liu M, Wang L, Wu Q, Zhang L, Liu S, Yan C, Zhou J, Lyu F, Wu P, Wang T, Zhang X, Lu Y, Liu D, Yang J, Xiong M, Zhao Y, Fan G, Xiao X, Ma F, Yang L, Luo XQ, Li JM, Shen S, Zheng H, Chen S, Chen H, Zhao J, Zhang Z, Wang K Prof, Lu P, Liu H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40811852"},{"title01":"Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy","title02":"Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy","journal":"N Engl J Med","issue":"2025 Aug 21;393(8):823-825.","author":"Aleman A, Van Oekelen O, Melnekoff DT, Grossman L, Mouhieddine TH, Kurowski A, Odak I, Reci S, Desai S, Meledathu S, Naidu MP, Shukla RP, Dutta RP, Kappes K, Serebryakova K, Jackson H, Lu J, Chatikhine A, Kulkarni R, Moinfar Z, Croken MM, Mehrotra M, Baskovich B, Rayamajhi S, Richard S, Rossi AC, Salib C, Houldsworth J, Brown BD, Merad M, Lagan\u00e0 A, Brunner PM, Jagannath S, Brody JD, Parekh S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40834307"},{"title01":"Two decades of single-institution data reveal rare long-term survivors of relapsed\/refractory Burkitt lymphoma","title02":"Two decades of single-institution data reveal rare long-term survivors of relapsed\/refractory Burkitt lymphoma","journal":"Haematologica","issue":"2025 Aug 7. doi: 10.3324\/haematol.2024.287165. Online ahead of print.","author":"Molla R, Bantilan K, Berman E, Caron P, Falchi L, Hamlin P, Horwitz S, Intlekofer A, Kumar A, Lue J, Moskowitz A, Owens C, Palomba ML, Dahi PB, Salles G, Vardhana S, Shah G, Zelenetz A, Johnson W, Noy A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40820818"},{"title01":"Comprehensive risk stratification for adult T-cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation","title02":"Comprehensive risk stratification for adult T-cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 26. doi: 10.1111\/bjh.70102. Online ahead of print.","author":"Yu F, Yu X, Hu X, Jiang E, Zhou J, Lu Y, Zhu X, Wan J, Miao K, Fu Y, Niu J, Wan L, Zhou F, Song X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40856278"},{"title01":"Refining the risk stratification in advanced-stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models","title02":"Refining the risk stratification in advanced-stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models","journal":"Br J Haematol","issue":"2025 Aug 22. doi: 10.1111\/bjh.70115. Online ahead of print.","author":"Koca O, Eskazan AE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40843643"},{"title01":"Cracking the POD24 code in follicular lymphoma","title02":"Cracking the POD24 code in follicular lymphoma","journal":"Blood","issue":"2025 Aug 21;146(8):899-900","author":"Scherer F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839256"},{"title01":"Allo-HCT in Hodgkin lymphoma after CPI","title02":"Allo-HCT in Hodgkin lymphoma after CPI","journal":"Blood","issue":"2025 Aug 21;146(8):1030.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839251"},{"title01":"A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma","title02":"A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma","journal":"Blood","issue":"2025 Aug 19:blood.2025028649. doi: 10.1182\/blood.2025028649. Online ahead of print.","author":"Xu P, Zhu Y, Shi ZY, Wang L, Cheng S, Qian Y, Zhao Y, He Y, Yi H, Ouyang B, Jiang XF, Li B, Song Q, Mu RJ, Zhao W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40829156"},{"title01":"Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and\/or in main clone","title02":"Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and\/or in main clone","journal":"Br J Haematol","issue":"2025 Aug 17. doi: 10.1111\/bjh.70015. Online ahead of print.","author":"You H, Yao W, Yan L, Zhai Y, Yan Z, Shang J, Yan S, Shi X, Jin S, Ge X, Shen H, Pan J, Wu D, Fu C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40824203"},{"title01":"An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden","title02":"An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden","journal":"Blood","issue":"2025 Aug 27:blood.2025029215. doi: 10.1182\/blood.2025029215. Online ahead of print.","author":"Meermeier EW, Pfeffer K, Stein CK, Sharik M, Du MT, Tafoya Alvarado Y, Shi CX, Zhu YX, Bergsagel PL, Chesi M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40864972"},{"title01":"Deep dive into shallow myeloma cell pool","title02":"Deep dive into shallow myeloma cell pool","journal":"Blood","issue":"2025 Aug 21;146(8):906-907.","author":"Samur MK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40839255"},{"title01":"Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia","title02":"Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia","journal":"Leukemia","issue":"2025 Aug 26. doi: 10.1038\/s41375-025-02732-1. Online ahead of print.","author":"Curik N, Laznicka A, Krizkova J, Suchankova P, Vavrova A, Polivkova V, Pokorna E, Semerak P, Burda P, Kuzilkova D, Kalina T, Hochhaus A, Machova Polakova K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40858806"},{"title01":"Retinoic acid disrupts an NPM1c\/ROS\/SENP3\/ARF oncogenic axis in acute myeloid leukemia","title02":"Retinoic acid disrupts an NPM1c\/ROS\/SENP3\/ARF oncogenic axis in acute myeloid leukemia","journal":"Leukemia","issue":"2025 Aug 26. doi: 10.1038\/s41375-025-02731-2. Online ahead of print.","author":"Hleihel R, Skayneh H, Wu HC, Hamie M, Kurdi A, Dakour J, Machaalani C, El-Sabban M, de Th\u00e9 H, Bazarbachi A, El Hajj H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40858804"},{"title01":"Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia","title02":"Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia","journal":"Leukemia","issue":"2025 Aug 22. doi: 10.1038\/s41375-025-02735-y. Online ahead of print.","author":"Telzerow E, G\u00f6rlich D, Sauerland C, Rothenberg-Thurley M, Moret AS, Krau\u00df SM, Mumm FHA, Amler S, Berdel WE, W\u00f6rmann BJ, Krug U, Braess J, Heu\u00dfner P, Hiddemann W, Spiekermann K, Metzeler KH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40847197"},{"title01":"Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironment","title02":"Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironment","journal":"Leukemia","issue":"2025 Aug 15. doi: 10.1038\/s41375-025-02734-z. Online ahead of print.","author":"Ferrao Blanco MN, Kazybay B, Belderbos M, Heidenreich O, Vormoor HJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40817406"},{"title01":"Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax","title02":"Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax","journal":"Leukemia","issue":"2025 Aug 14. doi: 10.1038\/s41375-025-02733-0. Online ahead of print.","author":"Croden J, Jen WY, Marvin-Peek J, Xiao L, Bouligny IM, Loghavi S, Borthakur G, Daver NG, Abbas HA, Takahashi K, Sasaki K, Pemmaraju N, Short NJ, Hammond D, Jabbour E, Masarova L, Chien KS, Issa GC, Montalban-Bravo G, Yilmaz M, Maiti A, Alvarado-Valero Y, Garcia-Manero G, Ravandi F, Konopleva MY, Kantarjian HM, Kadia TM, DiNardo CD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40813623"},{"title01":"Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia","title02":"Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia","journal":"Leukemia","issue":"2025 Aug 14. doi: 10.1038\/s41375-025-02723-2. Online ahead of print.","author":"Amaral P, Christie R, Gresham DOF, Lucas EJM, Xu LK, Behrmann L, Bond J, Degerman S, van Delft FW, Goossens S, Hagleitner M, Halsey C, Jones N, Lammens T, van Leeuwen FN, Mansour MR, Ntziachristos P, O'Connor D, Barata JT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40813621"},{"title01":"APOLLO: Optimizing the Treatment of High-Risk Acute Promyelocytic Leukemia With All-Trans Retinoic Acid and Arsenic Trioxide While Minimizing the Role of Chemotherapy","title02":"APOLLO: Optimizing the Treatment of High-Risk Acute Promyelocytic Leukemia With All-Trans Retinoic Acid and Arsenic Trioxide While Minimizing the Role of Chemotherapy","journal":"J Clin Oncol","issue":"2025 Aug 18:JCO2501496. doi: 10.1200\/JCO-25-01496. Online ahead of print.","author":"Iland HJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40825155"},{"title01":"Co-operative epigenetic remodelling by Setd2 deficiency and Kras mutation drives juvenile myelomonocytic leukaemia development and MEK inhibitor sensitivity","title02":"Co-operative epigenetic remodelling by Setd2<\/i> deficiency and Kras<\/i> mutation drives juvenile myelomonocytic leukaemia development and MEK inhibitor sensitivity","journal":"Br J Haematol","issue":"2025 Aug 4. doi: 10.1111\/bjh.70060. Online ahead of print.","author":"Munyurangabo G, Zhang L, Zhou Y, Zhang P, Yu X, Qu D, Yang D, Ren X, Liu H, Wu Y, Kong G, Yang Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40755378"},{"title01":"HOX11 gene overexpression is associated with recurrence of acute B lymphoblastic leukaemia","title02":"HOX11<\/i> gene overexpression is associated with recurrence of acute B lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2025 Aug 5. doi: 10.1111\/bjh.70071. Online ahead of print.","author":"Zhong M, Yin C, Wang Y, Zeng L, Yang Q, Feng B, Chang Y, Zhang J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40762137"},{"title01":"Atypical cytoplasmic inclusions and erythrophagocytosis in acute myeloid leukemia with KMT2A::MLLT3 and U2AF1 mutation","title02":"Atypical cytoplasmic inclusions and erythrophagocytosis in acute myeloid leukemia with KMT2A<\/i>::MLLT3<\/i> and U2AF1<\/i> mutation","journal":"Blood","issue":"2025 Aug 7;146(6):765.","author":"Chen S, Xiao Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40773175"},{"title01":"Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study","title02":"Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study","journal":"Br J Haematol","issue":"2025 Aug 8. doi: 10.1111\/bjh.70082. Online ahead of print.","author":"Trab T, Ranad\u00f3ttir T, Chanchiri I, Ludvigsen Al-Mashhadi A, Berggreen Dall E, Rasch S, Johansen M, Haunstrup LM, Cunsolo G, Poulsen CB, Larsen TS, Husby S, Brown P, Hawkes EA, El-Galaly TC, Gr\u00f8nb\u00e6k K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40781827"},{"title01":"T-cell lymphoblastic lymphoma in children, adolescents and young adults","title02":"T-cell lymphoblastic lymphoma in children, adolescents and young adults","journal":"Br J Haematol","issue":"2025 Aug 13. doi: 10.1111\/bjh.70053. Online ahead of print.","author":"Te Vrugt M, Newman H, Teachey DT, Burkhardt B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40808247"},{"title01":"Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma","title02":"Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2025 Aug 11. doi: 10.1111\/bjh.70090. Online ahead of print.","author":"Morimoto S, Jo T, Kitawaki T, Sakamoto T, Mizumoto C, Kanda J, Nishikori M, Yamashita K, Nagao M, Takaori-Kondo A, Arai Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40785504"},{"title01":"Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma","title02":"Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma","journal":"Blood","issue":"2025 Aug 1:blood.2025028863. doi: 10.1182\/blood.2025028863. Online ahead of print.","author":"Sam J, Leclercq-Cohen G, Gebhardt S, Surowka M, Herter S, Lechner K, Relf J, Briner S, Varol A, Appelt B, Domocos I, Nicolini VG, Bez M, Bommer E, Jenni S, Schoenle A, Le Clech M, Colombetti S, Klein C, Uma\u00f1a P, Lundberg P, Korfi K, Bottos A, Bacac M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40749164"},{"title01":"Opening the Door to Tailored Treatment in Newly Diagnosed Multiple Myeloma","title02":"Opening the Door to Tailored Treatment in Newly Diagnosed Multiple Myeloma","journal":"N Engl J Med","issue":"2025 Jul 31;393(5):498-500.","author":"Richardson PG, Munshi NC, Longo DL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40742264"},{"title01":"Daratumumab for High-Risk Smoldering Multiple Myeloma. Reply","title02":"Daratumumab for High-Risk Smoldering Multiple Myeloma. Reply","journal":"N Engl J Med","issue":"2025 Aug 7;393(6):617.","author":"Dimopoulos MA, Voorhees PM, Rajkumar SV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40768726"},{"title01":"Daratumumab for High-Risk Smoldering Multiple Myeloma","title02":"Daratumumab for High-Risk Smoldering Multiple Myeloma","journal":"N Engl J Med","issue":"2025 Aug 7;393(6):616-617.","author":"Shanmugam SP, Awwad A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40768725"},{"title01":"Simultaneous whole-body multi-parametric 2-[(18)F]FDG-PET\/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact","title02":"Simultaneous whole-body multi-parametric 2-[(18)F]FDG-PET\/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact","journal":"Leukemia","issue":"2025 Aug 7. doi: 10.1038\/s41375-025-02717-0. Online ahead of print.","author":"Jamet B, Touzeau C, Necib H, Frampas \u00c9, Sun H, Francois C, Blin N, Carlier T, Monnet A, Lilli N, Bodet-Milin C, Moreau P, Kraeber-Bodere F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40775455"},{"title01":"The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma","title02":"The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma","journal":"Leukemia","issue":"2025 Aug 1. doi: 10.1038\/s41375-025-02712-5. Online ahead of print.","author":"Wang Y, Chen S, Liang Z, Gale RP, Liu S, Chen X, Chi P, Song Y, Zhang Y, Wang W, Li J, Xia Z, Liang Y, Huang X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40750676"},{"title01":"Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial","title02":"Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e621-e634.","author":"Bringhen S, Cani L, Antonioli E, Derudas D, Fazio F, Larocca A, Ronconi S, Cellini C, Falcone AP, Accardi F, Liberati AM, Galieni P, Belotti A, Cafro AM, Ria R, Benevolo G, Vincelli ID, Mannina D, Lotti F, Bruno B, Marasco V, Mazza R, Tosi P, Rivolti E, Boccadoro M, D'Agostino M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769686"},{"title01":"Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed\/refractory multiple myeloma patients: a target trial emulation using real-world data","title02":"Comparison of isatuximab-pomalidomide-dexamethasone versus<\/i> elotuzumab-pomalidomide-dexamethasone in relapsed\/refractory multiple myeloma patients: a target trial emulation using real-world data","journal":"Haematologica","issue":"2025 Mar 6;110(8):1875-1881.","author":"Martino EA, Pitino A, Offidani M, Pepa RD, Gozzetti A, Bongarzoni V, Maroccia A, Amico V, Stefanoni P, Zamagni E, Terlizzi S, Derudas D, Palmieri S, Bianco R, Conticello C, Brunori M, Rago A, Lotti F, Fontana R, Sgherza N, Rossi E, Cafro AM, Febbo MA, Quinto AM, Cerchione C, Casaluci GM, Citro A, Califano C, Zambello R, Mangiacavalli S, Liberatore C, Buda G, De Magistris C, Amendola A, Vigna E, Bruzzese A, Barbieri E, Quaresima M, Roccotelli D, Farina F, Micozzi J, Vincelli ID, Tarantini G, Antonioli E, Aquino S, Maggi A, Lombardo A, Bertuglia G, Furlan A, Mele A, Annibali O, Cotzia E, Benvenuti P, De Paoli L, Baril\u00e0 G, Mor\u00e8 S, De Stefano V, Di Raimondo F, Petrucci MT, Bolli N, Musto P, Neri A, Morabito F, Tripepi G, Gentile M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40761134"},{"title01":"Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy","title02":"Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy","journal":"Blood","issue":"2025 Aug 1:blood.2025029773. doi: 10.1182\/blood.2025029773. Online ahead of print.","author":"Dhakal B, Akhtar OS, Fandrei D, Jensen A, Banerjee R, Pan D, Richard S, Friend R, Rees MJ, Costello P, Vazquez Martinez MA, Pasvolsky O, Wagner CB, Davis JA, Castaneda Puglianini OA, Reshef R, Afrough A, Dima D, Bhutani M, Nadeem O, Parrondo RD, Freeman CL, Mikkilineni L, Raza S, Anderson LD Jr, Kapoor P, Hosoya H, Chhabra S, Grajales-Cruz A, Gaballa MR, Midha S, Alsina M, Sborov DW, Patel KK, Lin Y, Ferreri CJ, Gagelmann N, Kumar AD, Hansen DK, Cowan AJ, Costa LJ, Merz M, Sidana S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40749169"},{"title01":"Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression","title02":"Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression","journal":"N Engl J Med","issue":"2025 Aug 4. doi: 10.1056\/NEJMoa2503822. Online ahead of print.","author":"Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40757665"},{"title01":"Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial","title02":"Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial","journal":"Lancet Haematol","issue":"2025 Aug 7:S2352-3026(25)00172-3. doi: 10.1016\/S2352-3026(25)00172-3. Online ahead of print.","author":"Robin M, D'Aveni M, Stamatoullas A, Raffoux E, Chevallier P, Garnier A, Mediavilla C, Carre M, Himberlin C, S\u00e9bert M, Ravinet A, Desseaux K, Labussi\u00e8re H, Alani M, Rubio MT, Huynh A, Ad\u00e8s L, de Latour RP, Paul F, Chermat F, Petit R, Mokeddem C, Charbonnier A, Th\u00e9pot S, Chevret S, Fenaux P; Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC) and the Groupe Francophone des My\u00e9lodysplasies (GFM).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40784355"},{"title01":"Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial","title02":"Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e621-e634.","author":"Bringhen S, Cani L, Antonioli E, Derudas D, Fazio F, Larocca A, Ronconi S, Cellini C, Falcone AP, Accardi F, Liberati AM, Galieni P, Belotti A, Cafro AM, Ria R, Benevolo G, Vincelli ID, Mannina D, Lotti F, Bruno B, Marasco V, Mazza R, Tosi P, Rivolti E, Boccadoro M, D'Agostino M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769686"},{"title01":"A multimodal sexual dysfunction intervention versus enhanced usual care for survivors of haematopoietic stem-cell transplantation: a single-centre, open-label, randomised clinical trial","title02":"A multimodal sexual dysfunction intervention versus enhanced usual care for survivors of haematopoietic stem-cell transplantation: a single-centre, open-label, randomised clinical trial","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e611-e620.","author":"El-Jawahri A, Traeger L, Reese JB, Dizon D, Bober SL, Greer JA, Vanderklish J, Horick N, Ufere N, Reynolds MJ, Rice J, Clay M, Newcomb R, DeFilipp Z, Chen YB, Temel JS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769685"},{"title01":"Enhancing sexual function after haematopoietic transplantation","title02":"Enhancing sexual function after haematopoietic transplantation","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e562-e563.","author":"Stratton P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769679"},{"title01":"Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation","title02":"Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation","journal":"Br J Haematol","issue":"2025 Aug 7. doi: 10.1111\/bjh.70050. Online ahead of print.","author":"Capes A, Mooyaart JE, Blaise D, Bramanti S, Kwon M, Mohty M, Chevallier P, Vydra J, Rem\u00e9nyi P, Forcade E, L\u00f3pez Corral L, It\u00e4l\u00e4-Remes M, Bazarbachi A, Derenzini E, Hoogenboom JD, Kuball J, Battipaglia G, Malard F, Ruggeri A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40772384"},{"title01":"A pragmatic monitoring model for risk of non-relapse mortality based on biomarkers in patients undergoing allogeneic haematopoietic stem-cell transplantation","title02":"A pragmatic monitoring model for risk of non-relapse mortality based on biomarkers in patients undergoing allogeneic haematopoietic stem-cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 11. doi: 10.1111\/bjh.70070. Online ahead of print.","author":"Shao Y, Yang J, Li X, He Y, Guan D, Xu R, Miao L, Wen J, Feng X, Wu T, Yang F, Song Z, Liu R, Wang D, Wei Z, Wang J, Liu X, He Y, Dou L, Liu D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40789768"},{"title01":"High donor regulatory B cells (Bregs) and their rapid recovery are associated with protection from the development of acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation","title02":"High donor regulatory B cells (Bregs) and their rapid recovery are associated with protection from the development of acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 11. doi: 10.1111\/bjh.70058. Online ahead of print.","author":"Ramzi M, Hesamadini M, Sanaei M, Golmoghaddam H, Kalani M, Arandi N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40785639"},{"title01":"Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT","title02":"Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT","journal":"Blood","issue":"2025 Aug 1:blood.2025028418. doi: 10.1182\/blood.2025028418. Online ahead of print.","author":"McManus D, Copsel SN, Pfeiffer BJ, Wolf D, Barreras H, Ma S, Khodor A, Komai S, Burgos da Silva M, Hazime H, Gallardo M, Lime SGR, van den Brink MRM, Park JH, Abreu MT, Hill GR, Perez VL, Levy RB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40749165"},{"title01":"Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial","title02":"Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e621-e634.","author":"Bringhen S, Cani L, Antonioli E, Derudas D, Fazio F, Larocca A, Ronconi S, Cellini C, Falcone AP, Accardi F, Liberati AM, Galieni P, Belotti A, Cafro AM, Ria R, Benevolo G, Vincelli ID, Mannina D, Lotti F, Bruno B, Marasco V, Mazza R, Tosi P, Rivolti E, Boccadoro M, D'Agostino M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769686"},{"title01":"A multimodal sexual dysfunction intervention versus enhanced usual care for survivors of haematopoietic stem-cell transplantation: a single-centre, open-label, randomised clinical trial","title02":"A multimodal sexual dysfunction intervention versus enhanced usual care for survivors of haematopoietic stem-cell transplantation: a single-centre, open-label, randomised clinical trial","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e611-e620.","author":"El-Jawahri A, Traeger L, Reese JB, Dizon D, Bober SL, Greer JA, Vanderklish J, Horick N, Ufere N, Reynolds MJ, Rice J, Clay M, Newcomb R, DeFilipp Z, Chen YB, Temel JS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769685"},{"title01":"High donor regulatory B cells (Bregs) and their rapid recovery are associated with protection from the development of acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation","title02":"High donor regulatory B cells (Bregs) and their rapid recovery are associated with protection from the development of acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Aug 11. doi: 10.1111\/bjh.70058. Online ahead of print.","author":"Ramzi M, Hesamadini M, Sanaei M, Golmoghaddam H, Kalani M, Arandi N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40785639"},{"title01":"Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study","title02":"Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study","journal":"Br J Haematol","issue":"2025 Aug 12. doi: 10.1111\/bjh.70068. Online ahead of print.","author":"Tolosa-Ridao C, Gonz\u00e1lez MB, G\u00f3mez MA, Fox L, P\u00e9rez Artigas MDM, Santamar\u00eda A, Quintela Gonz\u00e1lez MDC, Salinas AS, Salmer\u00f3n Camacho JM, Illana \u00c1lvaro V, Abdallahi-Lefdil Z, Navascues JC, Pardo L, Fern\u00e1ndez-Luis S, Vega Su\u00e1rez LP, Villar S, Beorlegui-Murillo P, Esquirol A, Izquierdo Garc\u00eda I, Ribes-Amor\u00f3s J, Lavilla E, Lopez-Mar\u00edn J, Basalobre P, Filaferro S, Cedillo \u00c1, Bento L, Sureda A, Salas MQ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40796522"},{"title01":"HSCs with the “SUPER” power to make blood forever","title02":"HSCs with the “SUPER” power to make blood forever","journal":"Blood","issue":"2025 Jul 31;146(5):521-522.","author":"Wojtowicz EE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40742727"},{"title01":"Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT","title02":"Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT","journal":"Blood","issue":"2025 Aug 1:blood.2025028418. doi: 10.1182\/blood.2025028418. Online ahead of print.","author":"McManus D, Copsel SN, Pfeiffer BJ, Wolf D, Barreras H, Ma S, Khodor A, Komai S, Burgos da Silva M, Hazime H, Gallardo M, Lime SGR, van den Brink MRM, Park JH, Abreu MT, Hill GR, Perez VL, Levy RB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40749165"},{"title01":"Impact of lifetime anaemia and iron control on outcomes in \u03b2-thalassaemia: Data from the longitudinal de-LIGHT study","title02":"Impact of lifetime anaemia and iron control on outcomes in \u03b2-thalassaemia: Data from the longitudinal de-LIGHT study","journal":"Br J Haematol","issue":"2025 Jul 31. doi: 10.1111\/bjh.70047. Online ahead of print.","author":"Musallam KM, Vitrano A, Inzerillo A, Di Maggio R, Barone R, Giangreco A, Renda MC, Fecarotta E, Troia A, Giambona A, Ruffo GB, Vlachaki E, Venou TM, Ricchi P, Ziello B, Serra M, Colizzi E, Longo F, Culcasi M, Maggio A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40745912"},{"title01":"Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid-resistant immune thrombocytopenia","title02":"Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid-resistant immune thrombocytopenia","journal":"Br J Haematol","issue":"2025 Aug 8. doi: 10.1111\/bjh.70072. Online ahead of print.","author":"Yu Y, Xie X, Chen Z, Wei J, Ouyang J, Lin Z, Ma J, Guo P, Wu R, Jia L, Gui J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40781812"},{"title01":"Predictors of response to emergent therapies in paediatric immune thrombocytopenia","title02":"Predictors of response to emergent therapies in paediatric immune thrombocytopenia","journal":"Br J Haematol","issue":"2025 Aug 5. doi: 10.1111\/bjh.70064. Online ahead of print.","author":"O'Farrell C, Luckie TM, Willis MJ, Kirk SE, Lucari BR, Scheurer ME, Gao X, Grimes AB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40762147"},{"title01":"Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL)","title02":"Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL)","journal":"Leukemia","issue":"2025 Aug 8. doi: 10.1038\/s41375-025-02714-3. Online ahead of print.","author":"Smith C, Charbonnier G, Simonin M, Balducci E, Steimle T, Andrieu GP, Cieslak A, Courgeon M, LeLorc'h M, Mayakonda A, Plass C, Le Nezet A, Latiri M, Ifrah N, Dombret H, Huguet F, Baruchel A, Macintyre E, Petit A, Boissel N, Asnafi V, Touzart A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40781485"},{"title01":"Clinically associated genomic landscape of pediatric non-Down Syndrome acute megakaryoblastic leukemia in Chinese patients","title02":"Clinically associated genomic landscape of pediatric non-Down Syndrome acute megakaryoblastic leukemia in Chinese patients","journal":"Leukemia","issue":"2025 Aug 11. doi: 10.1038\/s41375-025-02741-0. Online ahead of print.","author":"Wu K, Liu H, Hu W, Liu Y, Wu W, Cui B, Wang H, Zhao S, Tang Y, Cai J, Wang Y, Wang X, Chen X, Mo Y, Liu T, Xie Y, Sun H, Zhong Y, Rao J, Fan R, Wang Y, Chen C, Wang Z, Wang R, Huang Y, Shi Q, Wang L, Chen J, Chen J, Li B, Chen X, Liu Y, Shen S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40789916"},{"title01":"Bidirectional anti-tumor and immunological strategies by targeting GARP-TGF-\u03b2 axis in adult T-cell leukemia\/lymphoma","title02":"Bidirectional anti-tumor and immunological strategies by targeting GARP-TGF-\u03b2 axis in adult T-cell leukemia\/lymphoma","journal":"Leukemia","issue":"2025 Aug 4. doi: 10.1038\/s41375-025-02725-0. Online ahead of print.","author":"Suzuki K, Kusayanagi S, Kuze Y, Hata M, Kozuma S, Jimbo K, Nannya Y, Suzuki Y, Uchimaru K, Yamagishi M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40759773"},{"title01":"A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias","title02":"A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias","journal":"Leukemia","issue":"2025 Aug 6. doi: 10.1038\/s41375-025-02705-4. Online ahead of print.","author":"P\u00e9rez-Amill L, Armand-Ug\u00f3n M, Val-Casals M, Mart\u00edn-Herreros B, \u00c1lamo JR, Pe\u00f1a S, Frigola G, Altuna A, Santos C, Guijarro F, Minguela A, Bataller \u00c0, Casanovas-Albert\u00ed B, Uribe-Herranz M, Navarro I, Guerreiro M, S\u00e1nchez-Mart\u00ednez D, Tirado N, Velasco-Hernandez T, Men\u00e9ndez P, Mart\u00ednez A, Rovira M, Colomer D, Gonz\u00e1lez-Navarro EA, Esteve J, Urbano-Ispizua \u00c1, Montesinos P, Delgado J, Juan M, Klein-Gonz\u00e1lez N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40770072"},{"title01":"Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial","title02":"Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial","journal":"Lancet Haematol","issue":"2025 Aug 7:S2352-3026(25)00172-3. doi: 10.1016\/S2352-3026(25)00172-3. Online ahead of print.","author":"Robin M, D'Aveni M, Stamatoullas A, Raffoux E, Chevallier P, Garnier A, Mediavilla C, Carre M, Himberlin C, S\u00e9bert M, Ravinet A, Desseaux K, Labussi\u00e8re H, Alani M, Rubio MT, Huynh A, Ad\u00e8s L, de Latour RP, Paul F, Chermat F, Petit R, Mokeddem C, Charbonnier A, Th\u00e9pot S, Chevret S, Fenaux P; Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC) and the Groupe Francophone des My\u00e9lodysplasies (GFM).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40784355"},{"title01":"Acute lymphocytic leukaemia","title02":"Acute lymphocytic leukaemia","journal":"Lancet","issue":"2025 Aug 1:S0140-6736(25)00864-5. doi: 10.1016\/S0140-6736(25)00864-5. Online ahead of print.","author":"Kantarjian H, Pui CH, Jabbour E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40759141"},{"title01":"Follow-up of osteonecrosis in paediatric acute lymphoblastic leukaemia patients treated with the NOPHO ALL2008 protocol","title02":"Follow-up of osteonecrosis in paediatric acute lymphoblastic leukaemia patients treated with the NOPHO ALL2008 protocol","journal":"Br J Haematol","issue":"2025 Aug 9. doi: 10.1111\/bjh.70085. Online ahead of print.","author":"Rokkanen R, Aarnivala H, Huhtaniska S, Palmu S, Pokka T, P\u00f6yh\u00f6nen T, Suo-Palosaari M, Utriainen P, J\u00e4rvel\u00e4 L, Niinim\u00e4ki R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40781902"},{"title01":"Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia","title02":"Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Aug 8. doi: 10.1111\/bjh.70077. Online ahead of print.","author":"Liu Y, Liu W, Mei Y, Huang Q, Liu X, Guo C, Chen M, Mou J, Wang S, Xie W, Tian Z, Tang K, Xing H, Wang Y, Wei H, Gu R, Rao Q, Wang M, Qiu S, Wang J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40781784"},{"title01":"Treatment-free remission in chronic myeloid leukaemia patients with accelerated phase or tyrosine kinase inhibitor therapy failure","title02":"Treatment-free remission in chronic myeloid leukaemia patients with accelerated phase or tyrosine kinase inhibitor therapy failure","journal":"Br J Haematol","issue":"2025 Aug 13. doi: 10.1111\/bjh.70080. Online ahead of print.","author":"Yuan M, Zhang Y, Liu B, Zhou L, Zhu Y, Li Z, Zang S, Liu Z, Li W, Jiang Q.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40799021"},{"title01":"Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study","title02":"Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study","journal":"Br J Haematol","issue":"2025 Jul 31. doi: 10.1111\/bjh.70046. Online ahead of print.","author":"Sch\u00f6nung M, Rathmann S, Ramamoorthy S, Lebrecht D, Klingebiel T, Locatelli F, Nysom K, Rossig C, Star\u00fd J, Zecca M, Patturajan M, Erlacher M, Strahm B, Niemeyer CM, Lipka DB, Flotho C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40740143"},{"title01":"Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I\/II study","title02":"Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I\/II study","journal":"Br J Haematol","issue":"2025 Aug 1. doi: 10.1111\/bjh.70035. Online ahead of print.","author":"Danylesko I, Shimoni A, Avigdor A, Kedmi M, Amitai I, Shem-Tov N, Yerushalmi R, Andersson BS, Nagler A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40746302"},{"title01":"Synergistic potential of CDK4\/6 inhibitors and ATRA in non-APL AML","title02":"Synergistic potential of CDK4\/6 inhibitors and ATRA in non-APL AML","journal":"Br J Haematol","issue":"2025 Aug 4. doi: 10.1111\/bjh.70057. Online ahead of print.","author":"Skopek R, \u00d6zcan SG, Chmiel P, Morgner S, Sch\u00fctt J, Ghazvini Zadegan F, Stanko C, Palusi\u0144ska M, Ma\u015bli\u0144ska-Gromadka K, Sbirkov Y, Stengel S, Fischer M, Brioli A, Zelent A, Szyma\u0144ski \u0141, Schenk T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40755307"},{"title01":"Immunoglobulin-containing vacuoles in CLL","title02":"Immunoglobulin-containing vacuoles in CLL","journal":"Blood","issue":"2025 Jul 31;146(5):647.","author":"Qamar A, Zhao C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40742719"},{"title01":"Magrolimab and the tale of indigestible AML","title02":"Magrolimab and the tale of indigestible AML","journal":"Blood","issue":"2025 Jul 31;146(5):527-528.","author":"R\u00f6llig C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40742723"},{"title01":"Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells","title02":"Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells","journal":"Blood","issue":"2025 Aug 1:blood.2024027822. doi: 10.1182\/blood.2024027822. Online ahead of print.","author":"Pauli C, Kienh\u00f6fer M, Blank MF, Begik O, Rohde C, Zimmermann SM, Werner L, Heid D, Xu F, Weidenauer K, Delaunay S, Krall N, Trunk K, Zhao D, Zhou F, Llovera L, Alexane O, Heit-Mondrzyk A, Platzbecker U, Baldus CD, Serve H, Bornh\u00e4user M, V\u00e5gb\u00f8 CB, Benitah SA, Krijgsveld J, Novoa EM, M\u00fcller-Tidow C, Frye M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40749163"},{"title01":"How I Manage Chronic Myeloid Leukemia During Pregnancy","title02":"How I Manage Chronic Myeloid Leukemia During Pregnancy","journal":"Blood","issue":"2025 Aug 4:blood.2024026513. doi: 10.1182\/blood.2024026513. Online ahead of print.","author":"Abruzzese E, Chelysheva E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40758938"},{"title01":"Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML","title02":"Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML","journal":"Blood","issue":"2025 Aug 6:blood.2025029556. doi: 10.1182\/blood.2025029556. Online ahead of print.","author":"Othman J, Potter N, Freeman SD, McCarthy N, Jovanovic J, Runglall M, Canham J, Thomas I, Johnson S, Gilkes AF, Cavenagh JD, Kottaridis P, Taussig DC, Arnold C, Hemmaway CJ Dr, Culligan D, Overgaard UM, Dennis M, Burnett AK, Russell NH, Dillon RJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40768751"},{"title01":"Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. Reply","title02":"Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. Reply","journal":"N Engl J Med","issue":"2025 Aug 7;393(6):620.","author":"Svoboda J, Hexner E, June CH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40768731"},{"title01":"Enhanced CAR T-Cell Therapy for Relapsed Lymphoma","title02":"Enhanced CAR T-Cell Therapy for Relapsed Lymphoma","journal":"N Engl J Med","issue":"2025 Aug 7;393(6):619-620.","author":"Vairamoorthy N, Kazi B, Patil V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40768730"},{"title01":"Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma","title02":"Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma","journal":"Leukemia","issue":"2025 Jul 30. doi: 10.1038\/s41375-025-02697-1. Online ahead of print.","author":"Heavican-Foral TB, Korell F, Scarf\u00f2 I, Wiggers CRM, B AT, Eisenbies Z, Powers F, Hegel J, Liu J, Kulp S, Silva H, Wu G, Letai A, Stegmaier K, Lohr JG, Weinstock DM, Maus MV, Knoechel B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40739330"},{"title01":"Bidirectional anti-tumor and immunological strategies by targeting GARP-TGF-\u03b2 axis in adult T-cell leukemia\/lymphoma","title02":"Bidirectional anti-tumor and immunological strategies by targeting GARP-TGF-\u03b2 axis in adult T-cell leukemia\/lymphoma","journal":"Leukemia","issue":"2025 Aug 4. doi: 10.1038\/s41375-025-02725-0. Online ahead of print.","author":"Suzuki K, Kusayanagi S, Kuze Y, Hata M, Kozuma S, Jimbo K, Nannya Y, Suzuki Y, Uchimaru K, Yamagishi M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40759773"},{"title01":"Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma","title02":"Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma","journal":"J Clin Oncol","issue":"2025 Aug 13:101200JCO2501534. doi: 10.1200\/JCO-25-01534. Online ahead of print.","author":"Roschewski M, Kurtz DM, Westin JR, Lynch RC, Gopal AK, Alig SK, Sworder BJ, Cherng HJ, Kuffer C, Blair D, Brown K, Goldstein JS, Schultz A, Close S, Chabon JJ, Diehn M, Wilson WH, Alizadeh AA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40802906"},{"title01":"Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma","title02":"Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma","journal":"J Clin Oncol","issue":"2025 Aug 13:101200JCO2501534. doi: 10.1200\/JCO-25-01534. Online ahead of print.","author":"Roschewski M, Kurtz DM, Westin JR, Lynch RC, Gopal AK, Alig SK, Sworder BJ, Cherng HJ, Kuffer C, Blair D, Brown K, Goldstein JS, Schultz A, Close S, Chabon JJ, Diehn M, Wilson WH, Alizadeh AA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40802906"},{"title01":"Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial","title02":"Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e588-e598.","author":"Mateos MV, Paiva B, Cedena MT, Puig N, Sureda-Balari AM, de la Calle VG, Oriol A, Ocio EM, Rosi\u00f1ol L, Montes YG, Bargay J, Garc\u00eda MEG, Lakhwani S, Payer AR, Suarez-Cabrera A, Blanchard MJ, Garz\u00f3n S, Montero FC, Caba\u00f1as V, de Oteyza JP, Gironella M, Martinez-Lopez J, Casas\u00fas AIT, Delgado-Beltr\u00e1n MP, Prieto E, Lahuerta JJ, Blad\u00e9 J, San-Miguel J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769684"},{"title01":"A new chapter in relapsed or refractory multiple myeloma","title02":"A new chapter in relapsed or refractory multiple myeloma","journal":"Lancet Haematol","issue":"2025 Aug;12(8):e561.","author":"The Lancet Haematology.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40769678"},{"title01":"Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study","title02":"Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study","journal":"Br J Haematol","issue":"2025 Aug 12. doi: 10.1111\/bjh.70068. Online ahead of print.","author":"Tolosa-Ridao C, Gonz\u00e1lez MB, G\u00f3mez MA, Fox L, P\u00e9rez Artigas MDM, Santamar\u00eda A, Quintela Gonz\u00e1lez MDC, Salinas AS, Salmer\u00f3n Camacho JM, Illana \u00c1lvaro V, Abdallahi-Lefdil Z, Navascues JC, Pardo L, Fern\u00e1ndez-Luis S, Vega Su\u00e1rez LP, Villar S, Beorlegui-Murillo P, Esquirol A, Izquierdo Garc\u00eda I, Ribes-Amor\u00f3s J, Lavilla E, Lopez-Mar\u00edn J, Basalobre P, Filaferro S, Cedillo \u00c1, Bento L, Sureda A, Salas MQ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40796522"},{"title01":"Myeloma: a sky full of MRD stars","title02":"Myeloma: a sky full of MRD stars","journal":"Blood","issue":"2025 Aug 7;146(6):649-650.","author":"Paiva B, San-Miguel JF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40773178"},{"title01":"Time-tested safety: FCARH143’s 5-year myeloma journey","title02":"Time-tested safety: FCARH143’s 5-year myeloma journey","journal":"Blood","issue":"2025 Jul 31;146(5):519-520.","author":"Al Hadidi S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40742722"},{"title01":"Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma","title02":"Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma","journal":"Blood","issue":"2025 Aug 4:blood.2025028963. doi: 10.1182\/blood.2025028963. Online ahead of print.","author":"Rivera J, Yan Q, Daneshmandi S, Lannes R, Katsuta E, Choi JE, Singh PK, Belal A, Alberico R, Lund I, Schaefer M, Hassan H, Parker S, Anderson KC, Munshi NC, Samur MK, McCarthy PL, Hillengass J, Mohammadpour H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40758944"},{"title01":"Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","title02":"Impact of TP53<\/i> variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","journal":"Leukemia","issue":"2025 Jul 14. doi: 10.1038\/s41375-025-02672-w. Online ahead of print.","author":"Zhao Y, Cao W, Shi J, Cao Y, Lu Y, Luo Y, Ouyang G, Chen L, Lan J, Song X, Chen Y, Yu L, Yu J, Lai X, Liu L, Fu H, Ye Y, Yang L, Mo X, Hu X, Huang H, Zhao Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40659988"},{"title01":"DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia","title02":"DNA demethylation-mediated downregulation of MNX1<\/i> in acute myeloid leukemia","journal":"Leukemia","issue":"2025 Jul 14. doi: 10.1038\/s41375-025-02680-w. Online ahead of print.","author":"Kelek\u00e7i S, Kelly K, Goyal A, Wehrwein N, Riedel A, Weichenhan D, Scherer M, Michels BE, K\u00f6rner C, Orzella I, Hakobyan M, B\u00e4hr M, Everatt E, Dunford J, Lipka DB, Lutsik P, Oppermann U, Plass C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40659989"},{"title01":"Leukemia stem cells in acute myeloid leukemia-mimicking “space and time continuum”?","title02":"Leukemia stem cells in acute myeloid leukemia-mimicking “space and time continuum”?","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.288003. Online ahead of print.","author":"Plesa A, Roumier C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671495"},{"title01":"A rare phenotype of peripheral T-cell lymphoma, NOS: coexpression of CD15, CD20, and T follicular helper markers in a DUSP22alt case","title02":"A rare phenotype of peripheral T-cell lymphoma, NOS: coexpression of CD15, CD20, and T follicular helper markers in a DUSP22<\/i>alt<\/sup> case","journal":"Blood","issue":"2025 Jul 10;146(2):260. doi: 10.1182\/blood.2025028986.","author":"Al Jabri M, Sakhdari A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40638196"},{"title01":"Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","title02":"Impact of TP53<\/i> variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","journal":"Leukemia","issue":"2025 Jul 14. doi: 10.1038\/s41375-025-02672-w. Online ahead of print.","author":"Zhao Y, Cao W, Shi J, Cao Y, Lu Y, Luo Y, Ouyang G, Chen L, Lan J, Song X, Chen Y, Yu L, Yu J, Lai X, Liu L, Fu H, Ye Y, Yang L, Mo X, Hu X, Huang H, Zhao Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40659988"},{"title01":"The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation","title02":"The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation","journal":"Br J Haematol","issue":"2025 Jul 29. doi: 10.1111\/bjh.70049. Online ahead of print.","author":"Bertz H, Sahlmann J, McMillan DC, Wehr C, Duque-Afonso J, Maas-Bauer K, W\u00e4sch R, Nikolaychuk J, Greil C, Arends J, Finke J, Zeiser R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40731308"},{"title01":"Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell\u00a0transplantation","title02":"Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell\u00a0transplantation","journal":"Br J Haematol","issue":"2025 Jul 19. doi: 10.1111\/bjh.70006. Online ahead of print.","author":"Desai N, Al-Shaibani E, Alfaro-Moya T, Law AD, Lam W, Remberger M, Pasic I, Novitzky-Basso I, Viswabandya A, Kim DD, Kumar R, Lipton JH, Mattsson J, Michelis FV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40682490"},{"title01":"The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy","title02":"The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy","journal":"Br J Haematol","issue":"2025 Jul 21. doi: 10.1111\/bjh.70016. Online ahead of print.","author":"Zhen S, Liu L, Liu F, Shen Y, Zhang T, Fan Y, Cui Y, Pan L, Liang C, Cao Y, Cao W, Wei J, Zhai W, Chen X, Ma Q, Zhang R, Yang D, He Y, Pang A, Han M, Jiang E, Feng S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40691838"},{"title01":"Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCR\u03b1\u03b2\/CD19 depletion or post-transplant cyclophosphamide","title02":"Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCR\u03b1\u03b2\/CD19 depletion or post-transplant cyclophosphamide","journal":"Br J Haematol","issue":"2025 Jul 21. doi: 10.1111\/bjh.70004. Online ahead of print.","author":"Masetti R, Leardini D, Gottardi F, Baccelli F, Ottaviano GAM, Vendemini F, Saglio F, Pierri F, Algeri M, Del Bufalo F, Merli P, Prete A, Cesaro S, Ussowicz M, Faraci M, Zecca M, Fagioli F, Balduzzi A, Dalle JH, Locatelli F, Pagliara D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40692189"},{"title01":"Allogeneic transplantation after failure of chimeric antigen receptor-T cells and exposure to bispecific antibodies: Feasibility, safety and survival outcomes","title02":"Allogeneic transplantation after failure of chimeric antigen receptor-T cells and exposure to bispecific antibodies: Feasibility, safety and survival outcomes","journal":"Br J Haematol","issue":"2025 Jul 22. doi: 10.1111\/bjh.70010. Online ahead of print.","author":"Barone A, De Philippis C, Stella F, Dodero A, Sarina B, Pennisi M, Santoro A, Carlo-Stella C, Guidetti A, Bramanti S, Corradini P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40695357"},{"title01":"Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study","title02":"Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study","journal":"Br J Haematol","issue":"2025 Jul 13. doi: 10.1111\/bjh.20262. Online ahead of print.","author":"Severinsen FT, Simonsen MR, Futtrup Maksten E, Jakobsen LH, Jensen RK, S\u00f8gaard KK, Jensen P, Brown PN, M\u00e9sz\u00e1ros J\u00f8rgensen J, Larsen TS, Poulsen CB, El-Galaly TC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40653138"},{"title01":"A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donors","title02":"A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donors","journal":"Br J Haematol","issue":"2025 Jul 16. doi: 10.1111\/bjh.70008. Online ahead of print.","author":"Shimomura Y, Komukai S, Kitamura T, Yoshimura K, Inamoto Y, Akahoshi Y, Kuwatsuka Y, Usui Y, Uchida N, Tanaka M, Onizuka M, Sakata-Yanagimoto M, Doki N, Hasegawa Y, Ishiwata K, Nakamae H, Sawa M, Katayama Y, Kawakita T, Yoshimitsu M, Fukuda T, Kanda Y, Ohbiki M, Nakasone H, Kanda J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671206"},{"title01":"Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial","title02":"Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial","journal":"Blood","issue":"2025 Jul 30:blood.2025028730. doi: 10.1182\/blood.2025028730. Online ahead of print.","author":"Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Mueller LP, Schmid C, Krause SW, Bethge WA, Jost E, Platzbecker U, Klein S, Niederland J, Kaufmann M, Sch\u00e4fer-Eckart K, Baldauf H, St\u00f6lzel F, Trost S, R\u00f6llig C, von Bonin M, Egger-Heidrich K, Kunadt D, Steffen B, Hauptrock B, Schliemann C, Sockel K, Lang F, Kriege O, Schaffrath J, Reicherts C, Berdel WE, Serve H, Ehninger G, Schmidt AH, Mikesch JH, Bornh\u00e4user M, Schetelig J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40737595"},{"title01":"RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT","title02":"RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT","journal":"Blood","issue":"2025 Jul 18:blood.2025029584. doi: 10.1182\/blood.2025029584. Online ahead of print.","author":"DeFilipp Z, Choe HK, Efebera YA, Saad A, Farhan S, Lekakis LJ, Yared JA, Schiller GJ, Mapara MY, Assal A, Gooley TA, Bui JD, Lee DD, Lane H, Chen YB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40680268"},{"title01":"Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease","title02":"Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease","journal":"Blood","issue":"2025 Jul 23:blood.2025028562. doi: 10.1182\/blood.2025028562. Online ahead of print.","author":"Ma L, Koehn BH, Zaiken MC, Hippen KL, Smith KD, Allred JR, Williams RL, Yao K, Fink J, Saha A, Kopp B, Payne N, Widelak R, Panoskaltsis-Mortari A, Riddle MJ, Tolar J, Eide C, Xia L, Witty AD, Mehta AK, Denholtz M, Hefazi M, Hani S, Kenderian SS, Miller JS, Molldrem JJ, Kean LS, Valamehr B, Blazar BR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700578"},{"title01":"Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","title02":"Impact of TP53<\/i> variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","journal":"Leukemia","issue":"2025 Jul 14. doi: 10.1038\/s41375-025-02672-w. Online ahead of print.","author":"Zhao Y, Cao W, Shi J, Cao Y, Lu Y, Luo Y, Ouyang G, Chen L, Lan J, Song X, Chen Y, Yu L, Yu J, Lai X, Liu L, Fu H, Ye Y, Yang L, Mo X, Hu X, Huang H, Zhao Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40659988"},{"title01":"Changing donors improves outcomes of second transplantation in patients who experienced graft failure after first allogeneic stem cell transplantation","title02":"Changing donors improves outcomes of second transplantation in patients who experienced graft failure after first allogeneic stem cell transplantation","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.287554. Online ahead of print.","author":"Ma R, Zhu XY, Lu Y, Chen J, Xuan L, Yuan HL, Cao Y, Cao WJ, Fang XS, Miao KR, Hu XX, Yi H, Zhao YM, Wu YB, Yang T, Wang HT, Yin Y, Zhang ZM, Zhang XH, Xu LP, Wang Y, Liu KY, Huang XJ, Sun YQ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671492"},{"title01":"Leukemia stem cells in acute myeloid leukemia-mimicking “space and time continuum”?","title02":"Leukemia stem cells in acute myeloid leukemia-mimicking “space and time continuum”?","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.288003. Online ahead of print.","author":"Plesa A, Roumier C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671495"},{"title01":"Comparative single-cell lineage bias in human and murine hematopoietic stem cells","title02":"Comparative single-cell lineage bias in human and murine hematopoietic stem cells","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.287897. Online ahead of print.","author":"Shamie I, Bliss-Moreau M, Lee JC, Mathieu R, Hoffman HM, Geng B, Lewis NE, Zhu YP, Croker BA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671503"},{"title01":"The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation","title02":"The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation","journal":"Br J Haematol","issue":"2025 Jul 29. doi: 10.1111\/bjh.70049. Online ahead of print.","author":"Bertz H, Sahlmann J, McMillan DC, Wehr C, Duque-Afonso J, Maas-Bauer K, W\u00e4sch R, Nikolaychuk J, Greil C, Arends J, Finke J, Zeiser R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40731308"},{"title01":"Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell\u00a0transplantation","title02":"Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell\u00a0transplantation","journal":"Br J Haematol","issue":"2025 Jul 19. doi: 10.1111\/bjh.70006. Online ahead of print.","author":"Desai N, Al-Shaibani E, Alfaro-Moya T, Law AD, Lam W, Remberger M, Pasic I, Novitzky-Basso I, Viswabandya A, Kim DD, Kumar R, Lipton JH, Mattsson J, Michelis FV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40682490"},{"title01":"The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy","title02":"The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy","journal":"Br J Haematol","issue":"2025 Jul 21. doi: 10.1111\/bjh.70016. Online ahead of print.","author":"Zhen S, Liu L, Liu F, Shen Y, Zhang T, Fan Y, Cui Y, Pan L, Liang C, Cao Y, Cao W, Wei J, Zhai W, Chen X, Ma Q, Zhang R, Yang D, He Y, Pang A, Han M, Jiang E, Feng S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40691838"},{"title01":"Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCR\u03b1\u03b2\/CD19 depletion or post-transplant cyclophosphamide","title02":"Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCR\u03b1\u03b2\/CD19 depletion or post-transplant cyclophosphamide","journal":"Br J Haematol","issue":"2025 Jul 21. doi: 10.1111\/bjh.70004. Online ahead of print.","author":"Masetti R, Leardini D, Gottardi F, Baccelli F, Ottaviano GAM, Vendemini F, Saglio F, Pierri F, Algeri M, Del Bufalo F, Merli P, Prete A, Cesaro S, Ussowicz M, Faraci M, Zecca M, Fagioli F, Balduzzi A, Dalle JH, Locatelli F, Pagliara D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40692189"},{"title01":"Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study","title02":"Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study","journal":"Br J Haematol","issue":"2025 Jul 13. doi: 10.1111\/bjh.20262. Online ahead of print.","author":"Severinsen FT, Simonsen MR, Futtrup Maksten E, Jakobsen LH, Jensen RK, S\u00f8gaard KK, Jensen P, Brown PN, M\u00e9sz\u00e1ros J\u00f8rgensen J, Larsen TS, Poulsen CB, El-Galaly TC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40653138"},{"title01":"Unusual suspects: a surprise cast in making blood stem cells","title02":"Unusual suspects: a surprise cast in making blood stem cells","journal":"Blood","issue":"2025 Jul 17;146(3):265-266.","author":"Hadland B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674120"},{"title01":"RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT","title02":"RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT","journal":"Blood","issue":"2025 Jul 18:blood.2025029584. doi: 10.1182\/blood.2025029584. Online ahead of print.","author":"DeFilipp Z, Choe HK, Efebera YA, Saad A, Farhan S, Lekakis LJ, Yared JA, Schiller GJ, Mapara MY, Assal A, Gooley TA, Bui JD, Lee DD, Lane H, Chen YB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40680268"},{"title01":"CD99 Promotes Self-renewal in Hematopoietic Stem Cells and Leukemia Stem Cells by Regulating Protein Synthesis","title02":"CD99 Promotes Self-renewal in Hematopoietic Stem Cells and Leukemia Stem Cells by Regulating Protein Synthesis","journal":"Blood","issue":"2025 Jul 23:blood.2024026271. doi: 10.1182\/blood.2024026271. Online ahead of print.","author":"Ji Y, Huang Y, Thomas T, Kapti EG, Tachibana R, Lark JA, Berezniuk I, Guo L, Ali MAE, Mims K, Kroger B, Hu W, Park CY, Chung SS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700577"},{"title01":"Loss of DCAF8 impairs hematopoietic stem cell function with cellular senescence via the DOCK11-CDC42 axis","title02":"Loss of DCAF8 impairs hematopoietic stem cell function with cellular senescence via the DOCK11-CDC42 axis","journal":"Blood","issue":"2025 Jul 10:blood.2024027335. doi: 10.1182\/blood.2024027335. Online ahead of print.","author":"Xu P, Zhang X, Li D, Jiao B, Nie J, Huang Y, Xia Z, Li J, Dan Y, Huang X, Yan L, Zhang R, Huang W, Wang X, Ji S, Cang Y, Ren R, Liu P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40643159"},{"title01":"Safety and efficacy of romiplostim in children with acquired aplastic anemia who are na\u00efve to immunosuppressive therapy","title02":"Safety and efficacy of romiplostim in children with acquired aplastic anemia who are na\u00efve to immunosuppressive therapy","journal":"Haematologica","issue":"2025 Jul 24. doi: 10.3324\/haematol.2025.288078. Online ahead of print.","author":"Bordbar M, Faghihi A, Zekavat OR, Shahriari M, Bordbar S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702901"},{"title01":"Alu-mediated FANCD2 exonic deletion contributes to Fanconi anaemia","title02":"Alu-mediated FANCD2 exonic deletion contributes to Fanconi anaemia","journal":"Br J Haematol","issue":"2025 Jul 28. doi: 10.1111\/bjh.70045. Online ahead of print.","author":"Shangguan S, Cui X, Li J, Li N, Liu R, Chen X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40726011"},{"title01":"Romiplostim with ciclosporin A in patients with aplastic anaemia na\u00efve to immunosuppressive therapy: A phase 2\/3 study","title02":"Romiplostim with ciclosporin A in patients with aplastic anaemia na\u00efve to immunosuppressive therapy: A phase 2\/3 study","journal":"Br J Haematol","issue":"2025 Jul 10. doi: 10.1111\/bjh.20206. Online ahead of print.","author":"Lee JW, Jang JH, Chiba S, Yoon SS, Oshikawa G, Usuki K, Mun YC, Kawakita T, Imada K, Cheong JW, Noshiro M, Matsuda A, Ozawa K, Mitani K, Kanda Y, Nakao S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40639944"},{"title01":"Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical care","title02":"Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical care","journal":"Br J Haematol","issue":"2025 Jul 15. doi: 10.1111\/bjh.20251. Online ahead of print.","author":"Ma J, Cui C, Ouyang J, Lin Z, Lin X, Hu Y, Wang Z, Dong S, Meng J, Zhang W, Cheng X, Chen Z, Tang Y, Wu R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40665492"},{"title01":"How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor","title02":"How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor","journal":"Blood","issue":"2025 Jul 29:blood.2024025482. doi: 10.1182\/blood.2024025482. Online ahead of print.","author":"Shadman M, Davids MS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40729699"},{"title01":"Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial","title02":"Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial","journal":"Blood","issue":"2025 Jul 30:blood.2025028730. doi: 10.1182\/blood.2025028730. Online ahead of print.","author":"Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Mueller LP, Schmid C, Krause SW, Bethge WA, Jost E, Platzbecker U, Klein S, Niederland J, Kaufmann M, Sch\u00e4fer-Eckart K, Baldauf H, St\u00f6lzel F, Trost S, R\u00f6llig C, von Bonin M, Egger-Heidrich K, Kunadt D, Steffen B, Hauptrock B, Schliemann C, Sockel K, Lang F, Kriege O, Schaffrath J, Reicherts C, Berdel WE, Serve H, Ehninger G, Schmidt AH, Mikesch JH, Bornh\u00e4user M, Schetelig J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40737595"},{"title01":"Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL\/SLL","title02":"Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL\/SLL","journal":"Blood","issue":"2025 Jul 30:blood.2024028205. doi: 10.1182\/blood.2024028205. Online ahead of print.","author":"Burger JA, Barr PM, Robak T Prof, Owen C, Tedeschi A, Sarma A, Patten PE, Grosicki S, McCarthy H Dr, Offner F, Szafer Glusman E, Zhou C, Szoke A, Neumayr L, Dean JP, Ghia P, Kipps T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40737596"},{"title01":"Secondary blastoid plasma cell leukemia: can an old dog learn new tricks?","title02":"Secondary blastoid plasma cell leukemia: can an old dog learn new tricks?","journal":"Blood","issue":"2025 Jul 17;146(3):396.","author":"Cheng J, Zhou J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674113"},{"title01":"PROTACtion against BCL-xL in post-MPN AML","title02":"PROTACtion against BCL-xL in post-MPN AML","journal":"Blood","issue":"2025 Jul 17;146(3):266-267.","author":"Arellano NS, Elf SE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674116"},{"title01":"Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial","title02":"Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial","journal":"J Clin Oncol","issue":"2025 Jul 17:JCO2500439. doi: 10.1200\/JCO-25-00439. Online ahead of print.","author":"Ferdinandus J, Kaul H, Foss\u00e5 A, H\u00fcttmann A, Keil F, Ko YD, Hitz F, Schwarz M, Trenker C, Kerkhoff A, Staib P, Wille K, Dresel I, Hahn D, Hertenstein B, Moosmann P, Mey U, Balabanov S, Armytage T, Roncolato F, Hellmuth JC, Hertzberg M, Kobe C, Klapper W, Baues C, Eich HT, Kreissl S, Fuchs M, Jablonski J, Schneider G, Tharmaseelan H, Eichenauer DA, von Tresckow B, Borchmann P, Br\u00f6ckelmann PJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674676"},{"title01":"Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients","title02":"Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients","journal":"J Clin Oncol","issue":"2025 Jul 17:JCO2501022. doi: 10.1200\/JCO-25-01022. Online ahead of print.","author":"Radhakrishnan VS, Johnson PWM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674680"},{"title01":"Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma","title02":"Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma","journal":"Haematologica","issue":"2025 Jul 24. doi: 10.3324\/haematol.2025.288114. Online ahead of print.","author":"Ghione P, Zinzani PL, Brown JR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702895"},{"title01":"Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis","title02":"Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2025.287547. Online ahead of print.","author":"Alhomoud M, Ibrahim R, Demetres M, Rejeski K, Scordo M, Shouval R, Tix T, Martinet J, Foley M, Gomez-Arteaga A, Shore T, Pagnini P, Aljurf M, Guzman ML, Formenti S, Yahalom J, Van Besien K, Imber BS, Chen Z, Yamshon S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637750"},{"title01":"Long non-coding RNA LINC00926 is a biomarker for na\u00efve B-cells with prognostic value in advanced stage classic Hodgkin Lymphoma","title02":"Long non-coding RNA LINC00926 is a biomarker for na\u00efve B-cells with prognostic value in advanced stage classic Hodgkin Lymphoma","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.287524. Online ahead of print.","author":"Iaccarino I, Beder T, Reinke S, Borchmann P, Von Tresckow B, Altenbuchinger M, Klapper W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671505"},{"title01":"Fit, unfit, or frail? Now easier to tell for Hodgkin lymphoma","title02":"Fit, unfit, or frail? Now easier to tell for Hodgkin lymphoma","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.288033. Online ahead of print.","author":"Moskowitz AJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671506"},{"title01":"A phase Ib\/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial","title02":"A phase Ib\/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial","journal":"Br J Haematol","issue":"2025 Jul 25. doi: 10.1111\/bjh.70028. Online ahead of print.","author":"Carpio C, de la Cruz-Vicente F, Garc\u00eda-Sanz R, Zeberio I, Barrenetxea C, Domingo-Domenech E, Bastos M, Rubio Martinez A, G\u00f3mez-Prieto P, Rodriguez A, Casanova M, Cladera-Serra A, Nu\u00f1ez Cespedes J, Mart\u00ednez C, Moreno-Vel\u00e1zquez M, Garcia-Galea E, Abrisqueta P, Bosch F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40714959"},{"title01":"A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis","title02":"A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis","journal":"Br J Haematol","issue":"2025 Jul 20. doi: 10.1111\/bjh.70017. Online ahead of print.","author":"Regazzo G, Vari G, Marchesi F, D\u00edaz M\u00e9ndez AB, Di Giuliani M, Sacconi A, Palombi F, Lulli V, Goeman F, Novello M, Tomassi M, Papa E, Bertoni F, Hohaus S, Mengarelli A, Rizzo MG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40685776"},{"title01":"Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS","title02":"Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS","journal":"Br J Haematol","issue":"2025 Jul 22. doi: 10.1111\/bjh.70020. Online ahead of print.","author":"Hossain NM, Ahn KW, Patel J, Lian Q, Abid B, Al Nughmush A, Bacher U, Bi X, Hashmi SK, Hilal T, Husnain M, Khimani F, Maziarz RT, Modi D, Ram R, Rizzieri D, Sica RA, Steinberg A, Vij R, Shadman M, Turtle C, Hamadani M, Herrera AF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40693472"},{"title01":"Nodal peripheral T-cell lymphoma in Finland between 2007 and 2019: Incidence, late morbidity and survival","title02":"Nodal peripheral T-cell lymphoma in Finland between 2007 and 2019: Incidence, late morbidity and survival","journal":"Br J Haematol","issue":"2025 Jul 10. doi: 10.1111\/bjh.20253. Online ahead of print.","author":"Partanen A, R\u00f6nk\u00e4 A, Anttalainen A, Ukkola-Vuoti L, Toppila I, Kuitunen H, Miettinen T, Kuittinen O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40641050"},{"title01":"Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study","title02":"Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study","journal":"Br J Haematol","issue":"2025 Jul 13. doi: 10.1111\/bjh.20262. Online ahead of print.","author":"Severinsen FT, Simonsen MR, Futtrup Maksten E, Jakobsen LH, Jensen RK, S\u00f8gaard KK, Jensen P, Brown PN, M\u00e9sz\u00e1ros J\u00f8rgensen J, Larsen TS, Poulsen CB, El-Galaly TC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40653138"},{"title01":"Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL\/SLL","title02":"Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL\/SLL","journal":"Blood","issue":"2025 Jul 30:blood.2024028205. doi: 10.1182\/blood.2024028205. Online ahead of print.","author":"Burger JA, Barr PM, Robak T Prof, Owen C, Tedeschi A, Sarma A, Patten PE, Grosicki S, McCarthy H Dr, Offner F, Szafer Glusman E, Zhou C, Szoke A, Neumayr L, Dean JP, Ghia P, Kipps T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40737596"},{"title01":"TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma","title02":"TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma","journal":"Blood","issue":"2025 Jul 23:blood.2024026919. doi: 10.1182\/blood.2024026919. Online ahead of print.","author":"Wang W, Cai Q, Liu Y, Nie L, Lee HH, Yan F, Fei Y, Yao Y, Li Y, Tan L, Lorenzi PL, Wang YN, Yao J, Chen Z, McIntosh J, Yu CT, Jain P, Jiang V, Vargas J, Li X, Zhang T, Li S, Santos D, Thirumurthi S, Seeley EH, Simon LM, Flowers CR, Ok CY, Wang ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700581"},{"title01":"\u03b1-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development","title02":"\u03b1-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development","journal":"Blood","issue":"2025 Jul 23:blood.2024028069. doi: 10.1182\/blood.2024028069. Online ahead of print.","author":"Jaafar C, Ethiraj P, Qiu Z, Lin AP, Simonis Seabra Martins Ferrari P, Aguiar R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700634"},{"title01":"Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell Therapy","title02":"Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell Therapy","journal":"Blood","issue":"2025 Jul 15:blood.2025028964. doi: 10.1182\/blood.2025028964. Online ahead of print.","author":"Kaulen LD, Martinez-Lage M, Abramson JS, Karschnia P, Doubrovinskaia S, Shankar GM, Choi BD, Ramundo CM, Ehret F, Barnes JA, El-Jawahri A, Hochberg E, Johnson PC, Soumerai JD, Plotkin SR, Batchelor TT, Wick W, Maus MV, Chen YB, Frigault MJ, Dietrich J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663771"},{"title01":"A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification","title02":"A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification","journal":"Blood","issue":"2025 Jul 15:blood.2025029628. doi: 10.1182\/blood.2025029628. Online ahead of print.","author":"Scarisbrick JJ, Quaglino P, Whittaker SJ, Bagot M, Guenova E, Papadavid E, Prince HM, Sanches JA, Miyashiro D, Servitje O, Querfeld C, Akilov OE, Arumainathan A, Bennett L, Battistella M, Benstead K Dr, Berti EF, Beylot-Barry M, Busschots AM, Cowan RA, Dummer R, Dunnill G, Estrach MT, Evison F, Bashir AE, Geskin LJ, Gru A, Guitart J, Herrera MC, Hodak E, Horwitz SM, Jonak C, Klemke CD, Knobler R, McKay P, Marschalk\u00f3 M, Massone C, Matin R, Mitteldorf C, Novoa RA, Ortiz-Romero PL, Pimpinelli N, Pujol RM, Ranki A, Vankeva L, Rieger KE, Stadler R, Trautinger F, Latzka J, Vermeer MH, Wachsmuth R, Weatherhead S, Wehkamp U, Wobser M, Kim YH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663780"},{"title01":"Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab","title02":"Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab","journal":"Blood","issue":"2025 Jul 15:blood.2025029117. doi: 10.1182\/blood.2025029117. Online ahead of print.","author":"Brooks TR, Zabor EC, Bedelu Y, Yang X MD, Karimi YH, Nedved AN, Wang Y, Dave NK, Landsburg DJ, Baron K, Hu B, Trotier D, Pophali PA, Miller J PharmD, Grover NS, Reinert C, Major A, Schwarz T, Patel K, Salafian K MD, Ayers EC, Sundaram S, Brody JD, McKenna M, Tiger YKR, Sears-Smith M, Ghosh N, Peterson C DO, Khan C, Bliven SP MD, Narkhede M, Gibson A, Kline J, Munoz J, Garza Morales R, Ho C, Smith SD, Niu A MD, Hernandez-Ilizaliturri FJ, Chinyengetere F MDPhD, Dave SS, Abdel-Razeq N, Alhaj Moustafa M, Caimi P, Hill BT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663785"},{"title01":"The Treatment of Marginal Zone Lymphoma","title02":"The Treatment of Marginal Zone Lymphoma","journal":"Blood","issue":"2025 Jul 15:blood.2024028269. doi: 10.1182\/blood.2024028269. Online ahead of print.","author":"Alderuccio JP, Noy A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663786"},{"title01":"High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease","title02":"High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease","journal":"Leukemia","issue":"2025 Jul 28. doi: 10.1038\/s41375-025-02715-2. Online ahead of print.","author":"Toscani D, Lungu O, Chiu M, Maccari C, Raimondi V, Taurino G, Bianchi MG, Scita M, Dalla Palma B, Iannozzi NT, Vescovini R, Dessena M, Sitzia C, Storti P, Andreoli R, Bussolati O, Giuliani N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40721650"},{"title01":"Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders","title02":"Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders","journal":"Leukemia","issue":"2025 Jul 23. doi: 10.1038\/s41375-025-02654-y. Online ahead of print.","author":"Zanwar S, Rajkumar SV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702148"},{"title01":"Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis","title02":"Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis","journal":"Leukemia","issue":"2025 Jul 16. doi: 10.1038\/s41375-025-02702-7. Online ahead of print.","author":"Yadav K, Mohan M, Wagner C, Chakraborty R, Sborov D, Godara A, McClune B, Schinke C, Dhakal B, D'Souza A, Szabo A, Mohyuddin GR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40670671"},{"title01":"Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma","title02":"Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma","journal":"Leukemia","issue":"2025 Jul 16. doi: 10.1038\/s41375-025-02707-2. Online ahead of print.","author":"Cooperrider JH, Karaoglu DA, Kubicki T, Jiang CR, Postich E, Shimamoto K, Arnold O, Macaraeg J, Ramsland A, Pula A, Kishtagari A, Pershad Y, Mack TM, Jones A, Bick AG, Savona M, Drazer MW, Dytfeld D, Jakubowiak A, Derman BA, Saygin C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40670674"},{"title01":"Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial","title02":"Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial","journal":"Lancet Oncol","issue":"2025 Aug;26(8):1067-1080.","author":"Hungria V, Robak P, Hus M, Zherebtsova V, Ward C, Ho PJ, H\u00e1jek R, Kim K, Grosicki S, Sia H, Bryant A, Pitombeira de Lacerda M, Martinez GA, Sureda Balar\u00ed A, Sandhu I, Cerchione C, Ganly P, Dimopoulos MA, Fu C, Garg M, Abdallah AO, Gatt ME, Oriol Rocafiguera A, Cavo M, Rifkin R, Fujisaki T, Mielnik M, Ficek J, Mantero A, Pirooz N, Varghese S, Lee J, McKeown A, Rogers R, Baig H, Eccersley L, Roy-Ghanta S, Mukhopadhyay P, Nielsen J, Opalinska J, Mateos MV; DREAMM-7 study investigators.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40680754"},{"title01":"Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial","title02":"Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial","journal":"Lancet Haematol","issue":"2025 Jul 15:S2352-3026(25)00163-2. doi: 10.1016\/S2352-3026(25)00163-2. Online ahead of print.","author":"Hungria V, Hus M, Fu C, Zherebtsova V, Ward C, Ho PJ, Mikulski D, Muronova L, Cerchione C, Loubert A, Bunod L, M'Hari M, Pirooz N, Rogers R, Lin CP, Roy-Ghanta S, Opalinska JB, Purser M, McKeown A, McNamara S, Baig H, Eccersley L, Pompilus F, Mateos MV; DREAMM-7 trial study group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40680752"},{"title01":"Rewriting Risk: A Data-Driven Look at Myeloma Genetics","title02":"Rewriting Risk: A Data-Driven Look at Myeloma Genetics","journal":"J Clin Oncol","issue":"2025 Jul 18:JCO2500988. doi: 10.1200\/JCO-25-00988. Online ahead of print.","author":"Patel K, Facon T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40680242"},{"title01":"Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myeloma","title02":"Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myeloma","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2025.287783. Online ahead of print.","author":"Dima D, Logue JM, Waqar SHB, Peres LC, Colin-Leitzinger CM, De Avila G, Smith EC, Skelson L, Matte KL, Blue B, Hovanky VN, Gaballa M, Pasvolsky O, Oswald LB, Fortuna GGM, Wagner CB, DeJarnette S, Dillard C, Perna F, Mikkilineni L, Hosoya H, Freeman CL, Shain KH, Baz RC, Grajales-Cruz A, Puglianini OC, Alsina M, Locke FL, Shune LO, Sborov DW, Patel KK, Sidana S, Hansen DK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637727"},{"title01":"Distinct patient, tumour and chimeric antigen receptor T-cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma","title02":"Distinct patient, tumour and chimeric antigen receptor T-cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma","journal":"Br J Haematol","issue":"2025 Jul 15. doi: 10.1111\/bjh.70012. Online ahead of print.","author":"Martin N, Thompson E, Stong N, Xu Y, Finney O, Rytlewski J, Flynt E, Marfo J, Descalzi-Montoya DB, Manrique I, Paiva B, Munshi N, Campbell TB, Kaiser SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40665490"},{"title01":"Cytolytic helper T cells: a new addition to myeloma immunity","title02":"Cytolytic helper T cells: a new addition to myeloma immunity","journal":"Blood","issue":"2025 Jul 24;146(4):402-403.","author":"Cupedo T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705390"},{"title01":"New prognostic systems for multiple myeloma in the context of contemporary therapies","title02":"New prognostic systems for multiple myeloma in the context of contemporary therapies","journal":"Blood","issue":"2025 Jul 30:blood.2024023841. doi: 10.1182\/blood.2024023841. Online ahead of print.","author":"Spencer A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40737601"},{"title01":"A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma","title02":"A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma","journal":"Blood","issue":"2025 Jul 23:blood.2025028597. doi: 10.1182\/blood.2025028597. Online ahead of print.","author":"Dutta D, Liu J, Wen K, Ray A, Salatino A, Liu X, Gulla A, Hideshima T, Song Y, Anderson KC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700574"},{"title01":"Silence of the myeloma clones: GPRC5D epigenetic regulation","title02":"Silence of the myeloma clones: GPRC5D epigenetic regulation","journal":"Blood","issue":"2025 Jul 10;146(2):133-135.","author":"Lee H, Bahlis NJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40638200"},{"title01":"Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics","title02":"Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics","journal":"Blood","issue":"2025 Jul 11:blood.2025028896. doi: 10.1182\/blood.2025028896. Online ahead of print.","author":"Yip RKH, Er J, Qin L, Nguyen QH, Motyer A, Rimes JS, Light A, Mishi RD, Ling L, Anttila CJA, Tsui E, Amann-Zalcenstein D, Dowling MR, Rogers KL, Bowden R, Chen Y, Harrison SJ, Hawkins ED.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40643106"},{"title01":"Rapid Recovery of Donor Hearts for Transplantation after Circulatory Death","title02":"Rapid Recovery of Donor Hearts for Transplantation after Circulatory Death","journal":"N Engl J Med","issue":"2025 Jul 17;393(3):267-274.","author":"Williams AM, Trahanas JM, Bommareddi S, Lima B, DeVries SA, Lowman J, Ahmad A, Quintana E, Scholl SR, Tsai S, Pedrotty D, Warhoover M, Moneypenny H, Tapia-Ruano S, Bacchetta M, Schlendorf K, Shah AS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40673585"},{"title01":"Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center","title02":"Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center","journal":"Haematologica","issue":"2025 Jul 24. doi: 10.3324\/haematol.2025.287628. Online ahead of print.","author":"Oran B, Thall P, Alousi A, Al-Atrash G, Mehta R, Marin D, Kebriaei P, Popat U, Bassett R, Bashir Q, Im J, Olson A, Jewell J, Smallbone P, Shpall E, Champlin R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702903"},{"title01":"Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21","title02":"Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2024.286719. Online ahead of print.","author":"Sakaguchi H, Sakaguchi K, Kato I, Noma H, Hiramatsu H, Ishida H, Yabe H, Goto H, Kawahara Y, Yamashita YI, Sanada M, Deguchi T, Takahashi Y, Saito AM, Takagi M, Okuno K, Taga T, Horibe K, Okamoto Y, Koh K, Manabe A, Umeda K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637726"},{"title01":"Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation","title02":"Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2024.287061. Online ahead of print.","author":"Sch\u00e4fer A, Buhler S, Farias TDJ, Kichula KM, Baldomero H, Sollet ZC, Ferrari-Lacraz S, Micheli B, Masouridi-Levrat S, Mesquita V, K\u00fcrsteiner O, Nair G, Halter J, G\u00fcng\u00f6r T, Schneidawind D, Chalandon Y, Passweg JR, Norman PJ, Villard J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637775"},{"title01":"Changing donors improves outcomes of second transplantation in patients who experienced graft failure after first allogeneic stem cell transplantation","title02":"Changing donors improves outcomes of second transplantation in patients who experienced graft failure after first allogeneic stem cell transplantation","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.287554. Online ahead of print.","author":"Ma R, Zhu XY, Lu Y, Chen J, Xuan L, Yuan HL, Cao Y, Cao WJ, Fang XS, Miao KR, Hu XX, Yi H, Zhao YM, Wu YB, Yang T, Wang HT, Yin Y, Zhang ZM, Zhang XH, Xu LP, Wang Y, Liu KY, Huang XJ, Sun YQ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671492"},{"title01":"ADH5\/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications","title02":"ADH5\/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications","journal":"Leukemia","issue":"2025 Jul 10. doi: 10.1038\/s41375-025-02687-3. Online ahead of print.","author":"Atkins J, Kukuyan AM, Toma M, Drzewiecka M, Vekariya U, Karami A, Nieborowska-Skorska M, Nejati R, Hadzijusufovic E, Valent P, Stoklosa T, Sliwinski T, Wasik M, Skorski T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40640557"},{"title01":"Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation","title02":"Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2024.287061. Online ahead of print.","author":"Sch\u00e4fer A, Buhler S, Farias TDJ, Kichula KM, Baldomero H, Sollet ZC, Ferrari-Lacraz S, Micheli B, Masouridi-Levrat S, Mesquita V, K\u00fcrsteiner O, Nair G, Halter J, G\u00fcng\u00f6r T, Schneidawind D, Chalandon Y, Passweg JR, Norman PJ, Villard J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637775"},{"title01":"On the mechanism of NPM1 mutations in acute myeloid leukemia","title02":"On the mechanism of NPM1 mutations in acute myeloid leukemia","journal":"Leukemia","issue":"2025 Jul 28. doi: 10.1038\/s41375-025-02722-3. Online ahead of print.","author":"Lieber MR, Hsieh CL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40721647"},{"title01":"Transcriptomic landscape of CD8+ and CD4\u2009+\u2009T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations","title02":"Transcriptomic landscape of CD8+ and CD4\u2009+\u2009T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations","journal":"Leukemia","issue":"2025 Jul 28. doi: 10.1038\/s41375-025-02708-1. Online ahead of print.","author":"Calabretto G, Binatti A, Teramo A, Buratin A, Baril\u00e0 G, Gasparini VR, Vicenzetto C, Gaffo E, Rampazzo E, Orsi S, Buson E, Trimarco V, Mariotti B, Facco M, Bazzoni F, Trentin L, Semenzato G, Zambello R, Bortoluzzi S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40721648"},{"title01":"Rare germline variant in NFATC4 associated with familial CLL","title02":"Rare germline variant in NFATC4 associated with familial CLL","journal":"Leukemia","issue":"2025 Jul 28. doi: 10.1038\/s41375-025-02713-4. Online ahead of print.","author":"Itchaki G, Bai H, Tiao G, Improgo R, Oppenheimer BE, Kasar S, Tesar B, Fernandes SM, Pochet N, Machado JH, Thrash EM, Freedman AS, Getz G, Brown JR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40721649"},{"title01":"Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal","title02":"Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal","journal":"Leukemia","issue":"2025 Jul 17. doi: 10.1038\/s41375-025-02693-5. Online ahead of print.","author":"Bond DR, Burnard SM, Uddipto K, Hunt KV, Harvey BM, Steffens Reinhardt L, Lawlor-O'Neill C, Roper EA, Humphries S, Murray HC, Mannan A, Dun MD, de Bock CE, Bowden NA, Enjeti AK, Verrills NM, Riveros C, L\u00ea Cao KA, Lee HJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40676205"},{"title01":"Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis","title02":"Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis","journal":"Leukemia","issue":"2025 Jul 21. doi: 10.1038\/s41375-025-02700-9. Online ahead of print.","author":"Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerov\u00e1 B, \u0160r\u00e1mek J, Valka J, Novak J, Zak P, Szotkowski T, Koristek Z, Krekeler C, Unglaub JM, Sauer T, Ruhnke L, Kraus S, Schaffrath J, M\u00fcller LP, Kaes S, Niemann D, Fransecky L, Hess PP, Crysandt M, Jost E, Millo J, Gaertner J, Repp R, Jentzsch M, Hoppe L, Klein S, Modemann F, Michalowski N, Fischbach K, Blau W, Ruhs M, Ritter M, Lohmeyer J, Steffen B, Hauser S, Kaufmann M, Krause SW, Knabe R, Spiekermann K, Serve H, Platzbecker U, Baldus CD, M\u00fcller-Tidow C, Lenz G, Reinhardt HC, Mayer J, Bornh\u00e4user M, R\u00f6llig C, Schliemann C, Hanoun M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40691504"},{"title01":"Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center","title02":"Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center","journal":"Haematologica","issue":"2025 Jul 24. doi: 10.3324\/haematol.2025.287628. Online ahead of print.","author":"Oran B, Thall P, Alousi A, Al-Atrash G, Mehta R, Marin D, Kebriaei P, Popat U, Bassett R, Bashir Q, Im J, Olson A, Jewell J, Smallbone P, Shpall E, Champlin R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702903"},{"title01":"Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21","title02":"Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2024.286719. Online ahead of print.","author":"Sakaguchi H, Sakaguchi K, Kato I, Noma H, Hiramatsu H, Ishida H, Yabe H, Goto H, Kawahara Y, Yamashita YI, Sanada M, Deguchi T, Takahashi Y, Saito AM, Takagi M, Okuno K, Taga T, Horibe K, Okamoto Y, Koh K, Manabe A, Umeda K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637726"},{"title01":"Ovarian tissue autotransplantation in acute leukemia: balancing the risk of relapse and the hope of parenthood","title02":"Ovarian tissue autotransplantation in acute leukemia: balancing the risk of relapse and the hope of parenthood","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2025.287942. Online ahead of print.","author":"Chevillon F, Labrune E, Clappier E, Lapillonne H, Ballerini P, Lange VB, Fortin A, Itzykson R, Soci\u00e9 G, Buzyn A, Leverger G, Dalle JH, Dh\u00e9din N, Boissel N, De Latour RP, Salle B, Roux C, Poirot C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637728"},{"title01":"Advancing quality of life research in chronic myeloid leukemia: where do we stand?","title02":"Advancing quality of life research in chronic myeloid leukemia: where do we stand?","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2025.288391. Online ahead of print.","author":"Lipton JH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637736"},{"title01":"Flow cytometric analysis of cerebrospinal fluid identifies patients with occult central nervous system involvement in relapsed pediatric acute lymphoblastic leukemia","title02":"Flow cytometric analysis of cerebrospinal fluid identifies patients with occult central nervous system involvement in relapsed pediatric acute lymphoblastic leukemia","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2025.287392. Online ahead of print.","author":"Thastrup M, Marquart HV, Levinsen M, Ulvmoen A, Albertsen BK, Pronk CJ, Olsen M, Wehner P, Taskinen M, Als-Nielsen B, Schmiegelow K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637739"},{"title01":"Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia","title02":"Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2025.287777. Online ahead of print.","author":"Murphy T, Zhang B, Zhang T, King I, Capo-Chichi JM, Gupta V, Maze D, McNamara CJ, Minden MD, Schimmer AD, Schuh AC, Sibai H, Yee KWL, Arruda A, Lu Z, Khalaf D, Rockwell C, Leber B, Sabloff M, Tierens A, Stockley TL, Chan SM, Ng SWK, Wang JCY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637740"},{"title01":"The small GTPase ARF6 regulates sphingolipid homeostasis and supports proliferation in acute myeloid leukemia","title02":"The small GTPase ARF6 regulates sphingolipid homeostasis and supports proliferation in acute myeloid leukemia","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2024.286228. Online ahead of print.","author":"Zhao HG, Cruz-Rodriguez N, Johnson KC, Pomicter AD, Bates B, Bateman B, Haferlach T, Gu T, Ahmann J, Yan D, Lee GS, Zhu W, Bishop J, Odelberg SJ, Deininger MW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637748"},{"title01":"Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey","title02":"Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2025.287772. Online ahead of print.","author":"Lang F, Pemberton-Whiteley Z, Clements J, Ruiz C, Rea D, Machado L, Takahashi N, Moon SH, Grigg A, Borowczak C, Schuld P, Frank P, Constantinescu C, Boquimpani C, Cortes JE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637752"},{"title01":"PHF6 interacts with the LMO2 complex in T-cell acute lymphoblastic leukemia","title02":"PHF6 interacts with the LMO2 complex in T-cell acute lymphoblastic leukemia","journal":"Haematologica","issue":"2025 Jul 10. doi: 10.3324\/haematol.2024.287124. Online ahead of print.","author":"Stanulovi\u0107 VS, Binhassan S, Jaber BA, Alazmi S, Saleman FMB, Potluri S, Pratt G, Ludwig C, Ward DG, Hoogenkamp M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637766"},{"title01":"Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia","title02":"Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2024.287253. Online ahead of print.","author":"Rockwell B, Goldfinger M, Mantzaris I, Shastri A, Saunthararajah Y, Gritsman K, Sica AR, Kornblum N, Shah N, Levitz D, Shapiro LC, Gupta R, Munoz A, Dhawan A, Fehn K, Comas M, Verceles J, Cooper DL, Konopleva M, Feldman EJ, Verma A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671491"},{"title01":"Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment","title02":"Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment","journal":"Haematologica","issue":"2025 Jul 17. doi: 10.3324\/haematol.2025.288105. Online ahead of print.","author":"Alkabbani O, Jabban Y, He R, Viswanatha D, Bessonen K, Greipp P, Jevremovic D, Foran JM, Badar T, Yi CA, Kusne Y, Saliba AN, Hefazi M, Matin A, Hogan WJ, Mangaonkar A, Alkhateeb H, Patnaik M, Shah M, Begna K, Litzow MR, Al-Kali A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40671498"},{"title01":"CD123-targeting immunotherapeutic approaches in acute myeloid leukaemia","title02":"CD123-targeting immunotherapeutic approaches in acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Jul 24. doi: 10.1111\/bjh.70019. Online ahead of print.","author":"Dreyzin A, Holtzman NG, Bonifant CL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707180"},{"title01":"Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring","title02":"Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring","journal":"Br J Haematol","issue":"2025 Jul 29. doi: 10.1111\/bjh.70059. Online ahead of print.","author":"Angotzi F, Cellini A, Danesin N, Zoletto S, Serafin A, Cavarretta CA, Bevilacqua A, Forlani L, Tonini A, Frezzato F, Bonaldi L, Pizzi M, Faggian D, Trentin L, Visentin A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40734248"},{"title01":"The impact of secondary hypogammaglobulinaemia in children with acute lymphoblastic leukaemia receiving maintenance chemotherapy","title02":"The impact of secondary hypogammaglobulinaemia in children with acute lymphoblastic leukaemia receiving maintenance chemotherapy","journal":"Br J Haematol","issue":"2025 Jul 20. doi: 10.1111\/bjh.70027. Online ahead of print.","author":"Cheng CN, Yang YN, Yeh YH, Chen JS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40685714"},{"title01":"Targeting NLRP1-CCL8 axis in the leukaemic niche suppresses AML via inhibition of PI3K-AKT signalling","title02":"Targeting NLRP1-CCL8 axis in the leukaemic niche suppresses AML via inhibition of PI3K-AKT signalling","journal":"Br J Haematol","issue":"2025 Jul 20. doi: 10.1111\/bjh.70011. Online ahead of print.","author":"Li X, Zhou Q, Hao X, Cao C, Adzraku SY, Song X, Sun C, Guo X, Li Y, Yuan S, Huang Y, Xu K, Qiao J, Zeng L, Ju W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40685774"},{"title01":"Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline-containing chemotherapy: A population-based matched cohort study","title02":"Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline-containing chemotherapy: A population-based matched cohort study","journal":"Br J Haematol","issue":"2025 Jul 21. doi: 10.1111\/bjh.70026. Online ahead of print.","author":"Jensen RH, Teglgaard C, Jensen JF, Baech J, Marcher CW, Roug AS, \u00d8rskov AD, Sch\u00f6llkopf C, Kristensen DT, Br\u00f8ndum RF, Severinsen MT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40692261"},{"title01":"Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML","title02":"Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML","journal":"Blood","issue":"2025 Jul 29:blood.2025028594. doi: 10.1182\/blood.2025028594. Online ahead of print.","author":"Nedumannil R, Ashby M, Rowland JP Dr, Malherbe JAJ, Fairbank J, Gray K, Loo S, Wright M, Reynolds J, Hiwase DK, Marlton P, Fleming SA, Bajel A, Wei AH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40729679"},{"title01":"Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients","title02":"Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients","journal":"Blood","issue":"2025 Jul 29:blood.2024028019. doi: 10.1182\/blood.2024028019. Online ahead of print.","author":"Smith A, Denny NDR, Chahrour C, Sharp K, Arachi M, Dopico-Fernandez AM, Elliott N, Harman J, Jackson T, Geng H, Smith O Professor, Bond J, Roberts I, Stam RWW, Crump N, Davies J, Roy A, Milne TA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40729681"},{"title01":"CD99 Promotes Self-renewal in Hematopoietic Stem Cells and Leukemia Stem Cells by Regulating Protein Synthesis","title02":"CD99 Promotes Self-renewal in Hematopoietic Stem Cells and Leukemia Stem Cells by Regulating Protein Synthesis","journal":"Blood","issue":"2025 Jul 23:blood.2024026271. doi: 10.1182\/blood.2024026271. Online ahead of print.","author":"Ji Y, Huang Y, Thomas T, Kapti EG, Tachibana R, Lark JA, Berezniuk I, Guo L, Ali MAE, Mims K, Kroger B, Hu W, Park CY, Chung SS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700577"},{"title01":"Fusion Oncoproteins and Cooperating Mutations Define Disease Phenotypes in NUP98-Rearranged Leukemia","title02":"Fusion Oncoproteins and Cooperating Mutations Define Disease Phenotypes in NUP98-Rearranged Leukemia","journal":"Blood","issue":"2025 Jul 23:blood.2025028993. doi: 10.1182\/blood.2025028993. Online ahead of print.","author":"Umeda M, Hiltenbrand RL, Michmerhuizen NL, Barajas JM, Thomas ME 3rd, Arthur B, Walsh MP, Song G, Ma JJ, Westover T, Kumar A, P\u00f6l\u00f6nen P, Mecucci C, Di Giacomo D, Locatelli F, Masetti R, Bertuccio SN, Pigazzi M, Pruett-Miller SM, Pounds SB, Rubnitz J, Inaba H, Papadopoulos KP, Wick MJ, Iacobucci I, Mullighan CG, Klco JM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700635"},{"title01":"A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLL","title02":"A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLL","journal":"Blood","issue":"2025 Jul 10:blood.2025028529. doi: 10.1182\/blood.2025028529. Online ahead of print.","author":"Guo M, Memis T, Ehrmann AS, Pittrof A, Baumann B, Ferrante F, Tausch E, Fischer K, D\u00f6hner H, Borggrefe T, Stilgenbauer S, Pannicke U, Schwarz K, Mertens D, Oswald F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40638689"},{"title01":"The acute myeloid leukemia microenvironment impairs neutrophil maturation and function through NF\u03baB signaling","title02":"The acute myeloid leukemia microenvironment impairs neutrophil maturation and function through NF\u03baB signaling","journal":"Blood","issue":"2025 Jul 15:blood.2024028199. doi: 10.1182\/blood.2024028199. Online ahead of print.","author":"Goel P, Aryal S, Franceski AM, Kuznetsova V, Costa AFO, Luca F, Connelly AN, Phillips DW, Ennis CC, Curtiss BM, Karfa S, Crown BL, Larson CR, Carminita E, Camacho V, Welsch D, Cheng C, Yokota A, Cobo I, Hirai H, Lu R, Bhatia R, Datta PK, Ferrell PB Jr, Welner RS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663784"},{"title01":"Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies","title02":"Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies","journal":"Leukemia","issue":"2025 Jul 24. doi: 10.1038\/s41375-025-02694-4. Online ahead of print.","author":"Chong SJF, Lai JXH, Iskandar K, Leong BJ, Wang C, Wang Y, Gui\u00e8ze R, Raman D, Lim RHF, Wu CJ, Chng WJ, Cheung AMS, Chuah C, Davids MS, Pervaiz S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707672"},{"title01":"Liquid-liquid phase separation of ZHX2 protects DLBCL cells against ferroptosis through induction of SLC3A2","title02":"Liquid-liquid phase separation of ZHX2 protects DLBCL cells against ferroptosis through induction of SLC3A2","journal":"Leukemia","issue":"2025 Jul 29. doi: 10.1038\/s41375-025-02718-z. Online ahead of print.","author":"Zhang J, Wang D, Luan M, Liu X, Wang N, Sheng X, Li S, Li B, Sun T, Ma D, Ye J, Lu F, Ji C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40730912"},{"title01":"A genome-wide association study identifies an African-specific locus on chromosome 21q22.12 associated with Burkitt lymphoma risk and survival","title02":"A genome-wide association study identifies an African-specific locus on chromosome 21q22.12 associated with Burkitt lymphoma risk and survival","journal":"Leukemia","issue":"2025 Jul 11. doi: 10.1038\/s41375-025-02690-8. Online ahead of print.","author":"Dutta D, Gouveia MH, Gorman BR, Adu-Gyamfi A, Lee CH, Ogwang MD, Kerchan P, Reynolds SJ, Tenge CN, Were PA, Wekesa WN, Tenge RK, Masalu N, Kawira EL, Kinyera T, Otim I, Nabalende H, Dhudha H, Candia B, Abaru J, Yan W, Florez-Vargas O, Xie Y, Ho M, Ayers LW, Bhatia K, Goedert JJ, Pfeiffer RM, Manning M, Hutchinson A, Cole N, Luo W, Hicks B, Chagaluka G, Johnston WT, Mutalima N, Borgstein E, Liomba GN, Kamiza S, Mkandawire N, Molyneux EM, Mitambo C, Newton R, Siebert R, Dean M, Yeager M, Chanock SJ, Prokunina-Olsson L, Mbulaiteye SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40646133"},{"title01":"Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma","title02":"Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma","journal":"Leukemia","issue":"2025 Aug;39(8):2035-2038. doi: 10.1038\/s41375-025-02658-8. Epub 2025 Jul 12.","author":"Zhao SH, Zhu ZM, Yang T, Gao D, Liu LH, Yang W, Wang XB, Zhao YX, Li M, Gao YN, Ma RJ, Yang Y, Li HP, Li L, Ao XL, Xiao XB, Hu CL, Yuan SZ, Ding Y, Chen XL, He JX, Liu Y, Huang WR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40652061"},{"title01":"Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell\/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing","title02":"Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell\/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing","journal":"Leukemia","issue":"2025 Jul 16. doi: 10.1038\/s41375-025-02679-3. Online ahead of print.","author":"Rausch T, Sch\u00e4fer H, Bein J, M\u00f6lder F, Beeck LK, K\u00f6lsch B, Borchert S, Benes V, Halbsguth T, Brunnberg U, Oellerich T, Tousseyn T, Ponzoni M, K\u00f6ster J, Hansmann ML, K\u00fcppers R, Hartmann S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40670673"},{"title01":"Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial","title02":"Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial","journal":"Lancet Oncol","issue":"2025 Aug;26(8):1081-1090.","author":"Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, Schaub V, H\u00fcttmann A, Keil F, Dierlamm J, H\u00e4nel M, Novak U, Meissner J, Hellmuth JC, Mathas S, Zijlstra JM, Foss\u00e5 A, Viardot A, Hertenstein B, Martin S, Giri P, Kamper P, Molin D, Jablonski J, Damaschin C, Robertz AS, Rosenbrock J, Fuchs M, Borchmann P, Behringer K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40652943"},{"title01":"Endogenous T cell responses to fusion-derived neoantigens in pediatric acute leukemias","title02":"Endogenous T cell responses to fusion-derived neoantigens in pediatric acute leukemias","journal":"Leukemia","issue":"2025 Jul 24. doi: 10.1038\/s41375-025-02710-7. Online ahead of print.","author":"Tirtakusuma R, Ghonim MA, Schattgen S, Muller B, Van de Velde LA, Khan TM, Crawford JC, Ma J, Abdelhamed S, Vegesana K, Awad W, Allen EK, Iacobucci I, Mullighan CG, Klco JM, Thomas PG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707674"},{"title01":"Heat stress targets and degrades BCR::ABL1 oncoproteins to overcome drug-resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia","title02":"Heat stress targets and degrades BCR::ABL1 oncoproteins to overcome drug-resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia","journal":"Leukemia","issue":"2025 Jul 22. doi: 10.1038\/s41375-025-02709-0. Online ahead of print.","author":"Yang C, Kang YY, Zhu CY, Ma Y, Yu PH, Yang T, Liu YQ, Zhang ZY, Suzuki N, Ogra Y, Bj\u00f6rklund M, Naranmandura H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40696139"},{"title01":"2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia","title02":"2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia","journal":"Leukemia","issue":"2025 Aug;39(8):1797-1813. doi: 10.1038\/s41375-025-02664-w. Epub 2025 Jul 11.","author":"Apperley JF, Milojkovic D, Cross NCP, Hjorth-Hansen H, Hochhaus A, Kantarjian H, Lipton JH, Malhotra H, Niederwieser D, Radich J, Rousselot P, Saussele S, Schiffer CA, Silver R, Soverini S, Stenke L, Turkina A, Casado LF, Castagnetti F, Cervantes F, Clark RE, Cortes J, Deininger M, Hughes TP, Janssen J, Jiang Q, Kim DW, Larson RA, Mahon FX, Mauro M, Mayer J, Nicolini FE, Pane F, Rea D, Richter J, Rosti G, Saglio G, Hehlmann R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40646132"},{"title01":"Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization","title02":"Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization","journal":"Leukemia","issue":"2025 Jul 16. doi: 10.1038\/s41375-025-02695-3. Online ahead of print.","author":"Vick EJ, Hassan A, Choi K, Bennett J, Muto T, Clough CA, Culver-Cochran AE, Hueneman K, Bolanos LC, Wunderlich M, Zhang X, McKnight C, Ceribelli M, Holland D, Klumpp-Thomas C, Greis KD, Thomas CJ, Starczynowski DT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40670672"},{"title01":"Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma","title02":"Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma","journal":"Haematologica","issue":"2025 Jul 24. doi: 10.3324\/haematol.2025.288114. Online ahead of print.","author":"Ghione P, Zinzani PL, Brown JR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702895"},{"title01":"Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)","title02":"Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)","journal":"Haematologica","issue":"2025 Jul 24. doi: 10.3324\/haematol.2025.288085. Online ahead of print.","author":"Yates SJ, Weiss JJ, Sneider A, Geramita E, Murthy GSG, Badar T, Im A, Lin C, Cheng W, Abaza Y, Swaroop A, Winer ES, Litzow MR, Atallah EL, Patel AA, Shallis RM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702896"},{"title01":"Genomic determinants of therapy response in ETV6::RUNX1 leukemia","title02":"Genomic determinants of therapy response in ETV6::RUNX1<\/i> leukemia","journal":"Leukemia","issue":"2025 Jul 9. doi: 10.1038\/s41375-025-02683-7. Online ahead of print.","author":"Oksa L, Moisio S, Maqbool K, Kramer R, Nikkil\u00e4 A, Jayasingha B, M\u00e4kinen A, Foroughi-Asl H, Rounioja S, Suhonen J, Krali O, Voutilainen M, Lahnalampi M, Veps\u00e4l\u00e4inen K, Huang S, Duque-Afonso J, Hauer J, Nordlund J, Wirta V, Lohi O, Hein\u00e4niemi M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634509"},{"title01":"Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response","title02":"Chemoresistance of TP53<\/i> mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response","journal":"Leukemia","issue":"2025 Jul 9. doi: 10.1038\/s41375-025-02668-6. Online ahead of print.","author":"Skuli SJ, Bakayoko A, Kruidenier M, Manning B, Pammer P, Salimov A, Riley O, Brake-Sill\u00e1 G, Dopkin D, Bowman M, Martinez-Gutierrez LN, Anderson CC, Reisz JA, Buono R, Paul M, Saland E, Liccardo F, DeVine A, Wong S, Xu JP, Nee E, Hausler R, Boettcher S, Sebti SM, Lai C, Maxwell KN, Sarry JE, Fruman DA, D'Alessandro A, Mesaros C, Keith B, Simon MC, Sung PJ, Wertheim G, Skuli N, Bowman RL, Matthews A, Carroll M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634510"},{"title01":"CD6 expression is an independent predictor of time to first treatment in chronic lymphocytic leukemia","title02":"CD6<\/i> expression is an independent predictor of time to first treatment in chronic lymphocytic leukemia","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2025.287564. Online ahead of print.","author":"Carrillo-Serradell L, Pi\u00f1eyroa JA, Bousquets-Mu\u00f1oz P, Planells-Romeo V, Arag\u00f3n-Serrano L, Casad\u00f3-Llombart S, Colomer D, Andr\u00e9s MV, Puente XS, Delgado J, Mozas P, Lozano F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605694"},{"title01":"B-lymphoblastic leukemia with KMT2A rearrangement with mature B-cell phenotype and surface \u03bb light-chain restriction","title02":"B-lymphoblastic leukemia with KMT2A<\/i> rearrangement with mature B-cell phenotype and surface \u03bb light-chain restriction","journal":"Blood","issue":"2025 Jun 26;145(26):3194.","author":"Deb PQ, Zhang X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40569637"},{"title01":"Are we ready for an MRD-driven approach in multiple myeloma?","title02":"Are we ready for an MRD-driven approach in multiple myeloma?","journal":"Blood","issue":"2025 Jul 3;146(1):2-4.","author":"Gay F, Mina R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40608349"},{"title01":"Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails","title02":"Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails","journal":"Blood","issue":"2025 Jul 3:blood.2025028403. doi: 10.1182\/blood.2025028403. Online ahead of print.","author":"Xiong S, Zhou J, Chng WJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40608868"},{"title01":"Immune Alterations in Myeloma Evolution and Outcomes: Quo Vadis?","title02":"Immune Alterations in Myeloma Evolution and Outcomes: Quo Vadis?","journal":"Blood","issue":"2025 Jul 7:blood.2024026227. doi: 10.1182\/blood.2024026227. Online ahead of print.","author":"Dhodapkar MV, Paiva B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623045"},{"title01":"More than myeloma: the trouble with “normal” plasma cells","title02":"More than myeloma: the trouble with “normal” plasma cells","journal":"Blood","issue":"2025 Jun 26;145(26):3066-3067..","author":"Firestone RS, Maura F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40569638"},{"title01":"When the silence speaks: T-cell dysfunction in myeloma","title02":"When the silence speaks: T-cell dysfunction in myeloma","journal":"Blood","issue":"2025 Jun 26;145(26):3064-3066.","author":"Friedrich MJ, Raab MS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40569640"},{"title01":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","title02":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","journal":"Leukemia","issue":"2025 Jul 9. doi: 10.1038\/s41375-025-02685-5. Online ahead of print.","author":"Rettinger E, Heckl D, Gibson B, Sauer M, Turkiewicz D, Kleinschmidt K, Kalwak K, Reinhardt D, Locatelli F, Klusmann JH; Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634512"},{"title01":"Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","title02":"Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e542-e554.","author":"Damaj G, Bazarbachi A, Berning P, Cottereau AS, Fox CP, Kyriakou C, Cwynarski K, Zinzani PL, Tournilhac O, Jurczak W, Karsten IE, Wang F, Marcais A, Tanase A, Nguyen-Quoc S, Serroukh Y, Aljurf M, Beauvais D, Wulf G, Sureda A, Corradini P, Hermine O, Hamadani M, Onida F, Ruggeri AL, Sanchez-Ortega I, Yakoub-Agha I, Dreger P, Schmitz N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610175"},{"title01":"Cardiac arrest linked to myeloid sarcoma after haematopoietic stem-cell transplantation","title02":"Cardiac arrest linked to myeloid sarcoma after haematopoietic stem-cell transplantation","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e560.","author":"Harrer DC, Mester P, Schmid S, Baborie A, Riemenschneider MJ, Fuchs A, Wolff D, Poeck H, Herr W, M\u00fcller M, Pavel V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610176"},{"title01":"The ESOT-Lancet Commission on Transplantation: a new vision for global sustainability, innovation, and equity in organ transplantation","title02":"The ESOT-Lancet<\/i> Commission on Transplantation: a new vision for global sustainability, innovation, and equity in organ transplantation","journal":"Lancet","issue":"2025 Jun 30:S0140-6736(25)01197-3. doi: 10.1016\/S0140-6736(25)01197-3. Online ahead of print.","author":"Oniscu GC, Muller E, Wilson C, Horton R; ESOT\u2013Lancet Commission on Transplantation.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40614742"},{"title01":"Policy innovations to advance equity in solid organ transplantation","title02":"Policy innovations to advance equity in solid organ transplantation","journal":"Lancet","issue":"2025 Jun 30:S0140-6736(25)00712-3. doi: 10.1016\/S0140-6736(25)00712-3. Online ahead of print.","author":"Jaure A, Jha V, McElroy LM, Muller E, Oniscu GC, Serper M, Purnell TS, Scholes-Robertson N, Reese PP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40614743"},{"title01":"Advancing patient monitoring, diagnostics, and treatment strategies for transplant precision medicine","title02":"Advancing patient monitoring, diagnostics, and treatment strategies for transplant precision medicine","journal":"Lancet","issue":"2025 Jun 30:S0140-6736(25)00195-3. doi: 10.1016\/S0140-6736(25)00195-3. Online ahead of print.","author":"Loupy A, Sablik M, Khush K, Reese PP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40614744"},{"title01":"Scientific advances in the assessment, modification, and generation of transplantable organs for patients with end-stage organ diseases","title02":"Scientific advances in the assessment, modification, and generation of transplantable organs for patients with end-stage organ diseases","journal":"Lancet","issue":"2025 Jun 30:S0140-6736(25)00239-9. doi: 10.1016\/S0140-6736(25)00239-9. Online ahead of print.","author":"Shaver CM, Reese PP, Griesemer A, Zuckermann A, Bacchetta M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40614745"},{"title01":"Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report","title02":"Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2024.287205. Online ahead of print.","author":"Prata PH, Eikema DJ, Piepenbroek B, Kulasekararaj A, Drexler B, Tjon JM, Vaht K, Aljurf M, Chevallier P, Gedde-Dahl T, Kaare A, Salmenniemi U, Schroeder T, Byrne J, Cornillon J, Barraco F, Maertens J, Tholouli E, Platzbecker U, Kr\u00f6ger N, Blaise D, Sica S, Zeiser R, Risitano AM, De Latour RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605711"},{"title01":"Precision transplant and cell therapies for non-malignant disorders-The path forward","title02":"Precision transplant and cell therapies for non-malignant disorders-The path forward","journal":"Br J Haematol","issue":"2025 Jul 5. doi: 10.1111\/bjh.20245. Online ahead of print.","author":"Lakkaraja M, Baker KS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40616382"},{"title01":"Aging-declined RNA exportation impairs hematopoietic stem cells by inducing R-loop","title02":"Aging-declined RNA exportation impairs hematopoietic stem cells by inducing R-loop","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2025.287765. Online ahead of print.","author":"Chen R, Dong Q, Zhou L, He H, Du Y, Sun Q, Suda T, Cheng T, Wang J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605703"},{"title01":"Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report","title02":"Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2024.287205. Online ahead of print.","author":"Prata PH, Eikema DJ, Piepenbroek B, Kulasekararaj A, Drexler B, Tjon JM, Vaht K, Aljurf M, Chevallier P, Gedde-Dahl T, Kaare A, Salmenniemi U, Schroeder T, Byrne J, Cornillon J, Barraco F, Maertens J, Tholouli E, Platzbecker U, Kr\u00f6ger N, Blaise D, Sica S, Zeiser R, Risitano AM, De Latour RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605711"},{"title01":"Haematopoietic stem cell transplant for inborn errors of immunity-Who and when?","title02":"Haematopoietic stem cell transplant for inborn errors of immunity-Who and when?","journal":"Br J Haematol","issue":"2025 Jul 7. doi: 10.1111\/bjh.20248. Online ahead of print.","author":"Oved JH, Marsh RA, Petrovic A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40619934"},{"title01":"Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipients","title02":"Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipients","journal":"Br J Haematol","issue":"2025 Jul 9. doi: 10.1111\/bjh.20254. Online ahead of print.","author":"Duret A, Charles O, Margetts BK, Booth J, Brown JR, Best T, Fernandes S, Amrolia P, Chiesa R, Silva J, Worth A, Standing JF, Rao K, Whittaker E, Gil E, Breuer J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40630011"},{"title01":"Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools","title02":"Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools","journal":"Br J Haematol","issue":"2025 Jun 30. doi: 10.1111\/bjh.20232. Online ahead of print.","author":"El Jurdi N, Waldman MA, Schulz E, Mina A, Li G, Carpenter A, Theis JD, Sethi S, Caza T, Seshan SV, Pavletic SZ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40589069"},{"title01":"Clusterin(g) and decoding HSC aging","title02":"Clusterin<\/i>(g) and decoding HSC aging","journal":"Blood","issue":"2025 Jul 3;146(1):4-5..","author":"Gerbaulet A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40608350"},{"title01":"Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis","title02":"Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis","journal":"Blood","issue":"lood. 2025 Jul 7:blood.2024027197. doi: 10.1182\/blood.2024027197. Online ahead of print.","author":"Perales MA, Awan FT, Boumendil A, Patel J, Castagna L, Angelucci E, Finel H, Kulagin AD, Glass B, Corradini P, Herrera AF, Blaise D, Kharfan-Dabaja MA, Halahleh K, Ahmed S, Martinez C, Giebel S, Montoto S, Jones RJ, Ahmed N, Lynch RC, de Lima MJ, Shadman M, Sauter CS, Ahn KW, Hamadani M, Bazarbachi A, Sureda A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623049"},{"title01":"Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report","title02":"Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2024.287205. Online ahead of print.","author":"Prata PH, Eikema DJ, Piepenbroek B, Kulasekararaj A, Drexler B, Tjon JM, Vaht K, Aljurf M, Chevallier P, Gedde-Dahl T, Kaare A, Salmenniemi U, Schroeder T, Byrne J, Cornillon J, Barraco F, Maertens J, Tholouli E, Platzbecker U, Kr\u00f6ger N, Blaise D, Sica S, Zeiser R, Risitano AM, De Latour RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605711"},{"title01":"Splenectomy: still a life-saving treatment in immune thrombocytopenia","title02":"Splenectomy: still a life-saving treatment in immune thrombocytopenia","journal":"Haematologica","issue":"2025 Jul 1;110(7):1451-1453.","author":"Rodeghiero F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40590188"},{"title01":"Type I interferon as a pre-lupus marker in anti-nuclear antibody-associated childhood immune thrombocytopenic purpura","title02":"Type I interferon as a pre-lupus marker in anti-nuclear antibody-associated childhood immune thrombocytopenic purpura","journal":"Br J Haematol","issue":"2025 Jul 5. doi: 10.1111\/bjh.20241. Online ahead of print.","author":"Granel J, Fernandes H, Wojciechowski E, Pillet P, Richer O, Clet J, Fournier B, H\u00e9ritier S, Leblanc T, Foray AP, Nombel A, Garnier L, Leibler C, Blanco P, Belot A, Aladjidi N; French reference center for paediatric autoimmune cytopenia (CEREVANCE).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40616374"},{"title01":"Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study","title02":"Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e505-e515.","author":"Strati P, Castro J, Goodman A, Bachanova V, Kamdar M, Awan FT, Solomon SR, Wong L, Wong C, Patel D, Bickers C, Zhao W, Bashir Z, Valamehr B, Elstrom RL, Patel K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610174"},{"title01":"Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","title02":"Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e542-e554.","author":"Damaj G, Bazarbachi A, Berning P, Cottereau AS, Fox CP, Kyriakou C, Cwynarski K, Zinzani PL, Tournilhac O, Jurczak W, Karsten IE, Wang F, Marcais A, Tanase A, Nguyen-Quoc S, Serroukh Y, Aljurf M, Beauvais D, Wulf G, Sureda A, Corradini P, Hermine O, Hamadani M, Onida F, Ruggeri AL, Sanchez-Ortega I, Yakoub-Agha I, Dreger P, Schmitz N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610175"},{"title01":"Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed\/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study","title02":"Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed\/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study","journal":"J Clin Oncol","issue":"2025 Jul 7:JCO2500399. doi: 10.1200\/JCO-25-00399. Online ahead of print.","author":"Kamdar M, Solomon SR, Arnason J, Johnston PB, Glass B, Bachanova V, Ibrahimi S, Mielke S, Mutsaers P, Hernandez-Ilizaliturri F, Izutsu K, Morschhauser F, Lunning M, Chow VA, Montheard S, Santamaria J, Colicino S, Ogasawara K, Stepan L, Liu FF, Abramson JS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623279"},{"title01":"BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?","title02":"BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2025.288196. Online ahead of print.","author":"Dogliotti I, Federico M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605702"},{"title01":"Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial","title02":"Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2025.288057. Online ahead of print.","author":"Danilov AV, Li H, Shadman M, Rimsza L, Zebari A, Smith SM, LeBlanc M, Friedberg JW, Carlson C, Song JY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605713"},{"title01":"Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter’s transformation or transformed non-Hodgkin lymphoma: results from a phase I trial","title02":"Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter’s transformation or transformed non-Hodgkin lymphoma: results from a phase I trial","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2024.286945. Online ahead of print.","author":"Shouse G, Chen C, Muir A, Popplewell L, Siddiqi T, Zain J, Herrera AF, Danilova O, Roleder C, Wang L, Spurgeon SEF, Kittai AS, Chen L, Xia Z, Davids MS, Danilov AV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605718"},{"title01":"We are on the right track for mantle cell lymphoma","title02":"We are on the right track for mantle cell lymphoma","journal":"Br J Haematol","issue":"2025 Jul 6. doi: 10.1111\/bjh.20259. Online ahead of print.","author":"Moioli A, Visco C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40619706"},{"title01":"Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with\u00a0relapsed\/refractory large B-cell lymphoma","title02":"Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with\u00a0relapsed\/refractory large B-cell lymphoma","journal":"Br J Haematol","issue":"2025 Jun 30. doi: 10.1111\/bjh.20240. Online ahead of print.","author":"Sharp J, Zhao Q, Voorhees TJ, Bond DA, Sawalha Y, Reneau J, Sigmund A, Hanel W, Sehgal L, Alinari L, Baiocchi R, Brammer JE, Maddocks K, Christian B, Bezerra E, Denlinger N, Vasu S, De Lima M, Prosek J, Epperla N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40589093"},{"title01":"Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience","title02":"Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience","journal":"Br J Haematol","issue":"2025 Jul 1. doi: 10.1111\/bjh.20234. Online ahead of print.","author":"Cassanello G, Luttwak E, Brown S, Devlin SM, Imber B, Ip A, Leslie LA, Accav NG, Avigdor A, Marcus R, Beyar-Katz O, Corona M, Luna De Abia A, Calabrese De Feo J, Rivas Delgado A, Lue JK, Grommes C, Shah GL, Park J, Perales MA, Salles G, Shouval R, Scordo M, Palomba ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40589238"},{"title01":"Vitrectomy as a rapid diagnostic tool for lymphoma: Cytology and flow cytometry approach","title02":"Vitrectomy as a rapid diagnostic tool for lymphoma: Cytology and flow cytometry approach","journal":"Br J Haematol","issue":"2025 Jul 1. doi: 10.1111\/bjh.20250. Online ahead of print.","author":"Gascon P, Frankel D, Fritz S, Comet A, Matonti F, Ramtohul P, Conrath J, David T, Robert P, Schenone L, Harlay V, Chinot O, Tabouret E, Nanni I, Astier A, Roll P, Kaspi E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40589309"},{"title01":"Virtual twins for personalised CAR T-cell therapy in myeloma","title02":"Virtual twins for personalised CAR T-cell therapy in myeloma","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e490-e491.","author":"Reiche K, Weirauch U, Kreuz M, Fischer L, Gras L, Neumuth T, Platzbecker U, K\u00f6hl U, Demlova R, Kremer A, Fr\u00f6hlich H, Franke S, Merz M; CERTAINTY Consortium.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610172"},{"title01":"Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network","title02":"Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network","journal":"Lancet Haematol","issue":"2025 Jun 25:S2352-3026(25)00117-6. doi: 10.1016\/S2352-3026(25)00117-6. Online ahead of print.","author":"van de Donk NWCJ, Moreau P, San-Miguel JF, Mateos MV, Dimopoulos MA, Zweegman S, Gay F, Engelhardt M, Mina R, Zamagni E, Delforge M, Beksac M, Spencer A, Schjesvold F, Driessen C, Kaiser M, Perrot A, W\u00e4sch R, Korst CL, Broijl A, Touzeau C, Manier S, Hajek R, Ludwig H, Fernandez de Larrea C, Popat R, Musto P, Rodriguez-Otero P, Yong K, Rasche L, Terpos E, Raab MS, Boccadoro M, Sonneveld P, Einsele H; EMN Guidelines Committee.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40580975"},{"title01":"Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study","title02":"Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study","journal":"Lancet Haematol","issue":"2025 Jun 27:S2352-3026(25)00139-5. doi: 10.1016\/S2352-3026(25)00139-5. Online ahead of print.","author":"Kumar SK, Harrison SJ, Cavo M, de la Rubia J, Popat R, Gasparetto C, Hungria V, Salwender H, Suzuki K, Kim I, Onishi M, Ku G, Pothacamury R, Jalaluddin M, Zeng J, Ross JA, Dobkowska E, Moreau P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40587991"},{"title01":"In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma","title02":"In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma","journal":"Lancet","issue":"2025 Jul 2:S0140-6736(25)01030-X. doi: 10.1016\/S0140-6736(25)01030-X. Online ahead of print.","author":"Xu J, Liu L, Parone P, Xie W, Sun C, Chen Z, Zhang J, Li C, Hu Y, Mei H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40617243"},{"title01":"Haematopoietic stem cell transplant for inborn errors of immunity-Who and when?","title02":"Haematopoietic stem cell transplant for inborn errors of immunity-Who and when?","journal":"Br J Haematol","issue":"2025 Jul 7. doi: 10.1111\/bjh.20248. Online ahead of print.","author":"Oved JH, Marsh RA, Petrovic A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40619934"},{"title01":"Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipients","title02":"Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipients","journal":"Br J Haematol","issue":"2025 Jul 9. doi: 10.1111\/bjh.20254. Online ahead of print.","author":"Duret A, Charles O, Margetts BK, Booth J, Brown JR, Best T, Fernandes S, Amrolia P, Chiesa R, Silva J, Worth A, Standing JF, Rao K, Whittaker E, Gil E, Breuer J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40630011"},{"title01":"Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools","title02":"Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools","journal":"Br J Haematol","issue":"2025 Jun 30. doi: 10.1111\/bjh.20232. Online ahead of print.","author":"El Jurdi N, Waldman MA, Schulz E, Mina A, Li G, Carpenter A, Theis JD, Sethi S, Caza T, Seshan SV, Pavletic SZ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40589069"},{"title01":"An AI model of transplantation risk for myelofibrosis","title02":"An AI model of transplantation risk for myelofibrosis","journal":"Blood","issue":"2025 Jun 26;145(26):3068-3069.","author":"M\u00e9ndez-Ferrer S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40569639"},{"title01":"Microbiota and chronic GVHD: a plasmablast link","title02":"Microbiota and chronic GVHD: a plasmablast link","journal":"Blood","issue":"2025 Jun 26;145(26):3073-3075.","author":"Rashidi A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40569643"},{"title01":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","title02":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","journal":"Leukemia","issue":"2025 Jul 9. doi: 10.1038\/s41375-025-02685-5. Online ahead of print.","author":"Rettinger E, Heckl D, Gibson B, Sauer M, Turkiewicz D, Kleinschmidt K, Kalwak K, Reinhardt D, Locatelli F, Klusmann JH; Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634512"},{"title01":"Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study","title02":"Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e505-e515.","author":"Strati P, Castro J, Goodman A, Bachanova V, Kamdar M, Awan FT, Solomon SR, Wong L, Wong C, Patel D, Bickers C, Zhao W, Bashir Z, Valamehr B, Elstrom RL, Patel K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610174"},{"title01":"Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","title02":"Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e542-e554.","author":"Damaj G, Bazarbachi A, Berning P, Cottereau AS, Fox CP, Kyriakou C, Cwynarski K, Zinzani PL, Tournilhac O, Jurczak W, Karsten IE, Wang F, Marcais A, Tanase A, Nguyen-Quoc S, Serroukh Y, Aljurf M, Beauvais D, Wulf G, Sureda A, Corradini P, Hermine O, Hamadani M, Onida F, Ruggeri AL, Sanchez-Ortega I, Yakoub-Agha I, Dreger P, Schmitz N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610175"},{"title01":"Cardiac arrest linked to myeloid sarcoma after haematopoietic stem-cell transplantation","title02":"Cardiac arrest linked to myeloid sarcoma after haematopoietic stem-cell transplantation","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e560.","author":"Harrer DC, Mester P, Schmid S, Baborie A, Riemenschneider MJ, Fuchs A, Wolff D, Poeck H, Herr W, M\u00fcller M, Pavel V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610176"},{"title01":"DCPS is a synthetic lethal therapeutic target in acute myeloid leukemia expressing low levels of FHIT","title02":"DCPS is a synthetic lethal therapeutic target in acute myeloid leukemia expressing low levels of FHIT","journal":"Leukemia","issue":"2025 Jun 26. doi: 10.1038\/s41375-025-02661-z. Online ahead of print.","author":"Grassi F, Singh M, Moussaud S, Rodriguez GV, Ali Z, Janssen K, Cheray M, Leonard E, Andersson M, de Milito A, Qian H, Walfridsson J, H\u00f6glund A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40571744"},{"title01":"SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells","title02":"SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells","journal":"Leukemia","issue":"2025 Jun 30. doi: 10.1038\/s41375-025-02673-9. Online ahead of print.","author":"Wang M, Zhu R, Small D, Lin L, Li L, Ma S, Xia L, Luo S, He W, Yu J, Li J, Wei R, Zhang A, Shi W, Hu Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40588567"},{"title01":"Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial","title02":"Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial","journal":"Leukemia","issue":"2025 Jun 30. doi: 10.1038\/s41375-025-02674-8. Online ahead of print.","author":"Gong X, Liu W, Liu Y, Fang Q, Gu R, Liu K, Lin D, Zhou C, Zhang G, Gong B, Wei S, Li Y, Li S, Wang Y, Hu Y, Qiu S, Liu B, Wang Y, Mi Y, Wei H, Wang J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40588568"},{"title01":"Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment","title02":"Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment","journal":"Leukemia","issue":"2025 Jul 3. doi: 10.1038\/s41375-025-02675-7. Online ahead of print.","author":"Ronnacker J, Ruhnke L, R\u00f6llig C, Middeke JM, Herbst R, Morgner A, Unglaub JM, Sauer T, Huber K, Baden D, Fransecky L, Gezer MN, Crysandt M, Jost E, Jentzsch M, Metzeler KH, Berdel AF, Urbahn MA, Kolloch L, Stelljes M, Platzbecker U, Br\u00fcmmendorf TH, Baldus C, M\u00fcller-Tidow C, H\u00e4nel M, Bornh\u00e4user M, Wethmar K, Krug U, Lenz G, Mikesch JH, Schliemann C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40603653"},{"title01":"Efficacy or convenience? Subcutaneous blinatumomab as a promising new treatment for B-cell acute lymphoblastic leukaemia","title02":"Efficacy or convenience? Subcutaneous blinatumomab as a promising new treatment for B-cell acute lymphoblastic leukaemia","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e485-e487. doi: 10.1016\/S2352-3026(25)00169-3.","author":"Curran E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610169"},{"title01":"Ibrutinib versus acalabrutinib in fixed-duration chronic lymphocytic leukemia therapy: a comparative analysis of efficacy","title02":"Ibrutinib versus acalabrutinib in fixed-duration chronic lymphocytic leukemia therapy: a comparative analysis of efficacy","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2025.288323. Online ahead of print.","author":"Molica S, Shanafelt TD, Giannarelli D, Allsup D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605690"},{"title01":"Relapsed acute lymphoblastic leukemia: back to the drawing board","title02":"Relapsed acute lymphoblastic leukemia: back to the drawing board","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2025.288191. Online ahead of print.","author":"Jacoby E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605705"},{"title01":"Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemia","title02":"Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemia","journal":"Haematologica","issue":"2025 Jul 3. doi: 10.3324\/haematol.2025.287794. Online ahead of print.","author":"Ahn JS, Park JH, Lee C, Song IC, Kim MY, Sohn SK, Yhim HY, Park Y, Kim I, Shin HJ, Park SK, Kim SH, Cheong JW, Lee HS, Lee H, Bae SH, Choi Y, Lee HG, Do YR, Han JJ, Kim MK, Park S, Kim HJ, Kim HJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40605710"},{"title01":"Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes","title02":"Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes","journal":"Br J Haematol","issue":"2025 Jul 7. doi: 10.1111\/bjh.20226. Online ahead of print.","author":"Zu Y, Yue X, Zhan X, Liu X, Ma H, Qin F, Duan L, Zhao H, Zhang Y, He S, Zhao H, Zhang C, Xin X, Zhang W, Song Y, Liu B, Li W, Zhang Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40624854"},{"title01":"ZIP10 as a potential therapeutic target in acute myeloid leukaemia","title02":"ZIP10 as a potential therapeutic target in acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Jun 30. doi: 10.1111\/bjh.20229. Online ahead of print.","author":"Rolles B, Chatain N, G\u00f6rg R, Vieri M, Tillmann-Tr\u00f6ster N, Bourgeois MG, Christen D, Walter J, Hillerbrand AC, Romine KA, Taylor KM, Bertram J, Jost E, Koschmieder S, Beier F, Stahl M, Br\u00fcmmendorf TH, Rink L, Wessels I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40583520"},{"title01":"Integration of [(18)F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma","title02":"Integration of [(18)F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma","journal":"Leukemia","issue":"2025 Jul 8. doi: 10.1038\/s41375-025-02688-2. Online ahead of print.","author":"Dondolin R, Garrou F, Almasri M, Terzi Di Bergamo L, Cosentino C, Bruscaggin A, Salehi M, Talotta D, Bruna R, Rivolta GM, Bellia M, Nabki J, Al Deeban B, Cividini L, Mouhssine S, Maher N, Ghanej J, Maiellaro F, Andorno A, Mercalli F, Leutner M, Lorenzi A, Mahmoud AM, Al Essa W, Diop NM, Secomandi E, Deambrogi C, Rasi S, Boldorini RL, Gentile M, Palumbo GA, Gattei V, Fo\u00e0 R, Rossi D, Sacchetti GM, Gaidano G, Moia R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40629066"},{"title01":"Off-the-shelf iPSC natural killer-cell therapy: a new chapter for B-cell lymphoma?","title02":"Off-the-shelf iPSC natural killer-cell therapy: a new chapter for B-cell lymphoma?","journal":"Lancet Haematol","issue":"2025 Jul;12(7):e484-e485.","author":"Tix T, Rejeski K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610168"},{"title01":"Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades","title02":"Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades","journal":"Br J Haematol","issue":"2025 Jul 2. doi: 10.1111\/bjh.20239. Online ahead of print.","author":"Alzahrani M, Gerrie AS, Sehn LH, Scott DW, Venner CP, Savage KJ, Villa D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40598970"},{"title01":"Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis","title02":"Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis","journal":"Blood","issue":"2025 Jul 7:blood.2024027197. doi: 10.1182\/blood.2024027197. Online ahead of print.","author":"Perales MA, Awan FT, Boumendil A, Patel J, Castagna L, Angelucci E, Finel H, Kulagin AD, Glass B, Corradini P, Herrera AF, Blaise D, Kharfan-Dabaja MA, Halahleh K, Ahmed S, Martinez C, Giebel S, Montoto S, Jones RJ, Ahmed N, Lynch RC, de Lima MJ, Shadman M, Sauter CS, Ahn KW, Hamadani M, Bazarbachi A, Sureda A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623049"},{"title01":"Targeting proteostasis in multiple myeloma through inhibition of LTK","title02":"Targeting proteostasis in multiple myeloma through inhibition of LTK","journal":"Leukemia","issue":"2025 Jul 9. doi: 10.1038\/s41375-025-02682-8. Online ahead of print.","author":"V\u00e5tsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Sk\u00e5nland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634511"},{"title01":"The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed\/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials","title02":"The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed\/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials","journal":"Leukemia","issue":"2025 Jul 2. doi: 10.1038\/s41375-025-02677-5. Online ahead of print.","author":"Ntanasis-Stathopoulos I, Filippatos C, Malandrakis P, Koutoulidis V, Trapali M, Kastritis E, Terpos E, Dimopoulos MA, Gavriatopoulou M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40603652"},{"title01":"The European Conference on Infections in Leukaemia (ECIL-10) guidelines for COVID-19 should take convalescent plasma into proper consideration","title02":"The European Conference on Infections in Leukaemia (ECIL-10) guidelines for COVID-19 should take convalescent plasma into proper consideration","journal":"Leukemia","issue":"2025 Jul 4. doi: 10.1038\/s41375-025-02691-7. Online ahead of print.","author":"Focosi D, Casadevall A, Sullivan DJ, Joyner MJ, Franchini M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40615657"},{"title01":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","title02":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","journal":"Leukemia","issue":"2025 Jul 9. doi: 10.1038\/s41375-025-02685-5. Online ahead of print.","author":"Rettinger E, Heckl D, Gibson B, Sauer M, Turkiewicz D, Kleinschmidt K, Kalwak K, Reinhardt D, Locatelli F, Klusmann JH; Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634512"},{"title01":"Profound phenotypic deficiencies in mature blood and bone marrow progenitor dendritic cells in chronic lymphocytic leukemia patients","title02":"Profound phenotypic deficiencies in mature blood and bone marrow progenitor dendritic cells in chronic lymphocytic leukemia patients","journal":"Leukemia","issue":"2025 Jun 26. doi: 10.1038\/s41375-025-02579-6. Online ahead of print.","author":"Welch BM, Parikh SA, Kay NE, Medina KL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40571743"},{"title01":"A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS","title02":"A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS","journal":"Br J Haematol","issue":"2025 Jul 1. doi: 10.1111\/bjh.20224. Online ahead of print.","author":"Searle E, Cluzeau T, O'Nions J, Recher C, Gyan E, Morillo D, Esteve J, Kulasekararaj A, Raffoux E, Walter HS, Pigneux A, Valc\u00e1rcel D, Daskalakis N, Bussolari J, Pietsch EC, Kuduk S, Bush T, Zhang X, Philippar U, Oluwasanjo A, Bradford K, Miller J, Van Bogaert C, Curtis M, Chang SY, Guttke C, Gaj S, Pearson R, Murphy J, van Dijck W, Alfonso Pi\u00e9rola A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40598790"},{"title01":"Reproductive patterns and birth rates in acute leukaemia survivors: A Danish population-based cohort study","title02":"Reproductive patterns and birth rates in acute leukaemia survivors: A Danish population-based cohort study","journal":"Br J Haematol","issue":"2025 Jul 2. doi: 10.1111\/bjh.20238. Online ahead of print.","author":"Nielsen NN, Jensen JF, \u00d8vlisen A, Zenas DR, Sch\u00f6llkopf C, Toft N, \u00d8rskov AD, Hansen DL, M\u00f8lle I, Kristensen DT, Severinsen MT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40603258"},{"title01":"Successful combined anti-CD19 immunotherapy of relapsed acute lymphoblastic leukaemia in a child with Nijmegen breakage syndrome","title02":"Successful combined anti-CD19 immunotherapy of relapsed acute lymphoblastic leukaemia in a child with Nijmegen breakage syndrome","journal":"Br J Haematol","issue":"2025 Jul 2. doi: 10.1111\/bjh.20244. Online ahead of print.","author":"Oszer A, Mielcarek-Siedziuk M, Marschollek P, Gamrot Z, Karolczyk G, Urbanska Z, Ussowicz M, Janczar S, M\u0142ynarski W, Pastorczak A, Ka\u0142wak K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40603265"},{"title01":"Therapy-related juvenile myelomonocytic leukemia","title02":"Therapy-related juvenile myelomonocytic leukemia","journal":"Blood","issue":"2025 Jul 3;146(1):127.","author":"Mohamed A, Richardson AI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40608348"},{"title01":"Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia","title02":"Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia","journal":"Blood","issue":"2025 Jul 3:blood.2025028935. doi: 10.1182\/blood.2025028935. Online ahead of print.","author":"Carter BZ, Mak PY, Ayoub E, Wu X, Ke B, Nishida Y, Futreal A, Ostermann LB, Bedoy AD, Boettcher S, DiNardo CD, Puzio-Kuter A, Poyurovsky MV, Levine AJ, Andreeff M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40608889"}]